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Genome stability in eukaryotic cells relies heavily on their ability to differentiate 
between telomeres - natural ends of linear chromosomes - and double strand 
breaks (DSBs), pathological lesions which can occur throughout the stretch of 
chromosomal DNA. The former are to be protected from fusions, 
recombination and recognition by DNA damage response, whereas the latter 
are to be detected by the checkpoint system and repaired by end joining or 
homologous recombination. Due to the end replication problem, continually 
dividing cells are confronted with an additional necessity to maintain stable 
telomere length, which in most eukaryotes is fulfilled by telomerase. 
Telomerase is downregulated in human somatic cells to limit their replicative 
capacity and prevent malignization, forcing pre-malignant cells to seek ways 
of re-establishing telomere length homeostasis. Most cancers perform it by 
reactivating telomerase. Recently, Makovets group found a yeast model for 
telomerase reactivation through aneuploidy in cells with temperature-induced 
telomerase insufficiency. Given that aneuploidy is a common feature of 
cancers, a deeper mechanistic understanding of aneuploidy-driven telomerase 
reactivation in yeast may shed more light on cancer telomere biology. 
In telomerase-negative cancers telomere attrition is counteracted by 
alternative lengthening of telomeres (ALT). ALT is related to one of DSB repair 
pathways - break-induced replication (BIR), which operates on single-ended 
DSBs, such as those originating from broken replication forks. Phosphorylated 
Pif1 helicase has been reported to be essential for BIR, but the molecular 
mechanism of this requirement has not been ascertained. We found that the 
need for phosphorylated Pif1 in BIR is alleviated in yeast expressing an N-
terminally truncated Dna2 nuclease/helicase. In my work I aim to gain insights 
into how yeast solve problems related to both natural chromosomal ends and 
DSBs by investigating mechanisms underlying aneuploidy-dependent 
telomerase reactivation in yeast cells with temperature-induced telomerase 





The human genetic makeup is composed of 46 chromosomes, each of them a 
linear DNA molecule with two ends. Bacterial genome is different in that 
regard, as in most bacterial species there is only one circular chromosome with 
no ends. Having two-ended chromosomes is a two-edged sword. As a species 
we benefit from the genetic diversity resulting from the constant reshuffling of 
genes between parental chromosomes in each generation, made easy by the 
linear topology of human chromosomes. But for an individual human cell, linear 
chromosomes present certain challenges, as the chromosome ends require 
protection from fusing and degradation. In addition, because of the properties 
of the machinery used by all living cells to copy their DNA, chromosomes with 
linear topology become ever shorter at the ends with each copying cycle. The 
ends of the chromosomes are called telomeres and consist of a stretch of 
repetitive DNA sequence, which is mostly meaningless in terms of 
informational content, but constitutes an essential reserve of chromosome 
length, which can be sacrificed for the greater good of DNA copying. Moreover, 
telomeres play essential role in protecting chromosomes from fusions and 
degradation. However, when many DNA replication cycles pass, the telomere 
reserve becomes exhausted and essential genes start being targeted by the 
chromosomal attrition. This attrition is considered to be one of the fundamental 
mechanisms of ageing both at the level of single cells and complex organisms, 
such as ourselves. Multicellular organisms die eventually, but their species 
prevail at the level of germline cells (which give rise to sperms and egg cells), 
while for single-celled organisms reproduction is tantamount to cellular 
division. Thus, in all eukaryotic species the continuation of life requires some 
way of restoring the telomeres lost in the process of DNA synthesis. This is 
made possible by a special molecular machine called telomerase, which adds 
on telomere repeats at chromosome ends. In humans telomerase is present 
in sufficient amounts in germline, embryonic and stem cells, while in the bulk 
of human cells the amount of telomerase diminishes at the embryonic stage 
and is kept low thought life. This is believed to be an evolved protective 
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mechanism, which prevents pre-cancerous cells from forming tumors by 
limiting their capacity to proliferate, as without telomerase such cells would 
eventually run out of telomere repeats to spare. However, cancers do occur in 
humans, which means that cancerous cells have ways of sustaining their 
telomeres. Most types of cancers do this by restoring the necessary amount of 
telomerase. The process of telomerase reactivation in cancer cells is thus of 
outmost interest for medical science and a major target of cancer therapy 
research.  
A lot of telomere biology research has been performed on buddying yeast – a 
convenient model organism, which is easy to grow and manipulate genetically. 
Being single-celled organisms, yeast normally possess active telomerase in 
each cell, however it was discovered that a rise in the growth temperature 
produces a decrease in the amount of the telomerase in yeast. Makovets lab 
have developed a yeast model of telomerase reactivation, which occurs at 
elevated growth temperature as a result of a major genetic rearrangement in 
yeast cells. Similarities between this yeast model and human cancers can be 
drawn, as genetic rearrangements are commonplace in cancer cells and are 
known to cause telomerase activation. The precise mechanism of telomerase 
reactivation in this yeast model is the focus of one of my PhD projects.  
The second project of my PhD addresses some aspects of the repair of 
chromosomal breaks. While the ends at the edges of chromosomes are a 
natural part of human life, the ends that are created as a result of chromosomal 
fragmentation are different and extremely dangerous for cells. Chromosomal 
breaks that produce such ends may result from radiation, toxins or simply as 
a consequence of metabolic processes in the cell. Luckily, cells possess an 
efficient machinery for tackling chromosomal breaks. Yet again, an extremely 
useful and life-giving process, such as chromosome break repair, may become 
hijacked by cancer cells for their malignant purposes, specifically, to maintain 
their telomeres in the absence of telomerase. At the same time, the reliance of 
cancer cells on specific types of chromosomal break repair for proliferation 
makes these types of repair cancer’s Achilles tendon, if only we were to learn 
how to target these processes. Many proteins are involved in chromosomal 
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break repair, Dna2 being one of them. My second PhD project is devoted to 
understanding some of the functions of Dna2 in break repair in yeast with the 
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TPE telomere position effect 
TRF terminal restriction fragment 
UV ultraviolet light 
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1.1. Properties, functions and maintenance of natural 
eukaryotic chromosome ends 
Telomeres are the ends of linear eukaryotic chromosomes and are crucial for 
maintaining genome stability (Kupiec, 2014). Two major components of 
telomeres are DNA (represented by TTAGG-type repeats in most eukaryotes, 
Palm and de Lange, 2008; Fulcher et al., 2014) and associated proteins which 
prevent chromosomes from fusion (Pardo and Marcand, 2005), nucleolytic 
degradation and recombination (Polotnianka, Li and Lustig, 1998). The 
telomeric DNA consists of a centromere-proximal double-stranded region 
followed by a centromere-distal G-rich 3’-overhang which varies in length 
across different groups of eukaryotes. 
1.1.1. An overview of mammalian telomeres 
The structure and functions of mammalian and, more specifically, human 
telomeres are particularly relevant to understanding and treating human 
telomere-related diseases, ageing and cancer. Mammalian telomeres 
represent a stretch of tandem repeats of the sequence TTAGGG which may 
span as long as 50 kbp (Lejnine, Makarov and Langmore, 1995). The G-rich 
3’-tail at the end of a human telomere is about 50-500 nucleotides long 
(Makarov, Hirose and Langmore, 1997; Stewart et al., 2003) and is not present 
as a free ssDNA overhang, but is instead base-paired to the double-stranded 
part of the telomere DNA causing an eviction of a region of the G-reach strand 
in the form of a D-loop (Griffith et al., 1999). The bigger loop that encompasses 
the D-loop and the terminal part of the telomere separated by the D-loop from 
the rest of the chromosome is termed the t-loop. As will be discussed below, 
the t-loop plays critical roles in telomere protection from checkpoint 
recognition, homologous recombination and telomere fusions. 
Mammalian telomeres are covered by a six-protein complex, called shelterin 
(Figure 1.1, De Lange, 2005), which performs vital protective functions, 
including the formation of the t-loop (Stansel, De Lange and Griffith, 2001). 
Two evolutionarily related shelterin proteins TRF1 and TRF2 form homodimers 
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which interact with the double-stranded telomere sequence via their C-terminal 
Myb/SANT domains (Bianchi et al., 1997; Broccoli et al., 1997; Court et al., 
2005; Hanaoka, Nagadoi and Nishimura, 2009) and directly or indirectly recruit 
other shelterin components and non-shelterin accessory factors to telomeres 
(Kim et al., 2009; reviewed in de Lange, 2018).  
 
Figure 1.1: Schematic of human shelterin complex and its association with a 
telomere 
From de Lange, 2018 
The single-stranded parts of the telomere (including the ssDNA of the 
telomeric D-loop) are bound by the shelterin component POT1 which forms a 
heterodimer with another shelterin protein TPP1 (Baumann and Cech, 2001; 
Liu et al., 2004; Loayza et al., 2004). Rodent cells possess two POT1 
paralogues – POT1a and POT1b, which have a partial separation of functions 
(Hockemeyer et al., 2006; Wu, Takai and De Lange, 2012). TPP1 is bridged 
to TRF1 and TRF2 via another shelterin protein TIN2, which thus connects the 
dsDNA-interacting part of the shelterin complex to the ssDNA-interacting part 
(Ye et al., 2004; Hu et al., 2017). Noteworthy, POT1 depends on the interaction 
with TPP1 for its nuclear localization and recruitment to the telomeric ssDNA 
(Liu et al., 2004; Ye et al., 2004; Chen, Liu and Songyang, 2007). In addition, 




Finally, the shelterin complex comprises RAP1, which is the only shelterin 
component with an ortholog among budding yeast telomere-capping proteins. 
Contrary to its S. cerevisiae counterpart, mammalian RAP1 demonstrates a 
low affinity to telomeric DNA, despite possessing a Myb domain (Hanaoka et 
al., 2001; Arat and Griffith, 2012), and predominantly depends on TRF2 for 
telomere association (Zhu et al., 2000; Celli and de Lange, 2005). 
Shelterin performs a range of tasks pertinent to telomere protection and 
genome stability. TRF2 is believed to facilitate t-loop formation by virtue of its 
ability to wrap DNA around itself, thus creating a local area of unwound DNA 
in the double-stranded part of the telomere, which promotes the invasion by 
the G-tail and D-loop formation (Amiard et al., 2007). Some models propose 
that the TRF2-dependent t-loop formation averts ATM activation by preventing 
the 3’-overhang from interacting with the MRN complex, thereby blocking the 
initial step of the ATM-dependent checkpoint cascade (see section 1.2.2 for 
the DNA damage checkpoint overview) (Palm and de Lange, 2008). Another 
checkpoint cascade, that is governed by the ATR kinase, is inhibited by POT1 
at telomeres (Denchi and De Lange, 2007). POT1 associates with telomeric 
ssDNA thus rendering it inaccessible for RPA binding, which is required for 
ATR activation (Gong and de Lange, 2010). Deletion of either POT1 or TRF2 
causes continuous checkpoint signalling, inhibiting the transition of cells into 
the S-phase or mitosis and eventually leading to senescence or apoptosis, 
depending on the cell type (Karlseder et al., 1999; Smogorzewska and De 
Lange, 2002; Celli and de Lange, 2005; Denchi and De Lange, 2007).  
Additionally, TRF2 hinders PARP1 signalling at telomeres by masking the 5’ 
ds-ssDNA junctions at the base of the t-loop from PARP1 detection (Poulet et 
al., 2009; Rai et al., 2016; Schmutz et al., 2017). When PARP1 is not restricted 
by TRF2 in its ability to recognize the 5’ ds-ssDNA junction, such as when 
cellular TRF2 lacks part of its N-terminus, it may recruit Holiday junction 
resolvases to the t-loop, potentially resulting in large terminal deletions. 
Apart from inhibiting checkpoint signalling at telomeres shelterin and the 
associated factors protect telomeres from the double-strand break (DSB) 
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repair processes, such as classic non-homologous end-joining (c-NHEJ), 
microhomology-mediated end-joining (MMEJ) and homologous recombination 
(see section 1.2.1 for the overview of DSB repair) (Van Steensel, 
Smogorzewska and De Lange, 1998; Celli, Denchi and de Lange, 2006; 
Mateos-Gomez et al., 2015). TRF2-induced t-loop has been proposed to 
repress telomere fusions by sequestering the telomere end from the Ku70/80 
protein complex (Doksani et al., 2013). Homologous recombination at 
telomeres is averted by Ku70/80 complex (Celli, Denchi and de Lange, 2006), 
which has been shown to associate with TRF2 (Song et al., 2000). Both 
shelterin complex and Ku70/80 have been implicated in alternative NHEJ (alt-
NHEJ) inhibition at telomeres (Sfeir and De Lange, 2012; Mateos-Gomez et 
al., 2015). 
1.1.2. An overview of mammalian telomerase 
Soon after deciphering the molecular mechanism of DNA replication it became 
apparent that telomeric ends of linear chromosomes cannot be completely 
copied by regular eukaryotic DNA-polymerases (as these enzymes require an 
RNA primer to initiate synthesis) and therefore must become ever shorter with 
each replication/division cycle (Olovnikov, 1973). This is actually the case for 
human somatic cells which hence divide only around 50 times in cell culture 
before they senesce and die (Hayflick, 1965; Gilson and Géli, 2007). But the 
fact that telomere length is maintained in germline cells, embryonic stem cells, 
cancer cells and unicellular organisms still required an explanation and it came 
with the discovery of Tetrahymena telomerase – the enzyme capable of 
extending telomeric DNA primer (Greider and Blackburn, 1985). 
It has since been established that in most other eukaryotes telomere length is 
also sustained by telomerase, with some exceptions, such as Drosophila 
melanogaster, whose cells maintain their telomere-length homeostasis 
through retrotransposition (Mason, Frydrychova and Biessmann, 2008; 




Similarly to most other eukaryotes, mammalian cells maintain stable telomere 
length using telomerase enzyme (Morin, 1989; Meyerson et al., 1997; 
Nakamura et al., 1997). Mammalian telomerase core includes a reverse 
transcriptase polypeptide (TERT) and an RNA (TERC) containing a template 
region for telomere extension (Feng et al., 1995; Beattie et al., 2001). In large 
mammals, such as humans, TERT gene is transcriptionally downregulated in 
most somatic cells, limiting their proliferative capacity (Gorbunova and 
Seluanov, 2009). When several telomeres in a cell reach critically short length, 
it undergoes apoptosis or transitions into a senescence state, likely due to 
shelterin deprotection (Karlseder, Smogorzewska and De Lange, 2002; 
D’Adda Di Fagagna et al., 2003; Zou et al., 2004). Cellular senescence 
resulting from reduced telomerase activity in somatic cells is 
considered among the main reasons of ageing in humans (Harley et al., 1992; 
Kim et al., 1994). Downregulation of telomerase gene is believed to serve the 
purpose of restricting proliferation of pre-cancerous cells in organisms with 
higher cell numbers and correspondingly a higher chance of cancer 
development (Gorbunova and Seluanov, 2009). However, human cells that 
have impaired DNA damage signalling due to the lack p53 and RB proteins 
are able to bypass senescence induced by telomere deprotection (Jacobs and 
De Lange, 2004). In cells with dysfunctional DNA damage signalling 
deprotected telomeres may initiate a cascade of severe genome 
rearrangements, which might result in malignant transformation (Chin et al., 
1999; Maser and DePinho, 2002; O’Hagan et al., 2002). In the absence of cell 
cycle arrest repeated break-fusion-bridge cycles caused by telomere fusion 
may lead to translocations, gene amplifications and loss of heterozygosity 
(LOH) (Riboni et al., 1997; Artandl et al., 2000; Roger et al., 2013). The 
consequences of telomere dysfunction also include chromothripsis and 
tetraploidization, the latter often followed by aneuploidy (Galipeau et al., 1996; 
Davoli, Denchi and de Lange, 2010; Davoli and de Lange, 2012; Maciejowski 
et al., 2015). All these kinds of genomic rearrangements have been connected 
to malignization (Artandl et al., 2000; Dumur et al., 2003; Davoli and de Lange, 
2011; Li et al., 2014). However, in the long run constant genome instability 
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may decrease cell viability and proliferative capacity due to extreme levels of 
genome deterioration (Jacobs and De Lange, 2004). Therefore, despite 
genome instability promoting cellular transformation at a certain step of cancer 
development, long-term survival of cancerous cells likely requires that genome 
instability is eventually restrained. This requirement has been postulated to 
create a selective pressure in cancerous cells to reestablish telomere 
protection by reactivating telomerase expression or switching to 
recombination-dependent alternative lengthening of telomeres (ALT) 
(Maciejowski and De Lange, 2017). Noteworthy, as many as 85% of cancers 
reactivate telomerase in order to overcome the end-replication problem limiting 
propagation (Shay and Bacchetti, 1997). Telomerase-positive cancers are 
often more aggressive than telomerase-negative variants (Tatsumoto et al., 
2000; Oh et al., 2008; Peifer et al., 2015). These notions underscore 
telomerase as both a relevant research object and a promising therapeutic 
target. 
1.1.3. The structure and the biological role of S. cerevisiae 
telomeres 
The structure of budding yeast telomeres has special properties (Figure 1.2) 
some of which are not shared by other model organisms. One of the key 
features of S. cerevisiae telomere dsDNA is that it is represented by a 
300±75bp stretch of degenerate repeats with consensus C1-3A/TG1-3 
(Shampay, Szostak and Blackburn, 1984) rather than a precisely repeated 
sequence. The terminal part of budding yeast double-stranded telomere region 
is juxtaposed to a single-stranded tail of G-rich strand. The latter sustains the 
length of 12-15 nt during most of the cell cycle (Larrivée, LeBel and Wellinger, 
2004) except for a short period within late S/G2 phase when it extends to ≥30-
100 nt (Wellinger, Wolf and Zakian, 1993). Safe for specific circumstances 
(Cesare et al., 2008), yeast telomeres are speculated to lack any base pairing 
between the relatively short overhang (the G-tail) and the double-stranded 
telomere stretch due to yeast telomeres being short and irregular in sequence 
(Tomaska et al., 2004; Luke-Glaser, Poschke and Luke, 2012). 
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Figure 1.2: Schematic of a yeast telomere with associated proteins 
Modified from Kupiec, 2014 
Budding yeast telomeres are preceded by subtelomeric sequences of two 
types – X and Y’ (Chan and Tye, 1983, see Figure 1.6). An X element is 
present on each S. cerevisiae telomere, whereas a Y’ element can be usually 
found on half of telomeres and is always centromere distal with respect to the 
X element. Sometimes multiple copies of the Y’ element occur on a single 
telomere. Two size classes of Y’ elements exist - short (5.2 kb) and long (6.7 
kb). Quite often a short stretch of telomeric GC-rich repeats can be observed 
at a junction between X and Y’ elements and is always present between 
multiple copies of the Y’ element (Wellinger and Zakian, 2012). 
The proteins bound to the S. cerevisiae telomere region form two distinctive 
sets corresponding to either double-stranded or single-stranded regions of the 
telomere. Rap1 is a major telomere-associated protein covering the double-
stranded area of telomeric repeats. The functions of this protein are diverse 
and are often mediated via its interaction with other proteins such as Rif1, Rif2, 
Sir2, Sir3, and Sir4. In the genome Sir (Silent Information Regulator) proteins 
play an important role in transcription repression and organization of 
heterochromatin (Rine et al., 1979; Palladino et al., 1993). At telomeres Sir 
9 
 
proteins participate in so-called telomere position effect (TPE) along with the 
Ku complex. TPE (silencing of a gene located next to a telomere) was 
discovered when a gene placed in a close proximity of a telomere was 
repressed regardless of its specific promoter sequence (Gottschling et al., 
1990; Pryde and Louis, 1999). The C-terminal domain of Rap1 protein is 
required for TPE and this effect is possibly explained by the fact that Sir 
proteins are recruited to the telomeres via their interaction with the Rap1 
carboxy-terminus (Hardy, Sussel and Shore, 1992; Palladino et al., 1993; 
Moretti et al., 1994). 
Among the key roles of Rap1 protein is protecting telomeres from fusions 
occurring by NHEJ. This function is executed via two parallel pathways 
involving proteins Rif2 and Sir4 (Marcand et al., 2008). Another important 
activity of Rap1 is preventing excessive resection of telomeres. Rap1-bound 
protein Rif2 has been shown to oppose the binding of Tel1/MRX complex to 
telomeres, the latter being a key player of the DBS and telomere resection 
pathway (Bonetti et al., 2010). In addition, Rif2, as well as Rif1, participate in 
the counting mechanism of regulation of telomere length (Levy and Blackburn, 
2004). 
Another prominent telomere-associated protein is Ku. The yeast Ku protein 
complex consists of two subunits – yKu70 and yKu80. Being a key participant 
of the NHEJ pathway it is somewhat counterintuitive that the Ku complex is 
encountered at telomeres. Nevertheless, it plays a pivotal role in telomere 
biology. As already mentioned, the Ku complex functions in TPE. Additionally 
it is involved in limiting telomere resection (Bonetti et al., 2010), in telomere 
tethering to the perinuclear space (Laroche et al., 1998), and telomerase 
trafficking into the nucleus (Gallardo et al., 2008), which will be considered 
below in more detail.  
The single-stranded G-tail is associated with a different set of proteins of which 
the proteins of the CST complex are the main constituents. CST is an 
abbreviation for the protein names Cdc13, Stn1 and Ten1. Being the physical 
ends of chromosomes, telomeres must be distinguished from double-strand 
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breaks in order to prevent cells from eliciting DNA damage response and an 
inappropriate cell-cycle arrest and this important distinction is largely due to 
the activity of the CST complex (Weinert and Hartwell, 1993; Petreaca, Chiu 
and Nugent, 2007). This protective effect is called telomere capping and 
involves preventing excessive resection of telomere C-strand by Exo1 
exonuclease and competitive inhibition of RPA binding to ssDNA at telomeres 
(Zubko, Guillard and Lydall, 2004; Kupiec, 2014). Efficient recruitment of 
telomerase – the telomere extending enzyme – to telomeres at late S stage of 
cell cycle depends upon interaction of telomerase subunit Est1 with Cdc13 
(Nugent et al., 1996; Evans and Lundblad, 1999; Chan, Boulé and Zakian, 
2008). 
1.1.4. S. cerevisiae telomerase overview 
A considerable part of telomerase research has been concentrated on 
Saccharomyces cerevisiae, as this organism is a relatively simple and well-
studied model eukaryote (Kupiec, 2014). Yeast telomerase comprises several 
protein subunits, namely Est1, Est2 and Est3, as well as an RNA-component 
- TLC1, the latter serving both as a structural element and a template for 
telomere extension. Est2 is the actual catalytic subunit which elongates 3’ 
telomere overhang using part of TLC1 RNA as a template (Singer and 
Gottschling, 1994; Counter et al., 1997). Figure 1.3 provides a schematic 
representation of S. cerevisiae telomerase structure. 
Figure 1.3: Schematic representation of S. cerevisiae telomerase 
Adapted from Tucey and Lundblad, 2014 
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The stem-loop structures of the TLC1 RNA provide sites for binding to multiple 
proteins including the Est1 and Est2 subunits of telomerase as well as the 
yKu80 protein (Zappulla et al., 2011). tlc1Δ48 deletion eliminates the 
interaction between yKu80 and TLC1 (Peterson et al., 2001) but no 
other impact of tlc1Δ48 on the rest of protein associations of TLC1 has been 
reported. Figure 1.4 outlines the model of secondary structure of TLC1 and 
highlights the stem-loops to which corresponding proteins bind. 
  
Figure 1.4: Model of stem-loop structures of the TLC1 RNA with the specific 
locations of its binding partners marked  




1.1.5. S. cerevisiae telomerase complex assembly 
Recent discoveries have shed light on some stages of the telomerase complex 
assembly (Tucey and Lundblad, 2014). The established steps are outlined in 
Figure 1.5. 
Figure 1.5: Scheme of telomerase quaternary complex assembly (1) and 
disassembly (2)  
 See the main text for details. Adapted from Tucey and Lundblad, 2014 
 
It has been proposed that the assembly of the telomerase quaternary complex 
(holoenzyme) is completed when the Est3 subunit binds to the preassembled 
complex consisting of Est1 and Est2 associated with TLC1 (Tucey and 
Lundblad, 2014). Est1 and Est2 have interfaces responsible for the interaction 
with Est3 and the latter was found to possess a single surface (dubbed “TEL” 
patch) for binding both (Rao et al., 2014; Tucey and Lundblad, 2014). A toggle 
switch serine 113 that negatively regulates Est3 inclusion into the preassembly 
complex is immediately adjacent to the “TEL” patch. This was inferred from the 
analysis of est3-S113Y mutants that demonstrate increased amount of 
holoenzyme along with slightly extended telomeres (Tucey and Lundblad, 
2014). Est3 incorporation is likely accompanied by a conformation change in 
the preassembly complex (symbolically depicted in Figure 1.5 as a change in 
the angle between Est1 and Est2), whereby Est3 simultaneously interacts with 
both Est1 and Est2. In the disassembly pathway Est2 leaves the holoenzyme, 









TLC1. Both the assembly and the disassembly processes accelerate towards 
late S stage, during which chromosomal termini are extended. The 
holoenzyme seems to be a transient stage that is linked by a dynamic 
equilibrium to the more stable and thus more abundant states of the 
preassembly and disassembly complexes, which raises a possibility, that Est2 
protein dissociation might be a way of terminating the enzymatic cycle of 
telomere elongation (Tucey and Lundblad, 2014). 
1.1.6. Yeast telomerase nuclear import and recruitment to 
telomeres  
Despite being active only during the late S stage, the telomerase Est2 subunit 
appears to have a constant cell concentration and is found at telomeres 
throughout the cell cycle, with two distinct peaks of telomere association: in G1 
stage and in late S stage (Fisher, Taggart and Zakian, 2004). The G1 
recruitment peak disappears completely in TLC1- and Ku-deficient strains and 
also in strains where TLC1-Ku interaction is abolished, whereas the S phase 
peak is diminished to ∼50 % of the WT level in these strains (Taggart, Teng 
and Zakian, 2002; Fisher, Taggart and Zakian, 2004). The second peak also 
decreases two-fold upon disruption of the interaction between TLC1 and Est1 
or between Est1 and Cdc13. Interestingly, among the mutations affecting the 
second peak of Est2 telomere recruitment, only those disrupting Est1 
association with either TLC1 or Cdc13 abrogate telomere length homeostasis. 
The disruption of telomere length maintenance in these mutants cannot be 
attributed to a more severe Est2 recruitment defect, since the level of S-phase 
Est2 recruitment in them is comparable to some mutants with stable telomeres. 
One solution to this apparent paradox is that Est1 plays an additional role in 
telomere maintenance distinct from Est2 recruitment to telomeres. For 
instance, it may activate the holoenzyme by recruiting the Est3 subunit to it 
(Osterhage, Talley and Friedman, 2006). 
Est1 has a single peak of telomere association in late S phase of the cell cycle 
which also corresponds to the increase of Est1 concentration in the cell during 
this period (Taggart, Teng and Zakian, 2002; Fisher, Taggart and Zakian, 
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2004; Chan, Boulé and Zakian, 2008). This association is decreased ~3-fold 
in yku70∆ and tlc∆48 strains (Fisher, Taggart and Zakian, 2004) and ~4-fold in 
cdc13-2 (a mutant defective in Cdc13-Est1 interaction) strains and, 
intriguingly, is completely lost in est2∆ strains (Chan, Boulé and Zakian, 2008). 
The latter notion indicates that Est1 probably interacts with Cdc13 only as part 
of the holoenzyme and not on its own (Chan, Boulé and Zakian, 2008). 
FISH-experiments probing for endogenous TLC1 showed that the interaction 
between TLC1 48nt stem-loop region and the Ku protein are necessary for 
nuclear retention of TLC1 (Gallardo et al., 2008). These results are in 
accordance with previous reports of the Ku protein-dependent nuclear 
localization of overexpressed TLC1 (Teixeira et al., 2002). The Est1/2/3 
proteins have been also demonstrated to take part in TLC1 nuclear trafficking 
as deletion of any of the three proteins resulted in localization of TLC1 in the 
cytoplasm (Gallardo et al., 2008). Since cytoplasmic TLC1 was still able to bind 
Est1 and Est2 proteins it has been proposed that after being transcribed in the 
nucleus TLC1 moves to the cytoplasm to undergo some important maturation 
steps involving binding to Est1 and Est2 proteins. The retention of TLC1 in the 
cytoplasm upon failing to associate with Est1 or Est2 might represent a safe-
guard mechanism that prevents accumulation of incomplete dominant-
negative telomerase complexes in the nucleoplasm (Osterhage, Talley and 
Friedman, 2006; Gallardo and Chartrand, 2008; Gallardo et al., 2008). 
However, some data indicate, that Est1 facilitates TLC1 distribution to the 
nucleus by keeping it inside nucleoplasm rather than by driving its import 
(Hawkins and Friedman, 2014). TLC1 nuclear localization could be also 
promoted by its association with telomeres, given that the deletion of TEL1 and 
of components of MRX complex, known to recruit telomerase to telomeres, 
also results in a decrease (albeit less pronounced) of TLC1 nuclear 
compartmentalization (Gallardo et al., 2008). Finally, TLC1 WT steady-state 
levels were shown to require direct interaction of TLC1 with Ku (Mozdy, Cech 
and Podell, 2008; Zappulla et al., 2011). 
Obviously, there should exist a way for the protein subunits of telomerase to 
be transferred to the nucleus as well. Consistent with the previously mentioned 
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holoenzyme incorporation-dependent TLC1 mode of nuclear import, Gallardo 
and Chartrand postulate a model, whereby the Est1/2/3 proteins are carried 
along with TLC1 into the nucleus (Gallardo and Chartrand, 2008). This 
mechanism was later questioned when Hawkins and Friedman demonstrated 
the existence of non-overlapping pathways for Est1 and TLC1 nuclear import 
(Hawkins and Friedman, 2014). 
Little is currently known about how Est2 and Est3 reach the nuclear 
compartment. The Small size (20.5 kDa) of Est3 suggests it could passively 
diffuse through the nuclear pores (Wang and Brattain, 2007). Although no 
nuclear localization motif has been conclusively identified in Est2 so far, a 
bipartite NLS has been recently found in the human ortholog of the telomerase 
catalytic subunit hTERT (Chung, Khadka and Chung, 2012). An equivalent 
sequence might exist in the yeast enzyme.  
Despite its importance for telomerase recruitment to telomeres and TLC1 
nuclear retention, Ku (along with Ku-mediated G1-recruitment of Est2 to 
telomeres) is dispensable for telomere length maintenance, since strains 
lacking Ku have stable (though short) telomeres and do not senesce (Boulton 
and Jackson, 1996). Recently it has been discovered that Ku cannot bind both 
dsDNA and the TLC1 RNA simultaneously which led to a complete revision of 
the traditional model of Ku-dependent telomerase recruitment to telomeres, 
where telomerase is bridged to telomeres via TLC1-Ku interaction (Pfingsten 
et al., 2012). The mutual exclusion between DNA and RNA binding to Ku 
explains why overexpression of an RNA containing three TLC1-Ku binding 
sites affects TPE (Peterson et al., 2001; Zappulla et al., 2011). 
The so-called “synapsing model” was proposed in an attempt to reconcile the 
Ku-mediated telomerase recruitment to telomeres with the fact that Ku cannot 
bind TLC1 and telomere simultaneously. It made use of the ability of the Ku 
complex to bring together two ends of a DSB apparently via an interaction 
between two Ku dimers bound to the two chromosomal ends during NHEJ. 
However separation-of-function Ku70 mutants were obtained that are 
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incapable of NHEJ (most likely due to defective Ku-Ku interaction), but are fully 
proficient in terms of their telomeric functions (Pfingsten et al., 2012). 
Alternative models as to how the Ku complex recruits telomerase to telomeres 
have been suggested, some of them prioritizing its TLC1 nuclear translocating 
role in bringing telomerase to telomeres (Pfingsten et al., 2012). More to this 
point, most of the telomere-bound Est2 is localized >100 bp away from the 
actual G-tail in G1 and therefore is effectively unable to elongate telomeres 
during this time (Sabourin, Tuzon and Zakian, 2007). The significance of 
telomerase recruitment to telomeres by Ku is further obscured by the faсt that 
it’s neither sufficient nor necessary to maintain stable telomere length (Chan, 
Boulé and Zakian, 2008). This notion prompted some authors to propose that 
the function of telomerase bound to telomeres in G1 is to cap them rather than 
to elongate (Vega et al., 2007; Chan, Boulé and Zakian, 2008). It has been 
also speculated that Ku-mediated localization of Est2 to telomeres in G1 might 
contribute to its subsequent S phase recruitment via Est2 dimerization (Fisher, 
Taggart and Zakian, 2004). Noteworthy, some evidence suggests that human 
telomerase acts as a dimer during the elongation (Beattie et al., 2001; Wenz 
et al., 2001; Ly et al., 2003). However, different groups report conflicting data 
on the matter of S. cerevisiae telomerase dimerization (Prescott and 
Blackburn, 1997; Livengood, Cech and Zaug, 2002; Friedman et al., 2003; 
Shcherbakova et al., 2009; Bajon, Laterreur and Wellinger, 2015). In any case, 
the precise mechanism and the role of the Ku complex action in trafficking of 
the telomerase TLC1 subunit to telomeres awaits further elucidation. 
1.1.7. Yeast telomerase-deficiency and telomerase-
insufficiency survivors 
Telomerase deletion survivors. If any of the four telomerase components is 
deleted, S. cerevisiae cells do not die instantly but rather continue to divide 
until their telomeres reach a critical length and activate cell cycle arrest 
(Lundblad and Szostak, 1989; Singer and Gottschling, 1994; Lendvay et al., 
1996). Consequently, most cells die but few survive and maintain their 
telomeres through recombination (Le et al., 1999).  
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There are two major kinds of telomerase-null survivors, which differ in the 
structure of their telomeres (Figure 1.6), their growth rates and their genetic 
requirements. 
 
Figure 1.6: Structure of WT X (A) and Y’ (B) telomeres, and type I (C) and type 
II (D,E) survivor telomeres  
In the right: a blow-up of type I survivor telomere structure showing XhoI restriction 
sites and fragments recognized by the probe in terminal restriction fragment (TRF) 
analysis. Combined and modified from Lydall, 2003; Maringele and Lydall, 2004 
 
Type I survivors are defined by the amplification of Y’-subtelomeric sequences 
and appearance of Y’-elements on the subset of telomeres that didn’t use to 
have them. Such survivors can be identified in a telomere-specific Southern 
blot by shorter than wild-type terminal restriction fragments (TRFs, terminal 
fragments of Y’-telomeres generated by cleavage with XhoI and visualized 
using a probe for telomeric repeats; see Figures 1.6-1.7) and intense 5.2 and 
6.7 kb bands consistent with the amplification of Y’-elements in subtelomeres 
(Teng and Zakian, 1999). Type II survivors originate via amplification of 
terminal TG-repeats, rather than subtelomeric sequences. A characteristic 
feature of this type of survivors is that the pattern of bands observed in 
telomere-specific Southern blot upon cleavage of their DNA with XhoI is 
distinct from that of a WT strain (Figure 1.7). Although in some strain 
backgrounds type II survivors occur less frequently than type I, they grow more 
rapidly and thus often outcompete the latter kind in liquid media (Teng and 
Zakian, 1999). Both types of survivors rely on the central recombination gene 




RAD52 for their emergence. Type I survivors also require RAD51, RAD54 and 
RAD55/57 genes, whereas type II survivors depend on SGS1, RAD50 and 
RAD59 (Teng and Zakian, 1999). These two sets of genes have been shown 
to participate in RAD51-dependent and RAD51-independent BIR-pathways, 
respectively (Signon et al., 2001).  
 
Figure 1.7: Terminal restriction fragment analysis in WT cells and type I and 
type II survivors  
Y’ TRF – terminal restriction fragment (∼1.3kb in WT) obtained from terminal Y’ 
elements by XhoI cutting. In type I survivors it is shorter and is accompanied by 
increased intensity of internal Y repeats (∼5.2kb and ∼6.7 kb), whereas in type II 






Telomerase insufficiency survivors. When propagated at higher 
temperatures, yeast telomeres equilibrate at shorter length than in normally 
used conditions of 30°C (Paschini et al., 2012). Yeast cells that grown at 
38.5°C undergo a viability crisis after ~80 generations due to critical telomere 
shortening and form survivors with short and stable telomeres – a morphology 
different from that seen in previously discussed telomerase-deficient survivors 
(Figure 1.8, Millet et al., 2015). Telomere shortening at elevated temperatures 
has been connected to a decrease of telomerase activity (Millet et al., 2015). 
Est2 subunit seems to be the likely limiting factor at high temperature as its 
steady-state level is dramatically decreased at 38.5°C, though the level of 
other telomerase components is hardly changed (Millet et al., 2015). 
 
Figure 1.8: Comparison of restriction patterns produced by XhoI cutting 
between temperature survivors (A) and telomerase-deficient survivors (B) 
In A the asterisk denotes type II survivor. In B the asterisk denotes type I survivor, the 
rest of the survivors in B are type II. Y’ TRF – terminal restriction fragment (∼1.3kb in 
WT) that was generated by XhoI cutting. In temperature survivors Y’ TRF is shorter 
than in WT, but there’s no amplification of Y’-repeats or change in the telomere band 
pattern, meaning that temperature survivors have different telomere morphology than 








Interestingly, temperature survivors were found to be near-diploids and 
monosomic for chromosome VIII (the strain was initially haploid). Diploidization 
and loss of chromosome VIII was observed around the time when the cell cycle 
arrest happened. Genetically engineered aneuploids with one copy of 
chromosome VIII did not experience a viability crisis at 38.5°C proving 
chromosome VIII monosomy could compensate for temperature-caused 
telomerase insufficiency. Detailed deletion analysis of chromosome VIII 
pointed to 4 genes, namely PRP8, UTP9, KOG1 and SCH9, simultaneous 
heterozygosity in which significantly delayed chromosome VIII loss during 
propagation of yeast at 38.5°C (Millet et al., 2015). 
Two of the mentioned genes - KOG1 and SCH9 are involved in the TOR 
pathway that regulates ribosomal protein biogenesis (Broach, 2012). UTP9 is 
important for pre-mRNA processing (Dragon et al., 2002) and PRP8 codes for 
a splicing factor (Vijayraghavan, Company and Abelson, 1989) (in yeast 
genome genes with introns predominantly encode ribosomal proteins, 
Spingola et al., 1999). 
These facts considered, it did not come as a surprise that the abundance of 
many of ribosomal proteins was reduced ≥ 1.5-fold relative to the total cell 
protein in aneuploid yeast cells compared to diploid cells (Millet et al., 2015). 
Meanwhile, the quantity of many non-ribosomal proteins was elevated (Millet 
et al., 2015). The amount of mature 5S and 5.8 rRNA was also decreased in 
aneuploid yeast relative to wild-type cells. This led the Makovets group to 
postulate the resource-shift hypothesis, according to which chromosome VIII 
monosomy leads to underproduction of normally abundant ribosomal proteins 
and rRNA and redirecting of the thus emancipated resources to production of 
non-ribosomal proteins and RNAs, including the components of the 
telomerase complex. The amount of Est3 and Est1 proteins as well as the 
TLC1 RNA was indeed shown to be 3-4 times higher in the aneuploid cells 
than in diploid cells at 38.5°C (Millet et al., 2015). Surprisingly the amount of 
Est2 protein stayed pretty much the same in aneuploids as in diploids at 38.5°C 
(Millet et al., 2015), which is slightly counterintuitive as Est2 had been shown 
to be the limiting factor for telomere length maintenance in the conditions of 
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high temperature and additional copies of either EST1, EST3 or TLC1 genes 
introduced in yeast cells had not prevented them from going through viability 
crisis at 38.5°C (Millet et al., 2015).  
So, even though the research conducted by Makovets lab drew a general 
outline of how yeast cell populations adapt to telomerase insufficiency caused 
by high temperatures through aneuploidy, some details of the proposed 
compensation mechanism are still not clear. In my postgraduate research I 
attempted to gain molecular insights into the mechanism of aneuploidy-
dependent bypass of temperature-induced telomerase insufficiency by 
addressing the following questions: 
1. Does the increase of Est1, Est3 and TLC1 steady-state in aneuploids 
compensate for the shortage of Est2 at elevated growth temperatures 
and, if yes, how? 
2. Why does aneuploidy result in the increase of Est1, Est3 and TLC1 




1.2. DNA double-strand breaks and their physiology 
1.2.1. An overview of double-strand break repair 
DNA double-strand breaks (DSBs) are among the most detrimental genetic 
lesions. An unrepaired DSB can lead to a variety of adverse consequences 
ranging from cellular death to gross chromosomal rearrangements and 
malignant transformation (Agmon et al., 2009). DSBs can be caused by 
external factors, such as radiation and chemotherapy drugs, as well as internal 
factors, including oxidative stress and topoisomerase activity (Hemnani and 
Parihar, 1998; Symington and Gautier, 2011). DSBs arise routinely during 
DNA replication (Mehta and Haber, 2014), necessitating efficient DSB 
detection mechanisms, which would allow DSB recognition and promote 
repair. Some cells also utilize programmed double-strand breaks for gene 
rearrangement and meiotic crossing-over (Ramsden and Gellert, 1995; Borde 
and de Massy, 2013). Cells can fix DNA double-strand breaks using several 
repair mechanisms (Figure 1.9), namely non-homologous end joining (NHEJ), 
microhomology-mediated end joining (MMEJ), single-strand annealing and a 
group of homology-dependent repair pathways (HDR), also known as 
homologous recombination (HR) (Symington and Gautier, 2011). Alternatively, 
a broken end can be stabilized by adding a telomere to the centromere-
carrying fragment of the broken chromosome (Schulz and Zakian, 1994; 
Pennaneach, Putnam and Kolodner, 2006). 
One of the major determinants of the repair pathway choice is the resection of 
the 5’-strands of the broken chromosome ends, which is regulated by the cell 
cycle (Huertas et al., 2008; Chen et al., 2011). Both NHEJ and MMEJ ligate 
the broken ends, but while NHEJ operates on unprocessed or scarcely 
processed ends, MMEJ requires a limited extent of 5’-strand resection to 
reveal microhomologies that would be annealed (Deng et al., 2014; Emerson 
and Bertuch, 2016; Sinha et al., 2016). Since neither NHEJ or MMEJ can 
recognize the origin of the chromosome fragments, they often lead to 
translocations by ligating fragments originating from different chromosomes in 
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case of multiple DSBs (Yu and Gabriel, 2004; Villarreal et al., 2012). In contrast 
to NHEJ and MMEJ, efficient homology-dependent repair and single-strand 
annealing are promoted by long-range 5’-strand resection (Zhu et al., 2008; 
Deng et al., 2014). Single-strand annealing pairs ssDNA sequences originating 
from direct repeats surrounding the break, while homologous recombination 
pathways entail copying of the missing sequence from an intact template 
(Agmon et al., 2009). Whereas single-strand annealing leads to the deletion of 
one of the direct repeats being annealed and all the sequences lying between 
the two repeats and their respective break ends (Bhargava, Onyango and 
Stark, 2016), homologous recombination can restore the integrity of the broken 
chromosome making it the least error-prone repair mechanism (Wyman and 






Figure 1.9: Overview of DSB repair pathways 




1.2.2. Detection of double-strand breaks and checkpoint 
activation  
Cells are equipped with sentinel proteins, which constantly monitor the integrity 
of chromosomes and are capable of recognizing DSBs. Upon detection of a 
DSB these proteins elicit signal cascades called DNA damage checkpoints 
(DDCs), which serve multiple purposes. One of the most important roles of the 
DDCs is to arrest cell cycle progression at the pre-anaphase stage in order to 
provide cells with sufficient time for the break repair before the mitotic 
separation of chromosomes (Harrison and Haber, 2006). 
The execution of DNA damage checkpoints depends on a number of proteins 
performing a variety of functions (Figure 1.10). In S. cerevisiae two apical 
phosphatidylinositol 3’ kinase-like kinases (PIKK) govern DDC initiation in 
response double-strand breaks: Mec1 and Tel1; their mammalian homologs 
are kinases ATR and ATM, respectively (Harrison and Haber, 2006). Mec1 is 
the primary checkpoint regulator in budding yeast, with Tel1 playing a less 
prominent role, whereas in mammalian cells the contributions of ATR and ATM 
to the checkpoint signalling are more equal, by comparison (Harrison and 
Haber, 2006; Mantiero et al., 2007). 
Ddc2 is the binding partner of Mec1 that recruits Mec1 to and stimulates its 
kinase activity at RPA-coated ssDNA (Paciotti et al., 2000; Rouse and 
Jackson, 2002; Zou and Elledge, 2003; Biswas et al., 2019). RPA-ssDNA 
tracts can arise as a result of the resection of a broken end (see section 1.2.3) 
or as a consequence of fork stalling during replication (Lanz, Dibitetto and 
Smolka, 2019). Although, both resected broken ends and stalled replication 
forks elicit Mec1-dependent signalling cascades, the cascade initiated by 
arrested forks is distinct from the DNA damage checkpoints and is called DNA 




Figure 1.10: Simplified schematic of DNA damage signalling pathways in S. 
cerevisiae 
Oval shapes denote proteins that act specifically in the S-checkpoint. Adapted from 
Harrison and Haber, 2006 and Lanz et al., 2019  
27 
 
During the S-phase DDC and DRC comprise two branches of the S-
checkpoint, but while the DRC operates only during S-phase, DNA damage 
checkpoints can be activated throughout the cell cycle (Pardo, Crabbé and 
Pasero, 2017). Furthermore, even though both types of pathways converge on 
the same effector kinase Rad53, the dynamics of Rad53 phosphorylation is 
different in these two cascades, with DRC producing a more rapid but less 
prolonged accumulation of Rad53-P than DDC (Pardo, Crabbé and Pasero, 
2017).  
Mere interaction between Mec1-Ddc2 complex is not sufficient for Mec1 
activation, which requires an additional input from other sensor proteins, such 
as 9-1-1 complex, Dpb11 and Dna2 (Mordes, Nam and Cortez, 2008; Navadgi-
Patil and Burgers, 2009; Kumar and Burgers, 2013). The 9-1-1 clamp 
(consisting of Rad17-Mec3-Ddc1), which resembles structurally the PCNA 
replication clamp, is loaded by a modified version of the RFC clamp loader 
(RFCRad24) on the 5’-ds-ssDNA junctions located in the proximity of a DNA 
lesion site (Venclovas and Thelen, 2000; Melo, Cohen and Toczyski, 2001; 
Majka and Burgers, 2003; Zou, Liu and Elledge, 2003). Upon the recruitment 
of Mec1, Ddc1 activates Mec1, which in turn phosphorylates Ddc1 allowing it 
to recruit Dpb11, thus Ddc1 and Dpb11 appear to be recruited to the same 
DNA structures (Puddu et al., 2008). As mentioned above, Dna2 also 
participates in Mec1 activation (Kumar and Burgers, 2013). Given the affinity 
of Dna2 to 5’-flaps covered with the RPA complex, secondary structures and 
G-quadruplexes, it could be speculated, that Dna2 activates checkpoint in 
response to detecting persistent structures of these kinds (Wanrooij and 
Burgers, 2015). During the S-checkpoint Ddc1, Dpb11 and Dna2 activate 
Mec1 in a partially redundant manner (Wanrooij and Burgers, 2015). 
Unprocessed DSBs are bound by the MRX complex which in turn recruits and 
activates Tel1 (Nakada, Matsumoto and Sugimoto, 2003; Lisby et al., 2004). 
MRX complex can also be recruited to stalled replication forks (Tittel-Elmer et 
al., 2009), indicating a possible role for Tel1 in the DNA replication checkpoint. 
The MRX complex together with the Sae2 nuclease participates in the initial 
resection (see next section), upon which the MRX complex dissociates from 
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the processed end along with Tel1 (Gobbini et al., 2013; Symington, 2014). 
Once the free 3’-strand of the broken end associates with the RPA complex, it 
becomes a suitable substrate for Mec1-Ddc2 recruitment, thus providing a 
switch from Tel1- to Mec1-dependent checkpoint signalling (Gobbini et al., 
2013). 
The apical checkpoint kinases Mec1 and Tel1 pass their signal through 
effector kinases Rad53 and Chk1 (Harrison and Haber, 2006). In budding 
yeast, Rad53 serves as the major effector kinase in the DNA damage 
checkpoint, while another checkpoint kinase Chk1 plays a relatively minor role 
(Sanchez et al., 1999). Despite S. cerevisiae Rad53 being homologous to the 
human CHK2 effector kinase (Matsuoka, Huang and Elledge, 1998), in terms 
of its function in the DNA damage signalling Rad53 is more equivalent to the 
mammalian CHK1 (Stracker, Usui and Petrini, 2009; Gobbini et al., 2013), 
although Rad53 and CHK1 share little sequence similarity. 
Both Mec1 and Tel1 phosphorylate histone H2A on serine 129 (Downs, 
Lowndes and Jackson, 2000; Lee et al., 2014). The phosphorylated form of 
this histone (γ-H2A) recruits the adaptor protein Rad9 to the damage site (Toh 
et al., 2006), where it is phosphorylated by Mec1 or Tel1 (Emili, 1998; Vialard 
et al., 1998), allowing Rad9 oligomerize (Soulier and Lowndes, 1999; Usui, 
Foster and Petrini, 2009) and to mediate the interaction between Mec1 and 
Rad53 (Sun et al., 1998; Gilbert, Green and Lowndes, 2001; Schwartz et al., 
2002). Rad9 also serves as a scaffold for Rad53 autophosphorylation, allowing 
Rad53 to amplify the checkpoint signal (Gilbert, Green and Lowndes, 2001).  
Phosphorylated Rad53 and Chk1 kinases spread the checkpoint signal over 
multiple targets. Chk1-dependent phosphorylation of anaphase inhibitor Pds1 
(securin) leads to Pds1 stabilization. Consequently, Pds1 prevents separase 
from degrading cohesin and separating the sister chromatids into anaphase 
(Sanchez et al., 1999; Wang et al., 2001). At the same time Chk1, Dun1 and 
Rad53 have been reported to prevent mitotic entry in yeast, thus promoting 
DNA damage-induced cell cycle arrest (Liang and Wang, 2007). Both Rad53 
itself and Rad53-phosphorylated Dun1 upregulate the transcription of 
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ribonucleotide reductase (RNR) subunits (Huang, Zhou and Elledge, 1998; 
Tsaponina et al., 2011), thus resulting in an increase of cellular dNTP pool, 
necessary for the survival of DNA damage (Chabes et al., 2003), stimulating 
replication of damaged templates (Poli et al., 2012) and promoting fork restart 
upon replicative damage (Morafraile et al., 2015).  
Upon the completion of DNA damage repair, yeast cells extinguish DNA 
damage signalling and restart the progression of the cell cycle via a process 
of checkpoint recovery (Clémenson and Marsolier-Kergoat, 2009). In case of 
failure to repair the damage after 12-14 hours of constitutive damage signalling 
yeast cells invoke the adaptation mechanism, whereby the checkpoint 
signalling is turned off and cells re-enter the cell cycle (Harrison and Haber, 
2006). Adaptation to DNA damage signalling has been also observed in 
mammals (Van Vugt, Brás and Medema, 2004). 
1.2.3. End resection and DSB repair pathway choice 
The search for homology and the invasion of the homologous sequence 
followed by strand exchange and the creation of a D-loop are all crucial steps 
in homologous repair of a double-strand break (Haber, 2018). All of these steps 
necessitate the resection of the 5’-strand of the broken end releasing the 3’-
ssDNA tail which initially associates with RPA and later with recombinase 
proteins, such as Rad51 or Dmc1, to form a nucleoprotein filament capable of 
homology search, pairing and strand displacement (, Symington and Gautier, 
2011; Andriuskevicius, Kotenko and Makovets, 2018). At the same time, end 
resection inhibits non-homologous end joining, and therefore represents a 
major decision-making point in the selection of the DSB repair pathway 
(Symington and Gautier, 2011). The resection is regulated by various inputs, 
such as cell cycle stage and DNA damage checkpoint, thus allowing for 
coordination between double-strand break repair and other cellular processes 
(Symington, 2014, 2016). Several protein complexes and enzymes, that 
participate in end resection, play partially redundant roles and constitute a 
functional network, regulated by multiple physical interactions, post-




Figure 1.11: Overview of DSB resection and repair pathways choice 




According to the current understanding in the field, the resection in eukaryotes 
occurs as a two-step process, consisting of initial resection and extensive 
resection, performed by distinct sets of nucleases (Mimitou and Symington, 
2008). In budding yeast initial resection is performed by the MRX complex, 
which consists of two copies of proteins Mre11, Rad50 and Xrs2 (Hopfner et 
al., 2001; Mimitou and Symington, 2008). Mre11 is a nuclease, which is 
conserved across all three domains of life and possess endonuclease and 3’-
5’ exonuclease activities (Sharples and Leach, 1995; Furuse et al., 1998; Paull 
and Gellert, 1998; Usui et al., 1998; K. P. Hopfner et al., 2000). Rad50, which 
is also a conserved protein, is a member of the structural maintenance of 
chromosomes (SMC) family of proteins (Karl Peter Hopfner et al., 2000). 
Rad50 contains coiled-coil domains created by intramolecular folding, as well 
as a nucleotide-binding domain on one end and a dimerization domain on the 
other end of the protein (Hopfner et al., 2002). Mre11 is associated with the 
nucleotide-biding domain of Rad50 (Hopfner et al., 2001). Dimerization of the 
MRX complex through the dimerization domain of its Rad50 subunit is believed 
to play an important role in NHEJ, by virtue of tethering the two broken ends 
together via an MRX dimer bridge (Bressan, Baxter and Petrini, 1999; 
Lobachev et al., 2004; Wiltzius et al., 2005).The Xrs2 subunit of the MRX 
complex binds to the Mre11 subunit and is responsible for the interaction with 
Tel1 (Nakada, Matsumoto and Sugimoto, 2003).  
The function of the MRX complex depends greatly on an additional factor Sae2 
(Clerici et al., 2006; Mimitou and Symington, 2008). Sae2 is a poorly conserved 
protein, that associates with the MRX complex and stimulates its 
endonuclease activity (Sartori et al., 2007; Wang et al., 2012; Cannavo and 
Cejka, 2014). The phosphorylation of Sae2 by CDK stimulates end resection 
and provides a regulatory mechanism which restricts the resection to the S/G2 
phase, when the CDK is active (Huertas et al., 2008). Given that resection 
channels repair towards HDR-dependent pathways, such regulation ensures 
that the HR is coordinated with the availability of sister chromatids, which serve 
as templates for HR (Symington and Gautier, 2011). 
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Despite possessing 3’-5’ exonuclease activity, the MRX complex cleaves the 
5’-strand of a broken end, rather than the 3’-strand (Paull and Gellert, 1998; 
Nicolette et al., 2010; Garcia et al., 2011). According to the current 
understanding, to achieve the 5’-strand resection, the MRX complex 
introduces a nick on the 5’-strand a short distance away from the breakpoint 
and then proceeds to degrade the 5’-strand, moving towards the broken end 
(Neale, Pan and Keeney, 2005; Garcia et al., 2011). 
In yeast cells double-strand breaks are immediately and independently bound 
by MRX and another protein complex – Yku70-Yku80 (Wu, Topper and Wilson, 
2008). The initial resection by the MRX complex is believed to trigger the 
dissociation of the Ku heterodimer from the broken end by creating a poor 
substrate for binding by the Ku complex (Mimitou and Symington, 2010). The 
Ku heterodimer plays an important role in NHEJ (Boulton and Jackson, 1996). 
Thus, cell-cycle controlled resection by MRX lies at the heart of the choice 
between NHEJ and other modes of repair. 
After the initial resection by the MRX complex two nucleases possessing 5’-3’ 
exonuclease activity, namely Exo1 and Dna2, take over the resection in a 
partially redundant manner (Zhu et al., 2008). The nicks introduced by the 
endonuclease activity of Mre11 may also provide a substrate for Exo1-
dependent 5’-3’ exonucleolytic degradation (Garcia et al., 2011). In addition, 
MRX physically recruits Dna2 to the break site, even in the absence of Sae2 
or Mre11 nuclease activity (Shim et al., 2010). Moreover, the initial resection 
releases a ssDNA tail, which associates with the RPA complex facilitating the 
recruitment of Sgs1 and stimulating Dna2 5’-3’ exonuclease activity (Cejka, 
Cannavo, et al., 2010; Niu et al., 2010). 
Although the initial resection at the DSBs created by HO-nuclease is delayed 
significantly in mre11Δ, rad50Δ and xrs2Δ cells, they are capable of 
commencing the resection later on, suggesting that chemically unmodified 
ends can in principle be processed in the absence of the MRX complex (Ivanov 
et al., 1994; Tsubouchi and Ogawa, 2000). In contrast, the ends which are 
covalently bound to proteins, such as those created during meiosis, can be 
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processed only in the presence of the MRX complex. MRX is the only resection 
nuclease with endonucleolytic activity, which can create a nick in the DNA 
strand conjugated to a protein, allowing removal of the protein along with a 
covalently-bound short oligonucleotide (Keeney and Kleckner, 1995; Moreau, 
Ferguson and Symington, 1999; Neale, Pan and Keeney, 2005). 
Dna2 is an essential nuclease/helicase with versatile cellular functions 
(Wanrooij and Burgers, 2015). In resection Dna2 acts in concert with the Sgs1-
Top3-Rmi1 complex (STR) (Cejka, Cannavo, et al., 2010). Sgs1 is a RecQ 
family helicase, that unwinds DNA, generating ssDNA suitable for Dna2-
dependent degradation (Cejka, Cannavo, et al., 2010). 
Similarly to the MRX complex, the nucleases participating in the long-range 
resection are also regulated by various cellular inputs. In the G1 phase the Ku 
complex inhibits the Exo1-dependent resection (Clerici et al., 2008; Mimitou 
and Symington, 2010). Dna2 is phosphorylated in a CDK-dependent manner, 
which regulates its nuclear import and localization to DSBs (Chen et al., 2011).  
Excessive resection is dangerous for cells, which thus evolved mechanisms 
that limit long-range resection. Rad53-dependent phosphorylation inhibits 
Exo1 activity (Morin et al., 2008), whereas Rad9, which associates with γ-H2A, 
is proposed to physically hinder the progression of Exo1 and Dna2 nucleases 
along the chromosome fragment (Ngo and Lydall, 2015). 
1.2.4. An overview of homology-dependent repair 
pathways 
Once resection is initiated cells commit to the repair either by MMEJ or by an 
HDR mechanism (Daley et al., 2005; Geuting, Reul and Löbrich, 2013; Deng 
et al., 2014; Shibata et al., 2014). The group of resection-dependent pathways 
includes several distinct mechanism with varying degrees of repair accuracy 
(see Figure 1.9). Within this group the single-strand annealing (SSA) pathway 
is traditionally regarded separately from the remaining repair mechanisms, 
collectively referred to as homologous recombination (HR) pathways (Heyer, 
2015), although some authors include SSA into the HR group (Agmon et al., 
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2009; Morrical, 2015). As implied by its name, SSA operates by annealing 
ssDNA strands, which distinguishes it from the HR pathways relying on the 
invasion of a homologous duplex by a recombinase-ssDNA nucleoprotein 
filament (Fishman-Lobell, Rudin and Haber, 1992; Haber, 1992; Ivanov et al., 
1996; Morrical, 2015). In buddying yeast during mitotic recombination such a 
filament is composed of a 3’-ssDNA tail covered by a stretch of Rad51 protein 
(Shinohara, Ogawa and Ogawa, 1992; Sung, 1994; Sung and Robberson, 
1995; Sugawara, Wang and Haber, 2003; Conway et al., 2004), while Dmc1 
has been identified as a meiosis-specific homolog of Rad51 (Bishop et al., 
1992). The requirement for Rad51 to perform the strand exchange reaction 
between the resected end and the homologous duplex explains why Rad51 
promotes HR, but appears to be dispensable for SSA (Ivanov et al., 1996; 
Malkova, Ivanov and Haber, 1996). The complementary ssDNA sequences 
that are annealed by SSA are exposed by resection of direct repeats 
surrounding the breaks (Mimitou and Symington, 2008), while the non-
homologous overhangs are clipped off (Bardwell et al., 1994) and the resulting 
gaps are filled in. SSA is inherently mutagenic, since the sequences that lie 
between the repeats are inevitably deleted in the process, along with one of 
the repeats (Fishman-Lobell, Rudin and Haber, 1992; Davis and Symington, 
2001). Moreover, in case of several DSBs SSA can give rise to chromosomal 
translocations, when the direct repeats belong to fragments originating from 
different chromosomes (Haber and Leung, 1996; Richardson and Jasin, 2000). 
As mentioned above, HR is stimulated by the assembly of a nucleoprotein 
filament, which facilitates homology search and strand exchange reaction 
(Sung and Robberson, 1995; Danilowicz et al., 2014) resulting in formation of 
a D-loop structure (Petukhova, Sung and Klein, 2000). The 3’-ssDNA tail, that 
is released upon end resection, initially associates with the RPA complex 
(Wang and Haber, 2004), which serves multiple purposes, such as protecting 
ssDNA from degradation and folding into secondary structures (Sugiyama, 
Zaitseva and Kowalczykowski, 1997; Sugiyama, New and Kowalczykowski, 
1998; Chen, Lisby and Symington, 2013). However, RPA competes with 
Rad51 for binding to ssDNA, creating a requirement for additional proteins to 
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assist Rad51 filament assembly. One such protein is Rad52, which promotes 
the nucleation of Rad51 filament at RPA-coated ssDNA tails followed by 
cooperative displacement of RPA by the growing Rad51 filament (Sugiyama 
and Kowalczykowski, 2002). The displacement of Rad51 from ssDNA is 
inhibited by the Rad55-Rad57 complex, which is incorporated into the filament 
as a minor constituent (Liu et al., 2011).  
Once the Rad51-filament is created, HR can proceed in one of several ways. 
If homology can be found only with one of DSB ends, the repair is carried out 
by break-induced replication (Malkova et al., 2005), wherein the broken end 
invades into a sister chromatid, a homologous chromosome or an ectopic 
homology and then primes a long-range copying of the template often all the 
way to the telomere (see Figure 1.12, Davis and Symington, 2004; Rosen et 
al., 2013; Mayle et al., 2015). Such a process often leads to extensive loss of 
heterozygosity (LOH) and occasionally may produce non-reciprocal 
translocations, when an ectopic homology is used as a template (VanHulle et 
al., 2007; Rosen et al., 2013). In addition, since in BIR the polymerization of 
the leading strand is accompanied by bubble(D-loop)-migration and is 
uncoupled from the lagging strand synthesis, long stretches of ssDNA are 
exposed and become vulnerable to mutagenic factors, resulting in frameshifts 
and base substitutions (Deem et al., 2011; Saini et al., 2013; Sakofsky et al., 
2014). 
When two ends are available for repair with their respective homologies 
located on the same duplex within the vicinity of each other, the repair is 
predominantly executed by one of the two gene conversion (GC) mechanisms: 
synthesis-dependent strand annealing (SDSA) or double-Holliday junction 
pathway (dHJ), sometimes termed double-strand break repair pathway 
(DSBR) for historical reasons (Szostak et al., 1983; Malkova et al., 2005). The 
model holds that both these pathways start by strand exchange between one 
of the two resected ends and the homologous duplex (Symington, Rothstein 
and Lisby, 2014). In the SDSA pathway once a stretch of DNA long enough to 
span the distance between the two resected ends is copied from the template, 
the D-loop is dismantled with the help of Srs2 helicase, followed by annealing 
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of the extended 3’-tail to the ssDNA-tail of the second DSB end (Ira et al., 2003; 
Liu et al., 2017). The repair finalizes by filling in the gaps on the damaged 
chromosome left by end resection. SDSA produces exclusively non-crossover 
outcomes, since the template remains intact after the completion of the repair 
(Ira et al., 2003). Instead, in the dHJ pathway the ssDNA tail of the second 
chromosome end is captured by the D-loop strand (Nimonkar, Sica and 
Kowalczykowski, 2009; Shi et al., 2009). Branch migration converts this 
configuration into a structure with two Holliday junctions. The two 
chromosomes connected in such a way can be disentangled by the process of 
dissolution, which requires the activities of Sgs1 and Top3 and yields 
exclusively non-crossover outcomes (Cejka, Plank, et al., 2010). Alternatively 
the Holliday junctions can be cut by resolvases (Mus81, Yen1) resulting in 
either crossover or non-crossover configurations depending on the positions 
of cuts (Ip et al., 2008). Given that the repair by GC requires only a limited 
DNA-synthesis and is far less mutagenic compared to BIR, it is understandable 
why the initiation of BIR is delayed by Sgs1 and Mph1 helicases, and GC 
pathways are favoured (Jain et al., 2016). 
1.2.5. BIR as a mechanism for repair of single-ended 
double-strand breaks 
When only one DSB end is present, cells are left with little choice as to the 
means of DSB repair, since NHEJ, MMEJ and GC are precluded by the lack 
of the appropriate substrate. Addition of a telomere to a single DSB end may 
lead to a terminal deletion potentially causing cell death or, in case of a 
multicellular organism, malignant transformation, making de novo telomere 
addition (DNTA) an undesirable choice for repair (Pennaneach, Putnam and 
Kolodner, 2006). Broken replication forks are a major source of single-ended 
DSBs (Vilenchik and Knudson, 2003), producing a demand for a mechanism 
capable of restoring the sequence missing from the broken chromosome. 
Repair of broken forks is particularly relevant for organisms with large 
genomes, which run a higher risk of fork collapse. BIR occurs by conservative 
DNA synthesis (Donnianni and Symington, 2013) coupled with D-loop 
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migration (Figure 1.12, Saini et al., 2013) and provides means for the repair of 
single-ended DSBs in eukaryotes (Davis and Symington, 2004) and 
prokaryotes (Motamedi, Szigety and Rosenberg, 1999). During S-phase, BIR 
initiates invasion into the sister chromatid and initial elongation of the broken 
end, but is soon terminated by an approaching replication fork or is itself 
converted into a conventional replication fork by Mus81-dependent D-loop 
digestion, limiting the extent of BIR-dependent mutagenesis (Mayle et al., 
2015). Conversely, in G2 phase BIR may proceed to the very end of the 
template, leading to an expansive LOH when a homologous chromosome 
serves as the template (Saini et al., 2013). 
BIR has a propensity to switch templates which may result in non-reciprocal 
translocations and other kinds of permutations (Mayle et al., 2015). A 
sequence of prematurely terminated BIR-events may lead to a cascade of half-
crossovers, causing continuous genome instability (Vasan et al., 2014).  
Noteworthy, BIR underlies alternative telomere lengthening (Dilley et al., 
2016), making it a promising target for cancer therapy research.  
The genetic requirements for BIR and the conventional replication do not fully 
overlap. For example, the Pol32 subunit of the lagging strand polymerase δ is 
required for BIR, but not normal replication (Lydeard et al., 2007). Obviously, 
components of the resection machinery as well as the proteins participating in 
the nucleoprotein filament assembly and strand exchange are more important 
for BIR (Ivanov et al., 1996; Chung et al., 2010), than for replication, at least in 
budding yeast, which have a relatively small genome by eukaryotic standards, 
making their DNA replication less eventful and reliant on recombinational 
repair compared to mammals. Interestingly, BIR can operate both by Rad51-
dependent and independent mechanisms (Ira and Haber, 2002; Davis and 





Figure 1.12: Overview of BIR 





Another key protein for BIR is Pif1. Pif1 is a 5’-3’ helicase, that is involved in 
many processes relevant to DNA metabolism. Pif1 functions include unwinding 
of G-quadruplexes, facilitating the bypass of hard-to-replicate regions, Okazaki 
fragment maturation, maintenance of mitochondrial DNA, inhibition of 
telomerase at DSBs and telomeres (Schulz and Zakian, 1994; Budd et al., 
2006; Cheng, Dunaway and Ivessa, 2007; Ribeyre et al., 2009; Dahan et al., 
2018). The precise role of Pif1 in BIR is still undetermined, although some 
models accounting for the function of Pif1 in BIR have been put forward. For 
example Wilson et al. have proposed that Pif1 might facilitate BIR by displacing 
the newly synthesized strand from the D-loop or by stimulating Pol δ-
dependent DNA synthesis (Wilson et al., 2013). Phosphorylation of Pif1 by 
Rad53 promotes BIR by an unknown mechanism as well as Pif1-dependent 
inhibition of telomerase at DSBs, but not at telomeres (Makovets and 
Blackburn, 2009; Vasianovich, Harrington and Makovets, 2014). Thus, Pif1 is 
another component of the regulatory network, governing the fate of 












Materials and Methods 





2.1. Yeast strains 
Yeast strains used in the study are listed in Table 2.1. 
2.2. Growth media 
Yeast and bacterial growth media used in the study are listed in Table 2.2. The 
concentrations of the media components are shown as weight/volume (w/v). 
The media were sterilised by autoclaving before use. 
2.3. Plasmids 
The plasmids used in the study are listed in Table 2.3. 
2.4. Primers 
Primers were designed using the Serial Cloner software and manufactured by 
Integrated DNA Technologies (IDT). 100 μM stocks were made by dissolving 
the primers in Milli-Q H2O and stored at -20°C. The primers used in the study 
are listed in Table 2.4. 
2.5. Restriction enzymes 
All the restriction enzymes and buffers were purchased from New England 




Table 2.1: Strains used in this study 
Strain 
Relevant genotype Source/construction 
notes 
 Saccharomyces cerevisiae A364a  
NK1 
MATa bar1::LEU2 trp1-289 ura3-52 leu2-
3,112 
Makovets & Blackburn, 
2009 
NK219 
MATα ura3-52 trp1-289 leu2-3,112 
bar1::LEU2 
Makovets & Blackburn, 
2009 
NK500 MATa tlc1Δ48 
Makovets lab yeast strain 
collection 
NK543 
MATa ura3-52 trp1-289 leu2-3,112 
bar1::LEU2 est2::EST2-MYC13-KAN 
Millet et. al., 2015 
NK828 
MATa ura3-52 trp1-289 leu2-3,112 
bar1::LEU2 pif1-m2 











Millet et. al., 2015 
NK2910 
matΔ::KAN/MATα, CHRVIII/chrVIIIΔ 
(aneuploid for CHRVIII) 
bar1::LEU2/bar1::LEU2 trp1-289/trp1-289 
ura3-5/ura3-52 leu2-3,112/leu2-3,112 
Millet et. al., 2015 
NK2914 
matΔ::KAN/MATα, CHRVIII/chrVIIIΔ 
(aneuploid for CHRVIII) 
bar1::LEU2/bar1::LEU2 trp1-289/trp1-289 
ura3-5/ura3-52 leu2-3,112/leu2-3,112 
Millet et. al., 2015 
NK2917 
matΔ::KAN/MATα, CHRVIII/chrVIIIΔ 
(aneuploid for CHRVIII) 
bar1::LEU2/bar1::LEU2 trp1-289/trp1-289 
ura3-5/ura3-52 leu2-3,112/leu2-3,112 
Millet et. al., 2015 
NK3003 
matΔ::KAN bar1::LEU2 trp1-289 ura3-52 
leu2-3,112 est3::EST3-MYC13-TRP1 
Millet et. al., 2015 
NK3161 
matΔ::KAN/MATα EST3/est3::EST3-MYC13-
TRP1, aneuploid for CHR VIII 
Millet et. al., 2015 
NK3292 
MATa-inc ura3::NAT leu2::LEU2-PGAL1-HO 
pif1-m2 trp1::HYG mnt2::HOsite-URA3-
STAR-TEL 
Vasianovich thesis 2015 
NK3725 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan 
G418R Ura- survivor of NK3725 
after DSB induction 
NK3725, NK3726 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan 
Vasianovich et al., 2014 
NK3726 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan 
G418R Ura- survivor of NK3726 
after DSB induction 
NK3728 G418R Ura- 
derivative clone 1-4 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-m2 
G418R Ura- survivor of NK3728 




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 
Vasianovich et al., 2014 
NK3729 G418R Ura- 
derivative clone 1-3,5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-m2 
G418R Ura- survivor of NK3729 
after DSB induction 
NK3731 G418R Ura- 
derivative clone 2-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-
m2::pif1-m1-4A 
G418R Ura- survivor of NK3731 
after DSB induction 
NK3731, NK3733 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2::pif1-m1-4A-TRP 
Vasianovich et al., 2014 
NK3733 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-
m2::pif1-m1-4A 
G418R Ura- survivor of NK3733 
after DSB induction 
NK3840, NK3841 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 dna2Δ::HYG 
Makovets lab yeast strain 
collection 
NK3848,3849 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 exo1Δ::HYG 
Makovets lab yeast strain 
collection 
NK3856, NK3857 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pol32::HYG 
Vasianovich et al., 2014 
NK3858, NK3859 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pol32::HYG 
Vasianovich et al., 2014 
NK3864 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan 
rad27Δ::HYG 
G418R Ura- survivor of NK3864 
after DSB induction 
NK3864 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-m2 
rad27Δ::HYG 
G418R Ura- survivor of NK3869 
after DSB induction 
NK3864, NK3865 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan rad27Δ::HYG 
Makovets lab yeast strain 
collection 
NK3865 G418R Ura- 
derivative clone 1-4 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan 
rad27Δ::HYG 
G418R Ura- survivor of NK3865 
after DSB induction 
NK3865 G418R Ura- 
derivative clone 1-4 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-m2 
rad27Δ::HYG 
G418R Ura- survivor of NK3871 
after DSB induction 
NK3869, NK3871 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 rad27Δ::HYG 
Makovets lab yeast strain 
collection 
NK3980, NK3891 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan 
G418R Ura- survivor of NK3725 
after DSB induction/Makovets 





MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::KAN-(ARO4-
SPO23)::HOsite-URA3-STAR-TEL HIS7::kan 






289 ura3-5/ura3-52 leu2-3,112/leu2-3,112, 
aneuploid for CHR VIII 
NK3003::pVL5273/HpaI 
NK5460-5461 
MATα bar1::LEU2 trp1-289 ura3-52 leu2-
3,112 est2::URA3-FLAG3-MYC12-Gly6-EST2 
This study 
NK5461 tlc1Δ clone 10 




NK5461 tlc1Δ clone 17 




NK5461 tlc1Δ clone 18 




NK5461 tlc1Δ clone 4 










NK3003 × NK5460, diploidy 







NK3003 × NK5461, diploidy 
confirmed by FACS 
NK5549 
MATa bar1::LEU2 trp1-289 ura3-52 leu2-
3,112 est3::EST3-MYC13-KAN 
NK1 est3::EST3-MYC13-KAN 
(PCR cassette amplified with 
OSM966 + OSM967 from 
pFA6a-kanMX6-MYC13) 
NK5550-NK5552 
MATα bar1::LEU2 trp1-289 ura3-52 leu2-
3,112 est3::EST3-MYC13-KAN 
NK219 est3::EST3-MYC13-KAN 



















MATα ura3-52 trp1-289 leu2-3,112 
bar1::LEU2 yku80Δ::TRP1 
NK5461 yku80Δ::TRP1 (PCR 
cassette amplified with 
































MATa bar1::LEU2 trp1-289 ura3-52 leu2-
3,112 est3::EST3-FLAG3-NAT 
NK1 est3::EST3-MYC13-KAN 
(PCR cassette amplified with 
OSM966 + OSM967 from 
pFA6a-FLAG3-natMX6) 
NK5830-NK5832 









(PCR cassette amplified with 
OSM966 + OSM967 from 
pFA6a-FLAG3-natMX6) 
NK5837-NK5839 









MATa bar1::LEU2 trp1-289 ura3-52 leu2-
3,112 est2::FLAG3-HA6-Gly6-EST2-URA3 
NK1::pyt419/HpaI 
NK5881 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan 
dna2::dna2ΔN248-TRP1 
G418R Ura- survivor of NK5881 
after DSB induction 
NK5881, 5882 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan dna2::dna2ΔN248-TRP1 
Makovets lab yeast strain 
collection 
NK5882 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan 
dna2::dna2ΔN248-TRP1 
G418R Ura- survivor of NK5882 
after DSB induction 
NK5883 G418R Ura- 
derivative clone 1-5 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-m2 
dna2::dna2ΔN248-TRP1 
G418R Ura- survivor of NK5883 
after DSB induction 
NK5883, 5884 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 dna2::dna2ΔN248-
TRP1 
Makovets lab yeast strain 
collection 
NK5884 G418R Ura- 
derivative clone 1-4 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::right arm of chrII 
(from ARO4 to telomere) HIS7::kan pif1-m2 
dna2::dna2ΔN248-TRP1 
G418R Ura- survivor of NK5884 




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2::pif1-m1-4A-HYG 
NK3731 trp1Δ::HYG (PCR 
cassette amplified with 
OSM910 + OSM911 from 
pFA6a-hphMX6) 
NK6381 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2::pif1-m1-4A-HYG 
NK3733 trp1Δ::HYG (PCR 
cassette amplified with 
OSM910 + OSM911 from 
pFA6a-hphMX6) 
NK6382, NK6383 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan dna2::dna2ΔN248-HYG 
NK5881 trp1Δ::HYG (PCR 
cassette amplified with 
OSM910 + OSM911 from 
pFA6a-hphMX6) 
NK6387 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan dna2::dna2ΔN248-HYG 
NK5882 trp1Δ::HYG (PCR 
cassette amplified with 
OSM910 + OSM911 from 
pFA6a-hphMX6) 
NK6388 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 dna2::dna2ΔN248-
HYG 
NK5883 trp1Δ::HYG (PCR 
cassette amplified with 
OSM910 + OSM911 from 
pFA6a-hphMX6) 
NK6389 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 dna2::dna2ΔN248-
HYG 
NK5884 trp1Δ::HYG (PCR 
cassette amplified with 
OSM910 + OSM911 from 
pFA6a-hphMX6) 
NK6501 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO HEM13::HOsite-URA3 pif1-m2 
RAD27-10MYC-TRP 
Makovets lab yeast strain 
collection 
NK6546 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-









TEL HIS7::kan pif1-m2::pif1-m1-4D,R3E-TRP 
dna2::dna2ΔN248-HYG 
NK6569 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan dna2::dna2ΔN248-TRP1 
pol32::HYG 
NK5881 pol32Δ::HYG (PCR 
cassette amplified with 
OSM1497 + OSM1498 from 
pFA6a-hphMX6) 
NK6573 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan dna2::dna2ΔN248-TRP1 
pol32::HYG 
NK5882 pol32Δ::HYG (PCR 
cassette amplified with 
OSM1497 + OSM1498 from 
pFA6a-hphMX6) 
NK6574 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 dna2::dna2ΔN248-
TRP1 pol32::HYG 
NK5883 pol32Δ::HYG (PCR 
cassette amplified with 
OSM1497 + OSM1498 from 
pFA6a-hphMX6) 
NK6576 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 dna2::dna2ΔN248-
TRP1 pol32::HYG 
NK5884 pol32Δ::HYG (PCR 
cassette amplified with 
OSM1497 + OSM1498 from 
pFA6a-hphMX6) 
NK6577 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 pol32::HYG 
NK3728 pol32Δ::HYG (PCR 
cassette amplified with 
OSM1497 + OSM1498 from 
pFA6a-hphMX6) 
NK6578 
MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-
TEL HIS7::kan pif1-m2 pol32::HYG 
NK3728 pol32Δ::HYG (PCR 
cassette amplified with 
OSM1497 + OSM1498 from 
pFA6a-hphMX6) 
NK6607, NK6608 
























































MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-





MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




















































MATa-inc ura3::NAT leu2::LEU2-PGAL1-HO 
MNT2::kan::HOsite-URA3-STAR-TEL 



























































































MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-




MATa-inc trp1-289 ura3::NAT leu2::LEU2-
PGAL1-HO MNT2::kan::HOsite-URA3-STAR-






Table 2.2: Media used in this study 
Yeast rich media 
YPD 1% bacto-yeast extract, 2% bacto-peptone, 2% dextrose (D-glucose) 
YPD Agar 
1% bacto-yeast extract, 2% bacto-peptone, 2% bacto-agar, 2% D-
glucose, 0.01% adenine sulphate, 0.01% L-tryptophan, 0.002% uracil  
YPGal 1% bacto-yeast extract, 2% bacto-peptone, 2% D-galactose 
YPGal Agar 
1% bacto-yeast extract, 2% bacto-peptone, 2% bacto-agar, 2% D- 
galactose, 0.01% adenine sulphate, 0.01% L-tryptophan, 0.002% 
uracil 
YPRaf 1% bacto-yeast extract, 2% bacto-peptone, 2% D-raffinose 
YPRaf Agar 
1% bacto-yeast extract, 2% bacto-peptone, 2% bacto-agar, 2% D-
raffinose, 0.01% adenine sulphate, 0.01% L-tryptophan, 0.002% uracil 
Yeast rich media with drugs * 
YPD Agar + G418 YPD Agar containing 200 μg/ml G418 disulphate (Formedium, G4185) 
YPD Agar + HYG YPD Agar containing 300 μg/ml Hygromycin B (Toku-E, H010)  
YPD Agar + NAT 
YPD Agar containing 100 μg/ml Nourseothricin (Jena Bioscience, AB-
102) 
Synthetic defined (SD) drop-out media 
SD –URA 
0.69% yeast nitrogen base without amino acids, 2% D-glucose, 2% 
bacto-agar supplemented with –URA complete supplement mixture 
(CSM) drop-out **  
SD –TRP 
0.69% yeast nitrogen base without amino acids, 2% D-glucose, 2% 
bacto-agar supplemented with –TRP complete supplement mixture 
(CSM) drop-out **  
SD –TRP–URA 
0.69% yeast nitrogen base without amino acids, 2% D-glucose, 2% 
bacto-agar supplemented with –TRP–URA synthetic complete 
(Kaiser) drop-out ** 
SD –LEU 
0.69% yeast nitrogen base without amino acids, 2% D-glucose, 2% 




1% bacto-tryptone, 0.5% bacto-yeast extract, 1% NaCl, pH adjusted 
to 7.0 with 1 M NaOH 
LB + Amp 
1% bacto-tryptone, 0.5% bacto-yeast extract, 1% NaCl, 100 g/ml 





drugs were dissolved in dH20, filter-sterilized and mixed with autoclaved media; 
** yeast nitrogen base and drop-out supplements were purchased from Formedium and 




Table 2.3: Plasmids used in this study 
Plasmid Description Source/construction notes 
pEHB12009 pMPY-FLAG3-URA-FLAG3 E. Blackburn lab plasmid collection 
pFA6a-FLAG3-
natMX6 
 (Longtine et al., 1998) 
pFA6a-HA3-TRP1  (Longtine et al., 1998) 
pFA6a-hphMX6  (Longtine et al., 1998) 
pFA6a-kanMX6  (Longtine et al., 1998) 
pFA6a-kanMX6-
MYC13 
 (Longtine et al., 1998) 
pFA6a-TRP1  (Longtine et al., 1998) 
pFA6a-TRP1-MYC13  (Longtine et al., 1998) 
pRS314-HA-DNA2-
6HIS 
 J. Campbell lab plasmid collection 
pRS314-HA-dna2-
E657A-6HIS 
 J. Campbell lab plasmid collection 
pRS314-HA-dna2-
E657A,K1080E-6HIS 
 J. Campbell lab plasmid collection 
pRS314-HA-dna2-
K1080E-6HIS 




Tucey, et. al., 2014 
pYT200 pRS404-pif1-m1-4D Makovets lab plasmid collection 
pYT356 pFA6a-EST3(3'-end)-MYC13 URA3 Makovets plasmid lab collection 








PCR product amplified with 
OSM2492 + OSM2494 from 
pVL5273 was digested with Sal 
+PstI and inserted into pVL5273 




HA3 sequence was amplified from 
pFA6a-HA3-TRP1 with OSM2495 + 
OSM2502, digested with SalI + XhoI 





1) Oligos OSM2497 and 2948 were 
annealed 2) The resulting double-
tailed duplex was amplified with 
OSM163 + OSM164 to generate 
FLAG3 sequence 3) The FLAG3 PCR 
product was digested with EcoRI 
and EcoRV and ligated into pYT365 
digested with SpeI then blunted 
with Mung bean nuclease and 




HA3 sequence was amplified from 
pFA6a-HA3-TRP1 with OSM2495 + 
OSM2496, digested with SalI and 







EST2(5'UTR) sequence was 
amplified from pYT401 with 
OSM2499 + OSM2500, digested 
with SalI and ligated into pYT401 




HA3 sequence was amplified from 
pFA6a-HA3-TRP1 with OSM2495 + 
OSM2502, digested with SalI + XhoI 
and ligated into pYT413::HA3 




HA3 sequence was amplified from 
pFA6a-HA3-TRP1 with OSM2495 + 
OSM2502, digested with SalI + XhoI 
and ligated as a tandem of two 
HA3 repeats into pYT413::HA3 




Makovets lab plasmid collection 
pYT540 pRS404-pif1-m1-R3E Makovets lab plasmid collection 
pYT542 pRS404-pif1-m1-4A,R3E Makovets lab plasmid collection 
pYT544 pRS404-pif1-m1-4D,R3E Makovets lab plasmid collection 
pYT563 pRS404-PGAL1-FLAG3-MYC12-Gly6 
PGAL1-FLAG3-MYC12-Gly6 sequence 
was amplified from pYT445 with 
OSM2940 + OSM2941, digested 
with EagI + EcoRI and ligated into 





DNA2 containing HA-DNA2 was 







E657A was subcloned into pYT563 






K1080E was subcloned into pYT563 












1)PGAL1 sequence was amplified 
from pYT445 using OSM2965 + 
OSM2966, with OSM2966 
introducing a mismatch to create 
XmaI site a the 5'end of the 
sequence 2) FLAG3-MYC12-Gly6 
sequence was amplified from 
pYT445 using OSM 2967 + 
OSM2968, with OSM2967 
introducing a mismatch to create a 
XmaI site on the 5'end of the 
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sequence 3) The two PCR products 
were fused by recombinant PCR to 
create PGAL1-FLAG3-MYC12-Gly6 
sequence with XmaI site between 
PGAL1 and FLAG3 4) The 
recombinant PCR product was 
digested with BglII + PstI and 
subcloned into pFA6a-TRP1 





fragment was amplified from 
pYT564 using OSM2940 + 
OSM2993 2) DNA2 fragment 
containing codons 248-405 was 
amplified using oligos OSM2994 + 
OSM2193 3) The two sequences 





DNA2 terminator was amplified 
from pYT564 using OSM2997 + 
OSM2998 and then subcloned as a 
XhoI-MseI fragment into pYT564 
digested with NdeI + XhoI 
pYT576 pRS404-dna2ΔN248-6HIS 
NdeI-XhoI fragment of pYT564 
subcloned into pYT394 
pYT578 pRS404-dna2ΔN248-K1080E-6HIS 
NdeI-XhoI fragment of pYT566 




NdeI-XhoI fragment of pYT567 
subcloned into pYT394 
pYT581 pRS404-PGAL1-RAD27-MYC13-TRP1 
1) PGAL1 was amplified from pFA6a- 
PGAL1-TRP1 plasmid using OSM3092 
+ OSM3093 2) RAD27 ORF was 
amplified from genomic DNA of 
NK6501 using OSM3093 + OSM631 
3) 13-myc-ADH1 terminator 
sequence was amplified from 
pFA6a-MYC13-TRP1 using 
OSM2995 + OSM3095 4) PGAL1-
RAD27-MYC13-TADH1 fragment was 
obtained by recombinant PCR 
using the PCR products from steps 
1-3 and OSM3092 + OSM3095 5) 
PGAL1-RAD27- TADH1 sequence was 
subcloned as a PstI-SalI fragment 
into pRS404  
pYT605 pRS404-PGAL1-FLAG3-Gly6-HA-DNA2 
Gly6-HA-DNA2(5'end) fragment 
was amplified from pYT564 from 
pYT564 using OSM2492 + 
OSM2194 and then was subcloned 





DNA2 terminator was amplified 
from pYT564 using OSM2997 + 
OSM2998 and then subcloned as a 
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XhoI-MseI fragment into pYT605 




1)DNA2 ORF fragment was 
amplified from pYT610 using 
OSM3410 + OSM3412 2)DNA2 
terminator was amplified from 
pYT610 using OSM3416 + 
OSM2997 3) the products from 
steps 1 and 2 were fused using 
recombinant PCR with OSM3410 + 
OSM 2997 and the resulting 
sequence was subcloned as a NcoI 




1) DNA2 ORF fragment was 
amplified from pYT610 using 
OSM3410 + OSM3413 2) DNA2 
terminator was amplified from 
pYT610 using OSM3416 + 
OSM2997 3)the products from 
steps 1 and 2 were fused using 
recombinant PCR with OSM3410 + 
OSM 2997 and the resulting 
sequence was subcloned as a NcoI 




1) DNA2 ORF fragment was 
amplified from pYT610 using 
OSM3410 + OSM3415 2) DNA2 
terminator was amplified from 
pYT610 using OSM3416 + 
OSM2997 3) the products from 
steps 1 and 2 were fused using 
recombinant PCR with OSM3410 + 
OSM2997 and the resulting 
sequence was subcloned as a NcoI 





Table 2.4: Oligos used in this study 































To knock out TLC1 with 
KAN/TRP1/HIS 
OSM171 TGGTGAAAAGGAAGAGCAATCCTGC 
To screen TLC1 













OSM196  ACTAGATTACCGCATGTCCGTCAGG 
To screen YKU80 
knockouts from the F 
side 
OSM205 TTAATTAACCCGGGGATCC 
To screen for 
pol32Δ::HYG 
OSM631 TTAATTAACCCGGGGATCCG 
To screen for 
integration of Pringle 
cassettes at the F-end 
OSM801 GTTTAAACGAGCTCGAATTC 
To screen for 
integration of Pringle 








































To screen for 
pol32Δ::HYG 
OSM2194 Cttactattactaatcgtactacgcc 
To test plasmid 
integration into DNA2 
locus 
OSM2408 GGTGACGAAAACATAACTCAAAGG 
To screen YKU80 
knockouts from the R 
side 
OSM2492 AaaagtcgacGGTGGAGGCAATGGAGGCG 
To amplify (Gly)6-EST2 
(first 1.5 kb) region of 
pVL5273 with a SalI 
site on R-end and 




To mutate SalI site and 
add a PstI site on R-end 
of (Gly)6-EST2 (first 1.5 
kb) amplification 
product of pVL5273 
(PCR with OSM2492) 




on both ends and SalI 
site on F-end, to 
mutate Cys to Ser and 
stop codon to Gly on R-
end and to create SalI 










(for C-tagging of EST3 
in pYT356) with stop-
codon and EcoRI site 
on R-end, EcoRV site 
on F-end and flanking 
sequences on both 







OSM2499 TCGAGGTCGACGGTATCGATAAGC To amplify EST2-
promotor containing 
region of pYT401 and 




R-end (for subsequent 
removal of FLAG3-tag 
sequence from pYT401 








on both ends, to 
mutate SalI site into 
XhoI site on F-end, to 
mutate Cys to Ser and 
stop codon to Gly on R-
end and to create XhoI 






from pYT445 and add 
EagI site to the 5’-side 
and EcoRI site to the 
3’-side of the PCR 
product for 
subsequent three-
piece ligation of this 
product together with 
DNA2 gene (cut by 




from pYT445 and add 
EagI site to the 5’-side 
and EcoRI site to the 
3’-side of the PCR 
product for 
subsequent three-
piece ligation of this 
product together with 
DNA2 gene (cut by 






pYT445, introduce a 
mutation in the PGAL1-
FLAG3 junction 
creating an XmaI site 
between PGAL1 and 
FLAG3 and add BglII 
site to the 5’ end and 
SalI site to the 3’ end 






















OSM2997 ccccctcgagTTCGTTTATGAGGAAGCTTTTGG To amplify DNA2 
terminator from 
pYT564 and mutate the 
first MseI site, add 
MseI site to the 5’-end 
and XhoI site to the 
3’end of the PCR 
product so as to 
subclone it into pYT564 
cut with XhoI and MseI 









MYC13-TADH1 from the 
genome of NK6501 
and fuse it to PGAL1 
using recombinant PCR 
and then subclone the 
construct into pRS404 








OSM3410 GGCCCCATGGAAGAAGTAATATGG To create a series of C-
terminal deletions of 
Dna2 N-terminus using 
recombinant PCR on 
the template of 
pYT610 with 
subsequent subcloning 
PCR products into 











2.6. Growth and genetic manipulations of yeast and 
bacteria 
2.6.1. Yeast stocks 
Materials: • 25% (w/v) glycerol in 50% YPD 
 
Cells for stocks were taken from purified strains and patched either on YPD 
plates or selective plates (such as -ura plates for certain types of strains with 
unstable genotypes) and grown overnight at 30°C. The cells were collected 
from a plate with a toothpick, resuspended in 2 mL of 25% (w/v) glycerol in 
50% YPD in Corning™ Cryogenic Vials by vortexing and frozen at -80°C for 
indefinite storage and retrieval.  
2.6.2. Yeast transformation via cell starvation in lithium 
acetate 
Materials: • 0.1 M lithium acetate 
 • 40% (w/v) polyethylene glycol 3350 (Sigma-
Aldrich®, P4338) in 0.1 M lithium acetate 
 • 10 mg/ml (w/v) Salmon Sperm ssDNA solution 
 
For yeast transformations, yeast cells from freshly grown patches were 
resuspended in YPD at OD600 ≤ 0.1 (5 mL of YPD culture per transformation + 
5 mL for no DNA control). The cells were grown at 30°C in a shaking incubator 
until the OD600 reached 0.4-0.6 and harvested by centrifugation in eppendorf® 
5810R centrifuge at 3,000 rpm for 3 minutes at room temperature. The medium 
was decanted and after an additional 12-second round of centrifugation the 
residual medium was removed with a pipette. The cells were washed two times 
in 1 mL of 0.1 M lithium acetate and resuspended in N × 100 µL of 0.1 M lithium 
acetate mixed with N × 10 µL of salmon sperm (or bovine) single-stranded 
carrier DNA, where N = the number of transformations for a particular strain + 
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1. Cell suspension was split into 110 µL aliquots, one per each transformation 
and one for a negative, no DNA, control sample. 3-10 µL of linearized plasmid 
or PCR product were added into each aliquot, except for the negative control, 
followed by the addition of 600 µL of freshly-made 40% (w/v) PEG 3.350 in 0.1 
M lithium acetate, and vortexed. Cell suspensions were then incubated at 30°C 
in an aluminium rack (to facilitate heat-transfer) for 30-40 minutes and 
transferred to a 42°С water-bath for 16-18 minutes to heat-shock. The cells 
were pelleted in an eppendorf® Centrifuge 5424 for 2 minutes at 5,000 rpm at 
room temperature, washed with 1 mL of YPD, resuspended in 100 µL of YPD 
and plated either directly onto selective media (in case of selection for 
auxotrophic markers) or first on YPD and replica-plated on drug plates the next 
day (in case of selection for drug-resistance markers).  
2.6.3. Yeast matings 
For yeast mating, cells from two haploid parental strains of opposite mating 
types were mixed and spotted on a pre-warmed YPD plate, followed by 
incubation at 30°C for at least 6 hours. Depending on the availability of 
selection directed against only one or both of the parental strains, the parents 
were mixed either in equal proportion (when both parents can be counter-
selected) or with a 20-fold excess of one parent over the other (the parent that 
can be selected against was in excess over the one with no available counter-
selection). After the 6 hour incubation, the cells from the centre of the spot 
were streaked for single colonies on selective media.  
Acquisition of the diploid genotype was tested by mating pheromone 
production assay (Sprague and Herskowitz, 1981). Cells from the putative 
diploid colonies were spotted onto two plates with freshly inoculated lawns of 
cells, one plate – with MATa sst1 (bar1) cells (the tester strain NK1), sensitive 
to the α-factor pheromone, and the other – with MATα sst2 cells (the tester 
strain NK1542), sensitive to the a-factor pheromone. Haploid cells produce 
mating pheromones that inhibit growth of the tester strain of the opposite 
mating type, thus forming an area of arrested growth in the lawn around the 
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spotted cell mass (a halo). Diploid strains do not produce mating pheromones 
and therefore do not form halos in the lawns of the tester strains.  
2.6.4. Active deletion of chromosome VIII 
The 2n-1 strains (CHRVIII) that were used in the experiments on co-
immunoprecipitation of the telomerase subunits were constructed is several 
steps. As a starting point for the strain construction, I used a MATα haploid 
strain (NK2795, Millet et al., 2015) with a modified chromosome VIII (). The 
URA3 marker had been introduced near the centromere region of 
chromosome VIII in this strain, and both arms of the chromosome had been 
marked with drug resistance markers (NAT and HYG). The strain was first 
modified by adding tags to its Est2 and/or Est3 proteins. Next, the strain was 
mated to a MATa haploid expressing the same tagged versions of Est2 and/or 
Est3 but with a WT chromosome VIII. The diploid clones were selected and 
verified as described in the previous section. The diploids were transformed 
with a PCR product that upon recombination with the CHRVIII, induced a 
deletion spanning the CHRVIII centromere and the adjacent URA3 marker. 
Deletion of CHRVIII centromere would lead to mitotic missegregation of 
chromosome VIII resulting in CHRVIII monosomy or trisomy. Deletion of 
CHRVIII centromere was selected for on 5-FOA plates. The clones were then 
screened on NAT and HYG plates for the loss of the marked copy of CHRVIII. 
The CHRVIII aneuploidy was additionally verified by quantitative pulse-field gel 











2.6.5. Preparation of chemically competent E. coli cells  
 
Materials: • 0.1 M CaCl2 
 • 20% (w/v) glycerol in 0.1 M CaCl2 
 
A colony of a recA E. coli K-12 strain (DH5 alpha) was inoculated into 10 mL 
of LB broth in a 100 mL flask and grown overnight at 37°C on a shaker. In the 
morning 2 mL of the overnight culture were transferred into a 2 L flask with 200 
mL of LB. The culture was grown to OD600=0.4-0.5 and rapidly cooled down in 
an ice-water bath for 5 minutes. The culture was poured into pre-cooled 50 mL 
conical plastic tubes and the cells were pelleted in eppendorf® 5810R 
centrifuge at 4,000 rpm for 10 minutes at 4°C. The supernatant was decanted, 
cells were gently resuspended in 25 mL of cold 0.1 M CaCl2, added to each 
tube, and incubated on ice for 1 hour. Upon the incubation, cell suspensions 
from two tubes were pooled into one tube and the cells were pelleted again 
under the same conditions. The supernatants were removed and the cells 
were gently resuspended in 5 mL of cold 20% glycerol in 0.1 M CaCl2 and 
aliquoted into 1.7 mL tubes pre-cooled at -80°C (100 µL per aliquot). The 
aliquots were stored at -80°C. 
2.6.6. Genetic assay of the efficiency of BIR and DNTA in 
cells with inducible double-strand breaks 
The strains for the assay were derived from the MATa-inc strains carrying the 
HO endonuclease gene under the PGAL1 promoter and MNT2::kan::HOsite-
URA3-STAR-TEL construct on their chromosome VII. The 3’-fragment of the 
KAN gene shares 500 bp of homology with a 5’ fragment of KAN on 
chromosome II so that BIR can be initiated via the homology. The cells were 
patched on YPRaf plates and incubated overnight at 30°C to de-repress the 
PGAL1 promoter. Next day, ~1 OD of cells was resuspended in 1 mL of YP and 
a series of 10-fold dilutions was made in YP going down to 10-4. 100 µL of each 
dilution were plated on YPGal plates and 100 µL of the dilution 10-4 were plated 
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on a YPD plate to estimate the cell titre. The plates were incubated at 30°C (2 
days for YPD plates and 3 days for YPGal plates). Once the colonies have 
emerged on the YPGal plates, they were replica-plated on SC-ura and G418 
plates. The plates were incubated at -30°C overnight. The colonies were 
scored the next day. The fractions of BIR- and DNTA-survivors were 
determined as the number of G418R Ura- and G418S Ura- colonies divided by 




2.7. Protein methods 
2.7.1. Rapid budding yeast protein extraction 
 
Materials: • Lysis Solution: 1.85 M NaOH, 7.4% (v/v) β-
mercaptoethanol 
 • 50% Trichloroacetic acid (TCA, 4°C cold) 
 • Acetone (-20°C cold) 
 • 4x Laemmli Sample Loading buffer: 200 mM Tris-
HCl, pH 6.8, 400 mM dithiothreitol (DTT), 8% SDS, 
40% (v/v) glycerol, 0.1% (w/v) bromophenol blue 
 • TCA Sample buffer: 1x Laemmli Sample Loading 
buffer, 50 mM DTT, 30 mM Tris (pH is not adjusted) 
 
For total protein extraction from S. cerevisiae, cells were harvested either upon 
growing in liquid growth media or from agar plates. When grown in liquid media 
cell pellets were collected by centrifugation at 1,300-2,350 g, washed with Milli-
Q water and either frozen at -80°C or immediately used to prepare protein 
extracts. Throughout the protein extraction procedure, samples were 
incubated on ice. 
Cells were lysed in 150 µL of 1.85 M NaOH solution with 7.4 % of 2-
mercaptoethanol for 10 minutes. 150 µL of cold 50% trichloroacetic acid were 
added to each sample. Samples were mixed by vortexing and incubated 10 
minutes on ice. Following that, total protein was pelleted by centrifugation at 
20,200 g for 2 minute 
s (room temperature). Pellets were washed with 1 mL of cold acetone (pre-
cooled at -20°) and resuspended in the TCA sample buffer by using a pipette 
tip for mechanical breaking of the pellet followed by hard vortexing. 
Samples were incubated for 5 minutes either in a heat-block at 100°С or in 
boiling water, centrifuged briefly to collect the condensate, mixed by vortexing 
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and centrifuged for 2 minutes at 20,200 g to separate cell debris from the 
solubilized proteins. The supernatant was transferred into new tubes and 
either preserved at -80°C or loaded immediately on polyacrylamide gel.  
2.7.2. SDS polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
Materials: • 30% acrylamide:bis-acrylamide solution (37.5:1) 
(Severn Biotech Ltd.) 
 • 1.5 M Tris-HCl, pH 8.8 
 • 0.5 M Tris-HCl, pH 6.8 
 • 10% (w/v) SDS 
 • 10% ammonium persulfate (APS) 
 • Tetramethylethylenediamine (TEMED, 
UltraPure™, Invitrogen) 
 • 4x Laemmli Sample Loading buffer: 200 mM Tris-
HCl, pH 6.8, 400 mM DTT, 8% SDS, 40% (v/v) 
glycerol, 0.1% (w/v) bromophenol blue 
 • TCA Sample buffer: 1x Laemmli Sample Loading 
buffer, 50 mM DTT, 30 mM Tris (pH is not adjusted) 
 • 10x SDS-PAGE Running Buffer: 250 mM Tris-HCl, 
pH 8.3, 1.92 M glycine, 1% (w/v) SDS 
 • Amersham™ ECL™ Rainbow™ molecular weight 
marker (#RPN800E) 
 
Polyacrylamide mini-gels were cast using vertically positioned gel-casting 
mini-plates fixed in a casting stand (Bio-Rad Mini-PROTEAN™3 Cell system). 
1.5 mm spacer plates were used for gel-casting, unless specified otherwise. 
Each mini-gel consisted of two layers, a stacking (top layer) and a resolving 
(bottom layer) one. For the resolving gel, the following reagents and 
concentrations were used: 
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Table 2.5: Recipe for resolving gel 
Reagent Final concentration 
1.5 M Tris-HCl (pH 8.8) 0.375 M 
30% acrylamide:bis-acrylamide, ratio 37.5:1 5-15% 
10 % SDS 0.1% 
10% APS (added just before pouring) 0.1% 
TEMED (added just before pouring) 0.1% 
 
For the stacking gel, the following reagents and concentrations were used: 
Table 2.6: Recipe for stacking gel 
Reagent Final concentration 
Tris-HCl (pH 6.8) 0.125 M 
30% acrylamide:bis-acrylamide, ratio 37.5:1 4-4.5% 
10 % SDS 0.1% 
10% APS (added just before pouring) 0.125% 





10 mL of the resolving gel mixture and 5 mL of the stacking gel mixture were 
routinely made per single 10 mL mini-gel. The concentration of acrylamide/bis-
acrylamide in the gel mixtures was adjusted according to the molecular weight 
of the target protein/proteins. In case of several target proteins with starkly 
different molecular weights, two layers of the resolving gel with the appropriate 
acrylamide concentrations were cast sequentially. 
The ingredients for the resolving gel were added to a 15 mL conical plastic 
tube and mixed by inverting the tube gently. 1 mL of the mixture was 
transferred into a separate tube, mixed with 2 µL of TEMED and 20 µL of 10% 
APS and used for sealing the bottom of the gel. After 5 minutes, the excess of 
the un-polymerized acrylamide was removed. 10 mL of the resolving gel were 
mixed with 10 µL of TEMED and 100 µL of 10% APS and the mixture was 
poured between the glass plates while leaving some space for the stacking gel 
to be cast later. The resolving gel was covered with 3 mL of 100% ethanol and 
left to polymerize for 20 minutes. The ethanol was removed and 5 mL of the 
stacking gel were mixed with 6.5 µL of TEMED and 62.5 µL of 10% APS, 
poured over the resolving gel and covered with a comb to shape wells. The 
stacking gel was left to polymerize for 20 minutes upon which the gel was 
either used immediately or preserved in 1x SDS-PAGE Running Buffer at 4°C 
overnight.  
Before sample loading, the gel was placed into a vertical electrophoresis 
apparatus (Bio-Rad) tank filled with 1x SDS-PAGE Running Buffer. Protein 
samples were loaded into the wells along with 3-5 µL of the molecular weight 
marker. The gel was run at 150 V until the samples entered resolving gel and 
at 200V afterwards, until the dye front reached the bottom of the gel. The SDS-




2.7.3. Western blotting using fluorophore-conjugated 
secondary antibodies 
 
Materials: • 1x western blotting Transfer buffer: 25 mM Tris, 192 
mM glycine 
 • 10x TBST: 0.5 M Tris-HCl, pH 7.6, 1.5 M NaCl, 1% 
(v/v) Tween 20 
 • Blocking solution: 5% (w/v) non-fat dry milk diluted 
in 1x TBST 
 • Whatman® 3MM CHR paper (GE Healthcare) 
 • Immobilon®-FL Transfer Membrane with 0.45 μm 
pores (Merck Millipore Ltd., #IPFL00010) 
 • Methanol (Fisher Chemical) 
 • Skimmed milk powder (Oxoid™, Thermo Fisher 
Scientific) 
 
Proteins resolved in a polyacrylamide gel were transferred onto a PVDF 
membrane. For the transfer the gel was separated from the glass plates and 
the stacking gel as well as the bottom part of the resolving gel were cut off. 
The PVDF membrane cut to the size of the trimmed gel was activated by 
incubation in methanol for at least 20 seconds. A gel sandwich was assembled, 
with the resolving gel covered with the membrane and three layers of 
Whatman® 3MM filter paper on one side and three sheets of the filter paper 
on the other side (see Figure 2.2). The sandwich was placed between two fiber 
pads and encased in a plastic transfer cassette while fully submerged in the 
transfer buffer (to avoid trapping bubbles between the layers of the sandwich). 
The transfer was performed in the western blotting transfer buffer in a Mini 
Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad) for 1 hour (unless 
otherwise specified) at constant current (250 mA).  
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Upon the completion of the transfer, the sandwich was disassembled and the 
membrane was blocked in 10 mL of 5% skimmed milk in 1xTBST by incubation 
with gentle rocking. Following the blocking, the membrane was incubated in a 
50 mL plastic tube with 4 mL of primary antibody diluted in 1xTBST (unless 
specified otherwise, the dilution was 1:1,000) either for 1 hour at room 
temperature or overnight at 4°С. The antibody was removed and the 
membrane was briefly rinsed with 1xTBST, washed 3 times in 1xTBST, 10-
minute per wash using an orbital shaker. Subsequently, the membrane was 
incubated in a plastic box with 7.5 mL of fluorophore-conjugated secondary 
antibody diluted 1:12,500 in 1xTBST for 1 hour on a rocker at room 
temperature. During the final steps of the procedure, the membrane was briefly 
rinsed in 1xTBST and then washed in TBST on an orbital shaker first for 15 
and then for 10 minutes. The membrane was scanned using Odyssey® CLx 
fluorescent scanner (LI-COR®) either in the 700 or 800 nm channel, 
depending on the fluorophore borne by the secondary antibody. Image 
analysis and protein band intensity quantifications were performed using the 
Image Studio™ Lite software.  
 
Figure 2.2: The structure of the protein transfer sandwich 
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2.7.4. Assessment of the DNA damage checkpoint 
activation upon overexpression of Dna2 or its 
mutant versions by Rad53 western blot analysis 
(ECL-based) 
 
Materials: • 30% acrylamide:bis-acrylamide solution (37.5:1) 
(Severn Biotech Ltd.) 
 • 1.5 M Tris-HCl, pH 8.8 
 • 0.5 M Tris-HCl, pH 6.8 
 • 10% (w/v) SDS 
 • 10% APS 
 • TEMED (UltraPure™, Invitrogen) 
 • 4x Laemmli Sample Loading buffer: 200 mM Tris-
HCl, pH 6.8, 400 mM DTT, 8% SDS, 40% (v/v) 
glycerol, 0.1% (w/v) bromophenol blue 
 • TCA Sample buffer: 1x Laemmli Sample Loading 
buffer, 50 mM DTT, 30 mM Tris (pH is not adjusted) 
 • 10x SDS-PAGE Running Buffer: 250 mM Tris-HCl, 
pH 8.3, 1.92 M glycine, 1% (w/v) SDS 
 • PVDF blotting membrane (Amersham™ Hybond® 
P 0.45, GE Healthcare, #RPN303F) 
 • Pierce™ ECL2 Western Blotting Substrate 
(Thermo Scientific, #80196) 
 • Immobilon®-FL Transfer Membrane with 0.45 μm 
pores (Merck Millipore Ltd., #IPFL00010) 
 • 1x western blotting Transfer buffer: 25 mM Tris, 192 
mM glycine 




 • Blocking solution: 5% (w/v) non-fat dry milk diluted 
in 1x TBST 
 • Whatman® 3MM CHR paper (GE Healthcare) 
 • Methanol (Fisher Chemical) 
 • Skimmed milk powder (Oxoid™, Thermo Fisher 
Scientific) 
 • Amersham™ ECL™ Rainbow™ molecular weight 
marker (#RPN800E) 
 
In yeast cells, the DNA damage checkpoint activation leads to the 
phosphorylation of Rad53 protein resulting in a slower Rad53 SDS-PAGE 
mobility readily detected by western blotting. Successful detection of the 
mobility shift requires sufficient level of protein mobility resolution during SDS-
PAGE. Therefore, I used a larger polyacrylamide gel to resolve protein 
samples for Rad53 ECL western blotting. ECL-based western blot visualisation 
was chosen for the detection of Rad53-P species since it allows for higher 
sensitivity of Rad53 signal detection.  
The gel was cast using glass plates, 1.5 mm spacers, and a comb from 
Biometra Model V15·17 Gel Electrophoresis system (Analytik Jena AG). The 
resolving and stacking layers were prepared using 6.5% and 4.5% 
acrylamide/bis-acrylamide (37.5:1) final concentrations, respectively. The 
stacking/resolving gel separation line was approximately 1 cm below the 
bottom of the wells. Upon the installation of the gel into the gel-running tank 
filled with 1x running buffer, the air bubbles trapped at the bottom of the gel 
were removed using a syringe with a 16G bent needle. 
The protein samples were prepared from liquid yeast cultures, grown as 
specified in the Results section of this work. Cells were centrifuged at 4°C, 
washed with cold water and either stored at -80°С or used immediately for 
protein extraction using the TCA-based protocol (see section 2.7.1). For each 
OD unit of cells, 16.7 µL of the TCA sample buffer were added to the protein 
pellets before boiling. Upon boiling, the samples were immediately used for 
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SDS-PAGE to avoid dephosphorylation of the Rad53-P species by repeated 
re-heating of the samples. 
10 µL of the protein samples (corresponding to 0.6 ODs of cells) were loaded 
per gel well and 10 µL of the molecular weight marker was loaded into a spare 
well. The samples were run through the stacking gel at 150 V (for 
approximately 50 minutes) and through the resolving gel at 200 V (for 
approximately 3 hours) allowing for a slight overrunning of the dye front, thus 
improving protein resolution. 
Two 9×7 cm gel slices containing the proteins running between the yellow (76 
kDa) and the green (102 kDa) dye markers were cut out and transferred onto 
Amersham™ Hybond® P 0.45 PVDF blotting membrane (GE Healthcare) 
optimized for ECL-western blot. The 9×5 cm gel slices immediately above the 
102 kDa marker band were transferred onto Immobilon® PVDF membrane 
which was processed according to the fluorescence-based western blot 
protocol (see section 2.7.3) in order to assay the expression of Dna2 and its 
variants. Both transfers were performed under identical conditions (250 A 
constant current for 1 hour at room temperature in transfer buffer in a Bio-Rad 
Mini Trans-Blot® Cell).  
All the following steps are specific to the ECL-western blot protocol.  
The membranes were blocked in 15 mL of 5% skimmed milk in 1xTBST for 1 
hour at room temperature and then incubated in 4 mL of 500-fold dilution of α-
Rad53 antibody (Goat polyclonal, yC-19, Santa Cruz Biotechnology, Inc.) in 
2% milk in 1xTBST overnight at 4°C. The membrane was rinsed and then 
washed three times in 1xTBST (each wash 10 minutes) and incubated for 1 
hour at room temperature with HRP-conjugated Donkey anti-Goat secondary 
antibody (Thermo Fisher), diluted in 2% milk in 1xTBST to 1:15,000. The 
membrane was rinsed and washed as after the incubation with the primary 
antibody.  
Rad53 was detected based on the chemiluminescence produced by the 
chemical reaction catalysed by HRP conjugated to the secondary antibody. 
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Pierce ECL Western Blotting Substrate (Thermo Fisher) was used to prepare 
the substrate for the reaction, according to the manufacturer’s 
recommendations. The membrane was incubated in the substrate mix for 5 
minutes immediately upon the substrate preparation. It was covered with 
Saran wrap and the excess of the substrate was blotted away by clean 
absorbent paper tissue. The membrane was immediately scanned by C-DiGit 
Blot Scanner (LI-COR) for 12 minutes. The image was analysed using Image 
Studio™ Lite software. 
 
2.7.5. Co-immunoprecipitation of Est2-myc13 with Est3-
FLAG3 
 
Materials: • Basic TMG buffer: 10 mM Tris-HCl (pH 8.0), 1 mM 
MgCl2, 5% (v/v) glycerol, 300 mM NaCl, 0.5% 
Tween 20 
 • TMG buffer: basic TMG buffer, 100 µM DTT, 12 
U/mL RNAsin® + cOmplete™ EDTA-free Protease 
Inhibitor Cocktail (1 mini-tablet/5 mL) 
 • 4x Laemmli Sample Loading buffer: 200 mM Tris-
HCl, pH 6.8, 400 mM DTT, 8% SDS, 40% (v/v) 
glycerol, 0.1% (w/v) bromophenol blue 
 
The protocol is based on Hughes et al., 2000; Tucey and Lundblad, 2014. See 
Figure 3.15 for the outline of the co-immunoprecipitation protocol. 
Cell cultures were grown either at 30°C or at 38.5 °C in 250 mL of YPD media 
up to OD600 = 0.8. The cells were harvested by centrifugation in a floor-top 
Avanti J-30I centrifuge (Beckman Coulter) at 2,300 g for 5 minutes at 4°C and 
then washed with 10 mL of cold water. The cell suspensions were transferred 
into 15 mL conical tubes, washed with 1 mL of basic TMG buffer, resuspended 
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in 1 mL of TMG and stored at -80°C. From this point onward, gloves were worn 
at all steps to avoid RNase contamination and prevent TLC1 degradation and 
the samples were incubated on ice whenever possible.  
The samples were defrosted on ice and 1 volume of 0.5 mm glass beads was 
added to each sample. Cells were lysed by bead-beating using high power 
vortexing in alternating cycles of 30 second vortexing followed by a minimum 
of 30 seconds incubation on ice to avoid sample overheating and protein 
degradation. The cycles were repeated until over 90% of the cells were lysed 
as assayed by light microscopy (normally, 10-20 cycles of bead-beating per 
sample). 
The 15 mL tubes were pierced at the bottom with 21G needles and inserted 
into a set of fresh 15 mL tubes (pre-cooled on ice). The lysates were separated 
from the beads by briefly centrifuging the lysates through the pierced tubes 
into the new ones in a tabletop centrifuge at ~1,200 rpm. A 20 µl aliquot of 
each sample was transferred into a new microcentrifuge tube for further 
analysis of the total lysate.  
The rest of the lysates were transferred into fresh microcentrifuge tubes and 
centrifuged in an eppendorf® 5417R microcentrifuge at 4,700 rpm for 10 
minutes at 4°C to remove cell debris and unbroken cells from the lysates (pellet 
1). The supernatants were transferred into fresh microcentrifuge tubes while 
measuring their volumes (V1). Pellet 1 was washed in 1 mL of the basic TMG 
buffer, centrifuged for 10 minutes at 4°C and 4,700 rpm one more time and 
resuspended in V1 of the TMG buffer. A 20 µl aliquot of this suspension was 
moved to a new tube and constituted the pellet 1 sample. 
The supernatant from the previous step was centrifuged for 30 minutes at 4°C 
and 14,000 rpm to separate the lysate from chromatin. During this 
centrifugation step, anti-FLAG Affinity gel resin (M2, Sigma) was defrosted and 
resuspended gently (no vortexing). A wide orifice tip was used to transfer the 
required volume of the slurry (40 µl × number of samples) into a new 
microcentrifuge tube with 1 mL of the basic TMG buffer already added (pre-
cooled on ice). The tip was washed by repeated pipetting of the basic TMG 
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buffer in the tube to avoid any loss of the resin. The resin was centrifuged 1 
minute at 2,500 rpm in the eppendorf® 5424 microcentrifuge at room 
temperature. The tube was lightly knocked against the bench to allow the resin 
to settle at the bottom of the tube. The bulk of the supernatant was removed 
using a 1 mL pipette, whereas the residual liquid was removed using a 200 µL 
pipette and a gel-loading tip pressed against the bottom of the tube. The resin 
was washed again with 1 mL of the basic TMG buffer, resuspended in 1 mL of 
the buffer and aliquoted into fresh tubes equal to the number of the samples 
being processed in the experiment. The basic TMG buffer was removed from 
the tubes upon aliquoting. 
20 µL of the lysate cleared upon 30 minute centrifugation were transferred into 
new tubes as cleared lysate samples (or input). The total volume of the 
cleared lysate was measured for each sample (V2). Equal volumes of the rest 
of the lysates were transferred into the tubes with the affinity resin (leaving 
cloudy dark pellet behind - pellet 2) and incubated on a rotator for 3 hours at 
4°C to allow binding of the target protein (Est3-FLAG3) to the resin. The pellet 
2 samples were washed with 1 mL of the basic TMG buffer, centrifuged for 30 
minutes at 4°C and 14,000 rpm and resuspended in volume 2 of the TMG 
buffer. 20 µL aliquots of these suspension were saved as the pellet 2 
samples.  
The resin was pelleted by centrifugation for 1 minute at 2,500 rpm in a 
microcentrifuge at 4°C. 20 µl aliquots of the supernatants were drawn as the 
depleted lysate samples (or flow-through), while the rest of the supernatants 
were discarded. The resin was washed in 1 mL of TMG once and resuspended 
in volume 2 of TMG buffer. 20 µl aliquots of the suspension were taken as the 
IP samples, while the rest of it was centrifuged once more (same conditions). 
The supernatant was removed using a 1 mL pipette and a 200 µL pipette with 
a gel-loading tip. 
The Est3-FLAG3 was eluted from the resin by incubating the resin in 30 µL of 
1% SDS at 65°C for 10 min, while flicking the tubes every 2 minutes to 
maximise the elution. The eluate was transferred into a new tube. For sample 
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preparation, 20 µL of 2x Laemmli was added to total lysate, cleared lysate, 
depleted lysate, pellet 1, pellet 2 and IP samples and 10 µL of 4x Laemmli 
were added to the eluate. The samples were boiled in water for 5 minutes and 
processed further as described in the section for SDS-PAGE (2.7.2). 20 µL of 
each sample, except the eluate samples (30 µL), were loaded into gel.  
 
2.7.6. Coimmunoprecipitation of Sgs1-myc7 with FLAG3-
HA-Dna2 
 
Materials: • Basic Budd buffer: 50 mM Tris (pH 7.5), 10% (v/v) 
glycerol, 150 mM NaCl, 0.1 % Tween 20 
 • Budd buffer: basic Budd buffer + cOmplete™ 
EDTA-free Protease Inhibitor Cocktail (1 mini-
tablet/5 mL) 
 • Protein LoBind Tubes, 1.5 mL (eppendorf®, 
#30108116) 
 • 4x Laemmli Sample Loading buffer: 200 mM Tris-
HCl, pH 6.8, 400 mM DTT, 8% SDS, 40% (v/v) 
glycerol, 0.1% (w/v) bromophenol blue 
 • 200 mM PMSF in DMSO (200x stock) 
 • 2.0 ml Graduated Conical Tubes (Starlab, #E1420-
2331) 
 • Dynabeads™ Protein G for Immunoprecipitation 
(Invitrogen™, #10004D) 
 
The protocol is based on Budd, Choe and Campbell, 1995. 
Cell cultures were pre-grown at 30°C in 10 mL of YPRaf media to the log 
phase, resuspended in 100 mL of YPRaf and grown at 30°C up to OD600 = 
0.35, at which point 2 g of galactose were added to each culture to induce 
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overexpression of SGS1-MYC3 and FLAG3-HA-DNA2, both of which were 
under the GAL1 promotor. The cultures were incubated at 30°С for two more 
hours and then transferred into pre-cooled 50 mL conical tubes and 
centrifuged at 3,000 rpm for 3 minutes at 4°C in an eppendorf® 5810R table-
top centrifuge. The media was decanted and the tubes were centrifuged again 
for 12 seconds to collect residual media at the bottom of the tubes. The cells 
were washed once in 500 µL of cold water and once in 500 µL of the basic 
Budd buffer. Cell pellets were transferred into 2 mL screw-cap tubes (Starlab), 
resuspended in the Budd buffer + 1 mM PMSF (5 µL per 1 OD unit of cells) 
and combined with an equal volume of 0.5 mm glass beads. Cells were lysed 
by bead-beating using a Mini-Beadbeater-16 (Biospec Products) at 4°C in 
cycles of alternating 30-second periods of bead-beating and 1-minute periods 
of incubation on ice to avoid sample overheating and protein degradation. The 
cycles were repeated until over 95% of the cells were lysed as assayed by light 
microscopy (normally, 12 cycles of bead-beating per sample). 
Upon bead-beating, the 2 mL tubes were pierced with 21G syringe needles 
and inserted into 1.7 mL microcentrifuge tubes, the lysate was transferred into 
the tubes by centrifugation at 2,000 rpm for 1 minute at 4°C in an eppendorf® 
5417R microcentrifuge. The lysates were resuspend by pipetting and 20 µL 
aliquots of the lysates were saved as a set of total lysate samples. The rest 
of the lysates were transferred into new microcentrifuge tubes and centrifuged 
at 4,700 rpm for 10 minutes at 4°C in the eppendorf® 5417R microcentrifuge 
to remove cell debris and unbroken cells from the lysates (pellet 1). The 
supernatants were transferred into fresh microcentrifuge tubes while 
measuring their volume (V1). Pellet 1 was washed in 0.5 mL of the basic Budd 
buffer and resuspended in V1 of the Budd buffer + 1mM PMSF. A 20 µl aliquot 
of each suspension was moved to a new tube and saved as a pellet 1 sample. 
The supernatant from the previous step was centrifuged for 30 minutes at 4°C 
and 14,000 rpm to separate the lysate from chromatin. During this 
centrifugation, M2 anti-FLAG antibody (Sigma) was diluted 10-fold in the Budd 
buffer + 1mM PMSF. 20 µL of the lysate cleared upon 30 minute centrifugation 
were transferred into new tubes as cleared lysate samples (or input). The 
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total volume of the cleared lysate was measured for each sample (V2) and 
equal volume aliquots (V3) of the cleared lysate were transferred into new 
tubes and mixed with 1/50 V3 of the 10-fold M2 antibody dilution (resulting in 
1/500 final antibody dilution) and incubated on a rotator for 1 hour at 4°C. Dark 
and cloudy pellet 2 left behind upon the removal of the cleared lysate was 
washed with 0.5 mL of the basic Budd buffer, centrifuged for 30 minutes at 4°C 
and 14,000 rpm one more time and resuspended in V2 of the Budd buffer +1 
mM PMSF. 20 µL of this suspension was saved as a pellet 2 sample.  
During the 1 hour incubation, the required volume of protein G magnetic beads 
(Invitrogen) (100 µL of slurry per 200 OD units of cells) was transferred into a 
microcentrifuge tube with 1 mL of the basic Budd buffer. The beads were 
washed twice in the fresh basic Budd buffer and resuspended in 1 mL of the 
basic Budd buffer and divided into X equal volume aliquots (X= the number of 
samples) in the low protein binding 1.5 mL tubes (eppendorf®) to be used later 
for the M2 antibody pull-down. The buffer was removed from the magnetic 
beads after 1 hour incubation of the lysate with M2 antibody immediately 
followed by the transfer of the lysate-antibody mixture into the tubes with 
magnetic beads. This was followed by 2 hour incubation on a rotator at 4°С. 
The beads were separated from the lysate and 20 µL aliquots were saved as 
depleted lysates or flow-through. The rest of the lysates were discarded and 
the magnetic beads were washed once in 0.5 mL of the basic Budd buffer 
followed by transfer of the suspension into a new set of low protein binding 
tubes. During the washing steps, the samples were washed one-by-one to 
avoid extended periods of drying the beads. The beads were separated one 
more time and then resuspended in V3 of the Budd Buffer + 1mM PMSF. 20 
µL of this suspension was saved as an IP sample, while the rest of the 
suspension was transferred into a new low protein binding tube. Upon wash 
removal, 30 µL of 2x Laemmli buffer were added to each IP sample. 20 µL of 
2x Laemmli sample buffer were added to each of the rest of the samples. The 
samples were boiled in water for 5 minutes and processed further as described 
in the section 2.7.2. 5 µL of each sample, except for eluate samples (30 µL), 
were loaded per well.  
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2.8. DNA manipulations 
2.8.1. PCR to amplify modules for yeast gene deletion, 
truncation or addition of tagging sequences  
Materials: • 10x PCR buffer: 500 mM KCl, 100 mM Tris-HCl, pH 
9.0, 1% (v/v)Triton X-100 
 • 25 mM MgCl2 
 • 10 mg/ml Purified BSA (NEB, #B9001 ) 
 • dNTPs mix (10 mM each) from Taq PCR Core Kit 
(Qiagen, #201225) 
 • Taq DNA polymerase (NEB, #M0273) 
 • Vent™ DNA polymerase (NEB, #M0254) 
 
The modules for yeast gene modifications are described in Longtine et al., 
1998. For the list of plasmid templates and primers see Tables 2.3-2.4. 
Mixtures for module PCR amplification were prepared according to the recipe 




Table 2.7: Recipe for module amplification PCR 
Reagent Volume added, µL Final concentration 
10x PCR Buffer 5 1x 
Template DNA (1:10 dilution of 
a plasmid Miniprep) 
1 0.1-0.5 ng/µL 
Tris-HCl(1M, pH 9) 0.5 10 mM 
MgCl2 (25 mM) 3 1.5 mM 
dNTP (10 mM each) 1 0.2 mM 
Forward primer (100 µM) 0.25 0.5 µM 
Reverse primer (100 µM) 0.25 0.5 µM 
BSA (10mg/mL) 0.5 0.1 mg/mL 
Vent polymerase (2 U/µL) 0.5 0.02 U/µL 
Taq polymerase(2 U/µL) 0.5 0.02 U/µL 




The following program was implemented for module amplification: 
Table 2.8: Program for module amplification PCR  
Step Temperature Length Number of cycles 
Initial denaturation 
94°C 2 minutes 1 
80°C 2 minutes 1 
Denaturation 94°C 1 minute 
30 Annealing 55°C 45 seconds 
Elongation 72°C 2 minutes 50 seconds 
Final elongation 72°C 10 minutes 1 
 
2.8.2. High-fidelity PCR to amplify DNA fragments for 
cloning 
Materials: • Pfu DNA Polymerase 10X Reaction Buffer with 
MgSO4 (Promega, #M776A) 
 • Pfu DNA Polymerase (Promega, #M7745) 
 • Herculase II Fusion DNA Polymerase (Agilent 
Technologies, #600675) 
 • 5× Herculase II Reaction Buffer (Agilent 
Technologies) 
 • Q5® High-Fidelity DNA Polymerase (#M0491G) 
 • 5X Q5 Reaction Buffer 





Three different proofreading DNA polymerases were used to amplify DNA 
fragments for cloning: Pfu DNA polymerase (Promega), Herculase II Fusion 
DNA Polymerase (Agilent Technologies) or Q5® High-Fidelity DNA 
Polymerase (NEB). The reaction mixes were prepared according to the 
manufacturers’ protocols and the amplification programs for these enzymes 
are described in the tables below. All high-fidelity PCRs were hot-started to 
avoid primer degradation by the polymerases’ proofreading activities.  
Table 2.9: Program for Pfu PCR  
Tm (primer melting temperature) was determined using IDT OligoAnalyser 
(https://www.idtdna.com/calc/analyzer). The lower Tm of two primers used in a 
reaction was used to calculate Ta 
Pfu 
Step Temperature Length # of cycles 
Initial denaturation 95°C 1 min. 1 
Denaturation 95°C 30 sec. 
20 Annealing Ta (Tm-2°C) 30 sec. 
Elongation 72°C 1 min./kb 




Table 2.10: Program for Herculase II Fusion PCR 
Tm (primer melting temperature) was determined using IDT OligoAnalyser 
(https://www.idtdna.com/calc/analyzer). The lower Tm of two primers used in a 
reaction was used to calculate Ta 
Herculase 
Step Temperature Length # of cycles 
Initial denaturation 95°C 2 min. 1 
Denaturation 95°C 20 sec. 
20 Annealing Ta (Tm-5°C) 20 sec. 
Elongation 72°C 30 sec/kb 
Final elongation 72°C 3 minutes 1 
 
Table 2.11: Program for Q5® PCR 
Ta (primer annealing temperature) was determined using NEBTm Calculator 
(http://tmcalculator.neb.com/#!/main) 
Q5 
Step Temperature Length # of cycles 
Initial denaturation 98°C 30 sec. 1 
Denaturation 98°C 10 sec. 
20 Annealing Ta 30 sec. 
Elongation 72°C 30 sec/kb 




Following DNA amplification, the PCR products were purified using QIAquick 
PCR Purification Kit (Qiagen) according to the manufacturer’s protocol and 
eluted in 100 µL of pre-warmed (~55°C) Milli-Q water. After adding water, the 
columns were incubated for 15 minutes at room temperature before the final 
spin. For clonings, 5 µL of the purified PCR product were used per one 30 µL 
restriction reaction. 
2.8.3. Screening yeast recombinants by colony PCR 
Materials: • 20 mM NaOH 
 • Taq PCR Core Kit (Qiagen, #201225) 
 
Colony PCR was used to identify positive clones after yeast transformations. 
To this end, a small amount of cells was picked from a colony and lysed in 3 
µL of 20 mM NaOH by heating at 99°C for 10 minutes in a PCR machine. A 
PCR reaction mix was prepared using the reagents from Taq PCR Core Kit 
(Qiagen) and added to the cell lysates. The following program was used for 
amplification: 
Table 2.12: Program for yeast colony PCR 
Tm (primer melting temperature) was determined using IDT OligoAnalyser 
(https://www.idtdna.com/calc/analyzer). The lower Tm of two primers used in a 
reaction was used to calculate Ta 
Step Temperature Length # of cycles 
Initial denaturation 94°C 2 min. 1 
Denaturation 94°C 30 sec. 
20 Annealing Ta (Tm-2°C) 
30 
seconds 
Elongation 72°C 1 min./kb 




2.8.4. Screening E.coli transformants by colony PCR 
 
Materials: • 10X ThermoPol® Reaction Buffer (NEB, #B9004S) 
 • dNTPs mix (10 mM each)  
 • Taq DNA polymerase (NEB, #M0273) 
 
E. coli colony screen was used for identifying positive clones after bacterial 
transformation. The PCR mixture for E. coli colony screen was prepared as 
described in Table 2.13: 
Table 2.13: Recipe for E. coli colony PCR mix 
 
Reagent Volume added, µL 
10X ThermoPol® Reaction Buffer (NEB) 2.5 
dNTP (10 mM each) 0.5 
Forward primer (100 µM) 0.5 
Reverse primer (100 µM) 0.5 
Taq (NEB) 0.25 
H2O to 25 
 
Cells were picked from the colonies using a pipette tip and mixed with the 




Table 2.14: Program for E. coli colony-screen PCR 
Tm (primer melting temperature) was determined using IDT OligoAnalyser 
(https://www.idtdna.com/calc/analyzer). The lower Tm of two primers used in a 
reaction was used to calculate Ta 
Step Temperature Length # of cycles 
Initial denaturation/disintegration 94°C 10 min. 1 
Denaturation 94°C 30 sec. 
35 Annealing Ta (Tm-2°C) 30 sec. 
Elongation 72°C 1 min./kb 
Final elongation 72°C 10 min. 1 
 
2.8.5. Yeast genomic DNA extraction 
 
Materials: • SE solution: 1 M sorbitol, 0.1 M EDTA 
 • Zymolyase-100T from Arthrobacter luteus, 100 
U/mg (MP Biomedicals, #08320932) 
 • EDS solution: 50 mM EDTA, 0.2% (w/v) SDS, 2.5 
mM NaOH 
 • 8 M ammonium acetate 
 • Isopropanol 
 • 70% (v/v) ethanol (4°C cold) 
 • 1x TE: 10 mM Tris, pH 8.0, 1 mM EDTA 





All centrifugation steps were performed at room temperature in the eppendorf® 
centrifuge 5424. Cells for genomic DNA extraction were either collected from 
a freshly-grown patch on an agar plate or harvested by centrifugation from 
liquid culture. ~5 OD units of cells were resuspended in 150 µL of the SE 
solution with zymolyase-100T (0.1 - 1mg/ml final concentration) and incubated 
in a water bath at 42°C for 10-20 minutes until spheroplast sedimentation 
became visible at the bottom of the tubes. The spheroplasts were pelleted by 
centrifugation at 5,000 rpm for 2 minutes. Most of the SE solution was removed 
with a pipette, leaving ~20 µL of liquid behind. The pellets were resuspended 
by brief vortexing. In order to lyse the cells, 150 µL of the EDS solution were 
added to each sample followed by brief (up to three seconds) vortexing. The 
samples were incubated in a water bath at 65°С for 15 minutes to inactivate 
cellular nucleases. 75 µL of 8M ammonium acetate were added to each 
sample and the samples were incubated on ice for at least 30 minutes to 
precipitate proteins. The samples were centrifuged for 10 minutes at top speed 
in a microcentrifuge and the supernatants were transferred into a new set of 
1.7 mL tubes. 135 µL of isopropanol were added to each sample and the tubes 
were inverted 4 times for gentle mixing. Precipitated nucleic acids were 
pelleted by centrifugation at top speed for 10 minutes and washed with 500 µL 
of cold 70% (v/v) ethanol. The ethanol was removed in two steps, each 
following a 5-minute round of centrifugation. The pellets were dried in air for 
several minutes, dissolved in 20-50 µL of the TE buffer with 20 mg/L of RNase 
A and incubated at room temperature for 1 hour or at 4°C overnight. The 




2.8.6. Agarose gel electrophoresis 
 
Materials: • 10x TBE: 0.89 M Tris, 0.89 M boric acid, 20 mM 
EDTA 
 • 6x Gel-Loading buffer: 0.25% (w/v) bromophenol 
blue, 0.25% (w/v) xylene cyanol FF, 15% (w/v) 
Ficoll-400 
 • Agarose, molecular biology grade (Melford, 
#MB1200) 
 • 10 mg/mL ethidium bromide (Fisher Scientific, 
#E/P800/03) 
 • 100 bp and 1 kb DNA ladder, 500 μg/ml (NEB, 
#N3231L, #N3232L) 
 
0.5-2% of agarose in 1x TBE were melted in a microwave. Upon complete 
dissolving of agarose, ethidium bromide was added to the mixture to the final 
concentration of 0.5 µg/mL. The gel was cast in a horizontal gel tank. 
Depending on the application, combs with different teeth size were used to 
shape wells. 1x TBE was used as running buffer.  
DNA samples were mixed with 1/5 volume of 6X loading buffer and loaded into 
wells along with a corresponding DNA molecular weight marker. The samples 
were resolved at constant electric field strength (1.5-11 V/cm, depending on 
the application) until a satisfying degree of band separation was achieved. The 
DNA was visualized using Molecular Imager® Gel Doc™ XR System in the 




2.8.7. Labelling of DNA probes with α-32P-dATP or γ-32P-
ATP 
Materials: • Prime-it II Random Primer Labelling Kit (Agilent 
Technologies, #300385) 
 • α-32P-dATP, 6,000 Ci/mmol (Perkin Elmer, 
#BLU012Z) 
 • γ-32P-ATP, 6,000 Ci/mmol (Perkin Elmer, 
#BLU002Z) 
 • T4-polynucleotide kinase, 10 U/μl (NEB, #M0201S) 
 • 10X ThermoPol® Reaction Buffer (NEB, #B9004S) 
 • dNTPs mix (10 mM each)  
 • Taq DNA polymerase (NEB, #M0273 
 • illustra™ Microspin G-25 columns 
 
α-32P-dATP was used to label probes templated by PCR-products. The PCR 
products used as templates for probe labelling were synthesized using yeast 
genomic DNA as a template according to the following protocol: 
Table 2.15: Recipe for probe template synthesis by PCR 
Reagent Volume added, µL  
10X ThermoPol® Reaction Buffer (NEB) 2.5 
Template DNA (genomic DNA, dilution 
1:10) 
1 
dNTP (10 mM each) 0.5 
Forward primer (100 µM) 0.5 
Reverse primer (100 µM) 0.5 
Taq (NEB) 0.25 
H2O to 25 
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Table 2.16: PCR program to amplify a template for a DNA probe 
Step Temperature Length # of cycles 
Initial denaturation 94°C 10 min. 1 
Denaturation 94°C 30 sec. 
35 Annealing Tm-2°C 30 sec. 
Elongation 72°C 1 min./kb 
Final elongation 72°C 2 min. 1 
 
After the amplification, the PCR product was run in an agarose gel and gel-
purified using QIAquick Gel Extraction Kit (Qiagen). The concentration of the 
purified PCR-product was adjusted to 2.5 ng/µL. The labelling was performed 
using Prime-it II Random Primer Labelling Kit and α-32P-dATP (6,000 
Ci/mmol). During the first step the following components were combined in a 
PCR tube: 
Table 2.17: Mixture for DNA probe labelling 
Reagent Volume added, µL 
PCR product (2.5 ng/µL) 2.5 
Random 9-mer Primers 2.5 




The mixture was heated up in a PCR machine for 5 minutes at 99°C and cooled 
at room temperature for 2 minutes. 2.5 µL of 5x reaction buffer with dNTPs 
(except dATP) were added to the mix. 0.5 µL of Exo(–) Klenow DNA 
polymerase were put on the wall of the tube without contacting the rest of the 
mix. In the radiation room, 2.5 µL of α-32P-dATP were added to the reaction 
mix, which was then mixed by pipetting and used to wash the enzyme off the 
tube wall, followed by more mixing. The tube was immediately transferred to a 
PCR machine pre-set at 37°C and incubated at 37°C for 35-40 minutes. 
Subsequently, 60 µL of Milli-Q water were added to the reaction and the probe 
was purified from unincorporated nucleotides using an illustra™ Microspin G-
25 column according to the manufacturer’s protocol. The probe was stored at 
-20°C. 
γ-32P-ATP was used to label the oligo OSM32 (see Table 2.4) to probe for 
yeast telomeric repeats in dot-blots. The labelling was performed using T4-
polynucleotide kinase (PNK) (10 U/μl). 2.5 µL of 2 µM oligo were combined 
with 2 µL of 5x PNK buffer and 5 µL of γ-32P-ATP in a PCR tube. Once the 
components were mixed, 0.5 µL of T4 PNK were added to the mix and the 
tube was incubated at 37°C in a PCR machine for 15-30 minutes. The reaction 
was mixed with 40 µL of Milli-Q water and the labelled oligo was purified from 
the excess of γ-32P-ATP using illustra™ Microspin G-25 column according to 
the manufacturer’s protocol. The probe was stored at -20°C. No boiling was 




2.8.8. Southern blotting  
 
Materials: • Depurination solution: 0.25 M HCl 
 • Denaturing solution: 0.5 M NaOH, 1.5 M NaCl 
 • Neutralizing solution: 1.5 M NaCl, 0.5 M Tris-HCl, 1 
mM Na-EDTA, pH 7.2 
 • 20x SSC: 3 M NaCl, 0.3 M sodium citrate, pH 7.0 
 • 20x SSPE: 3 M NaCl, 0.2 M NaH2PO4, 20 mM 
EDTA, pH 7.4 
 • 100x Denhardt’s solution: 2% (w/v) bovine serum 
albumin (BSA), 2% (w/v) polyvinylpyrrolidone 
(PVP), 2% (w/v) Ficoll-400 
 • Hybridization buffer: 6x SSPE, 0.5% (w/v) SDS, 5x 
Denhardt’s solution 
 • Wash buffer: 0.1x SSPE, 0.1% (w/v) SDS 
 • Positively charged nylon transfer membrane 
Amersham Hybond®-N+ (GE Healthcare, 
#RPN303B) 
 
The DNA transfer from agarose gels onto the membranes was performed 
under neutral conditions, unless otherwise specified. After the completion of 
the gel run, the DNA was visualized and photographed using Molecular 
Imager® Gel Doc™ XR System in the ethidium bromide visualization mode, 
with a fluorescent ruler placed next to the DNA size marker. The unused sides 
of the gel were cut off and the gel was incubated in 3 volumes of depurination 
solution for 30 minutes at room temperature with gentle agitation. The gel was 
rinsed with deionised water and incubated in 3 volumes of denaturation 
solution for 30 minutes at room temperature with gentle agitation. The gel was 
rinsed again with deionised water and incubated in 3 volumes of neutralisation 
buffer for 45 minutes at room temperature with gentle agitation. During the last 
incubation, a piece of charged nylon membrane and three pieces of Whatman 
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3MM paper were prepared, with the dimension exceeding the measurements 
of the gel by 5 mm. The membrane was firstly incubated in deionised water for 
1 minute and then equilibrated in 20X SSC for 10 minutes. Once the incubation 
in the neutralisation buffer was complete, the gel was laid face-down onto a 
paper wick (3 sheets of 20X SSC-soaked Whatman) covering a plexiglass 
support positioned in a tray filled with 20X SSC. The gel was covered with the 
charged nylon membrane and then with the three sheets of Whatman 3MM 
paper soaked with 20X SSC. A glass pipette was rolled over the surface of the 
sheet stack to remove any trapped bubbles. The area of the tray surrounding 
the gel was covered with Saran Wrap. A stack of blotting paper was placed on 
top of the Whatman sheets and weighed down with a plexiglass plate and glass 
bottles (see Figure 2.3). The transfer was performed overnight. In the morning, 
the membrane was retrieved from the transfer system and air-dried for 30 
minutes. The DNA was crosslinked to the membrane in a UVP CX-2000 
Ultraviolet Crosslinker at 1200 J/cm2. The membrane was incubated in 15 mL 
of hybridization buffer for 1 hour at 65°C. The buffer was replaced with 10 mL 
of fresh pre-warmed (65°C) hybridization buffer. 5 µL of a random-primed 
labelled probe (see section 2.8.7 for probe preparation) was combined with 50-
100 µL of water, melted in a PCR machine at 99°C for 5 minutes and added to 
the hybridization buffer immediately. The hybridization was performed at 65° 
for at least 8 hours, in a hybridisation bottle on a rotisserie. After the 
hybridization, the membrane was rinsed 3 times with the washing solution and 
incubated with ~30 mL of the washing solution at 65°C for 40 minutes on a 
rotisserie. The membrane was rinsed again 3 times with the washing solution, 
wrapped in Saran Wrap and exposed to a phosphor storage screen for up to 
several days depending on the activity of the probe. Upon the exposure, the 
screen was scanned with Typhoon FLA 7000 scanner and the image was 




Figure 2.3: Capillary transfer setup for Southern blotting 
 
2.8.9. Stripping of a probe off a Southern blotting 
membrane 
 
Materials: • Stripping buffer: 50% (v/v) 
formamide, 5x SSPE 
 • Wash buffer: 0.1x SSPE, 
0.1% (w/v) SDS 
 
Count reading emitting from the membrane was taken with a Geiger counter 
before and after stripping to provide a rough estimate of the stripping efficiency. 
The membrane was stripped in 25 mL of the stripping buffer for 1 hour at 65°C, 
in a hybridisation bottle on a rotisserie. The membrane was rinsed three times 
with the wash buffer and incubated in ~30 mL of the wash buffer for 1 hour at 
65°C. Subsequently, the membrane was rinsed three more times with the 




2.8.10. Telomere length analysis by Southern blotting 
Materials: • 1x TE: 10 mM Tris-HCl, pH 8.0, 1 mM EDTA 
 • Ribonuclease A (RNase A) from bovine pancreas 
(Sigma, #R4875) 
 • NEBuffer™ 1.1 (NEB, # B7201S) 
 • KpnI (NEB, #R0142S) 
 • 6x Gel-Loading buffer: 0.25% (w/v) bromophenol 
blue, 0.25% (w/v) xylene cyanol FF, 15% (w/v) 
Ficoll-400 
 • Agarose, molecular biology grade (Melford, 
#MB1200) 
 • 10 mg/mL ethidium bromide (Fisher Scientific, 
#E/P800/03) 
 • 1 kb DNA ladder, 500 μg/ml (NEB, #N3232L) 
 
Telomere length was equilibrated by passaging strains at 30°C (unless 
specified otherwise) for ~80 generations (4 streaks). Genomic DNA was 
extracted from the cells of the last streak as described in section 2.8.5 and 
resuspended in 50-100 µL of TE buffer + 20 mg/L of RNAse A. 5 µL of each 
DNA sample were mixed with 8 µL of Milli-Q water, 1.5 µL of NEB buffer 1.1 
and 0.5 µL of KpnI. The digest was performed overnight at 37°C in a PCR 
machine. In the morning, the samples were mixed with 3 µL of 6X loading 
buffer, loaded into a 25 cm-long 0.85% agarose gel, along with NEB 1 kb 
ladder and resolved at 3.4 V/cm for approximately 8.5 hours (until the 0.5 kb 
band of the ladder migrated 17-17.5 cm away from the wells). The regions of 
the gel above the 10 kb band and below 0.5 kb band as well as to the left and 
right of the used lanes were cut off. The subsequent procedures were 
performed as described in section 2.8.8. The PCR product for the probe (KL1, 
Makovets, Herskowitz and Blackburn, 2004) annealing to the subtelomeric Y’-
element was synthesized using S. cerevisiae NK1 genomic DNA and the 
oligos OSM60 and OSM106 as described in section 2.8.7. 
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2.8.11. Quantitative DNA analysis using dot-blotting 
 
Materials: • Basic TMG buffer with 100 mM NaCl: 10 mM Tris-
HCl (pH 8.0), 1 mM MgCl2, 5% (v/v) glycerol, 100 
mM NaCl, 0.5% Tween 20 
 • Basic TMG buffer with 300 mM NaCl: 10 mM Tris-
HCl (pH 8.0), 1 mM MgCl2, 5% (v/v) glycerol, 300 
mM NaCl, 0.5% Tween 20 
 • TMG-100 buffer: basic TMG buffer with 100 mM 
NaCl, 100 µM DTT, 12 U/mL RNAsin® + 
cOmplete™ EDTA-free Protease Inhibitor Cocktail 
(1 mini-tablet/5 mL) 
 • TMG-300 buffer: basic TMG buffer with 300 mM 
NaCl, 100 µM DTT, 12 U/mL RNAsin® + 
cOmplete™ EDTA-free Protease Inhibitor Cocktail 
(1 mini-tablet/5 mL) 
 • NEBuffer™ 3.1 (NEB, #B7203S) 
 • Benzonase® Nuclease (Sigma-Aldrich®, #E1014) 
 • 200 mM EDTA (pH 8.2) 
 • 0.4 M NaOH 
 • 2x SSC: 0.3 M NaCl, 30 mM sodium citrate, pH 7.0 
 • 20x SSPE: 3 M NaCl, 0.2 M NaH2PO4, 20 mM 
EDTA, pH 7.4 
 • 100x Denhardt’s solution: 2% (w/v) bovine serum 
albumin (BSA), 2% (w/v) polyvinylpyrrolidone 
(PVP), 2% (w/v) Ficoll-400 
 • Hybridization buffer: 6x SSPE, 0.5% (w/v) SDS, 5x 
Denhardt’s solution 




 • Positively charged nylon transfer membrane 
Amersham Hybond®-N+ (GE Healthcare, 
#RPN303B) 
 
Dot-blotting was used to assess the relative efficiency of benzonase-mediated 
degradation of non-telomeric and telomeric DNA at different salt 
concentrations in yeast lysate. The dot-blotting protocol is based on Brown, 
2001 and involves using a vacuum manifold (DHM-96, Scie-Plas, Figure 2.4) 
and a vacuum pump (Laboport® N86KN.18).  
 
 
Figure 2.4: Vacuum manifold DHM-96, Scie-Plas 
From http://www.scie-plas.com/documents/SCIE-PLAS/distributors/493.pdf  
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To obtain cell lysate for the experiment the cultures were grown in 200 mL of 
YPD at 30°C starting from OD600 = 0.1. At the OD600 = 0.8-0.9 the cultures were 
poured into pre-cooled 250 mL centrifugation bottles and centrifuged in an 
Avanti J-30I centrifuge (Beckman Coulter) at 2,300g for 5 minutes at 4°C. The 
medium was removed and the cells were resuspended in 9 mL of cold water 
in a 15 mL conical tube. The cell suspension was split into halves and 
centrifuged in eppendorf® 5810R centrifuge at 3,000 rpm for 3 minutes at 4°C. 
One half of the cells from each culture was washed in 400 µL of the cold basic 
TMG buffer with 100 mM NaCl and the other half was washed with 400 µL of 
the cold basic TMG buffer with 300 mM NaCl. The cells were pelleted again 
under the same conditions and resuspended in 400 µL of the cold TMG-100 
and TMG-300 buffers, respectively. 500 µL of cold 0.5 mm glass beads were 
added to each tube and the cells were lysed by bead-beating in 30 cycles of 
alternating 30-second vortexing and 30-second incubation on ice, until >90% 
of cells lysed (as determined by light microscopy). Two 40 µL aliquots of the 
total lysate from each sample were transferred into new tubes, one of them 
was later used for DNA extraction and the other – for western blotting. The rest 
of the lysate was centrifuged in an eppendorf® 5417R centrifuge at 4,700 rpm 
for 10 minutes at 4°C. After the centrifugation, two 130 µL aliquots of the 
supernatant from each tube were transferred into two new tubes. 1.3 µL of 
100X benzonase stock (25 U/mL) in TMG-100 or TMG-300 were added to one 
of the two aliquots of the supernatant originating from a single tube (the buffers 
of the benzonase stock were chosen to match the buffers in which the cells 
were lysed). The tubes were then incubated for 10 minutes in an eppendorf® 
Thermomixer® comfort at 22°C and centrifuged in an eppendorf® 5417R 
centrifuge at 14,000 rpm for 30 minutes at 4°C to sediment chromatin. 85 µL 
of the supernatant were removed and 40 µL were saved as a cleared lysate 
sample to be used in western blotting later. Meanwhile, the pellet was washed 
with 500 µL of cold TMG-100 or TMG-300, depending on the buffer used during 
bead-beating. The pellet was centrifuged again under the same conditions, the 
liquid was removed and the pellet was resuspended in 125 µL of either TMG-
100 or TMG-300. Two 40 µL aliquots of resuspended chromatin pellet were 
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moved to new tubes, one of them was later used in western blotting as a pellet 
2 sample, and the other was used for DNA extraction.  
The DNA extraction was performed as described in section 2.8.5, starting from 
the step of adding 150 µL of EDS to the samples. At the final step, the nucleic 
acids were resuspended in 11 µL of TE + 20 mg/L of RNase A. After 1 hour 
incubation at room temperature (or overnight at 4°C), 1 µL of the DNA sample 
was mixed with 4 µL of Milli-Q water, 0.5 µL of NEB buffer 3.1 and 1 µL of 6X 
loading buffer and resolved in 0.5% agarose gel to assess the benzonase-
dependent degradation of genomic DNA at different salt concentrations.  
A piece of positively charged nylon membrane and a piece of Whatman 3MM 
paper were cut to the size of the grid of the manifold template (10.9 cm X 7.2 
cm). The membrane was incubated in deionised water for 10 minutes. The 
paper was submerged in deionised water and placed onto the grid of the 
manifold template and the membrane was placed on top of the paper. 
The 10 µL DNA extracts were mixed in a PCR tube with 0.9 µL of 200 mM 
EDTA (pH 8.2) and 7.3 µL of 1 M NaOH to the final concentration of 10 mM 
EDTA 0.4 M NaOH. The mixture was incubated at 99°C in a PCR machine for 
10 minutes followed by a brief centrifugation. The pump was turned on and the 
wells of the manifold were washed with 500 µL of deionised water. The 
samples were applied to the wells and the wells were rinsed with 500 µL of 0.4 
M NaOH. The membrane was removed from the manifold, rinsed briefly with 
2X SSC and air-dried.  
During the next step, the DNA was cross-linked to the membrane in a UVP 
CX-2000 Ultraviolet Crosslinker at 1,200 J/cm2. The membrane was incubated 
for 1 hour at 50°C in 15 mL of hybridization buffer in a bottle on a rotisserie 
and the buffer was replaced by fresh pre-warmed (50°C) hybridization buffer 
with 5 µL of the telomere-specific probe based on the OSM32 oligo. The 
hybridization was performed at 50°C for 8 hours. Following the hybridization, 
the membrane was rinsed three times in the low-stringency wash buffer, 
washed in ~30 mL of the same buffer for 40 minutes at 50°C and again rinsed 
three times. The membrane was wrapped in Saran Wrap and exposed a 
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storage phosphor screen overnight. The screen was scanned using a Typhoon 
FLA 7000 scanner and the image was analysed using the ImageQuant TL 
Software. After that the membrane was stripped of the telomere-specific probe, 
as described in section 2.8.9, the membrane was hybridized to either a URA3 
probe or an ARS1 probe as described in section 2.8.8 and exposed to a 
storage phosphor screen overnight. The screen was scanned using a Typhoon 
FLA 7000 scanner and the image was analysed with the ImageQuant TL 
Software. 
 
2.8.12. Cloning  
 
Materials: • QIAquick™ Gel Extraction Kit (Qiagen, #28706) 
 • MinElute PCR Purification Kit (Qiagen, #28006) 
 • Restriction enzymes (NEB) 
 • Calf Intestinal Alkaline Phosphatase (NEB, 
#M0290S) 
 • T4 DNA Ligase (NEB, #M0202S) 
 
All centrifugation steps throughout the procedure were performed at room 
temperature. 
DNA fragments for cloning were generated either by cutting out an existing 
fragment from a plasmid or generating such a fragment by high-fidelity PCR, 
with the desired restriction sites added to the 5’ends of the PCR primers. For 
the latter option, Pfu, Herculase, or Q5® polymerase was used (see section 
2.8.2 on high-fidelity PCR). For the digest of a PCR product, ~ 5% of the 
column-purified DNA of a single 50 µL PCR reaction were taken into a 
restriction reaction. 
Both vector and insert digests were usually performed in 30 µL reaction 
volumes. 5-20 U of restriction enzymes were used per 30 µL of the reaction. 
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The volume of each enzyme to be added was calculated according to the 






, 𝑉𝐴 + 𝑉𝐵 + 𝑉𝐶𝐼𝐹 ≤ 0.1 × 𝑉𝑇, where VA, VB 
are the volumes of stocks of enzymes A and B to be added into the restriction 
digest, respectively, VCIF is the volume of Calf Intestinal Phosphatase to be 
added into the restriction digest, VT is the total volume of the restriction mixture, 
NA and NB are the numbers of restriction sites in the DNA molecule used for 
activity assay of enzymes A and B, respectively and CA and CB are unit stock 
concentrations of enzymes A and B, respectively. Calf Intestinal Phosphatase 
was used when only one vector restriction site was used for cloning, or when 
two restriction sites where too close to each other to resolve fully-digested 
vector from linearized molecules.  
For two-enzyme vector digests, no-enzyme and single-enzyme 10 µL control 
mixtures were also made, allowing to visualise electrophoretic separation of 
the target fragment from the undigested and linearized forms of the plasmid 
and confirm efficient digestion of both target restriction sites.  
The restriction mixtures were incubated in a PCR machine at the optimal 
temperature for 1 hour (plasmid digests) or 3-4 hours (PCR product digests). 
The plasmid fragments were resolved in agarose gel electrophoresis and gel 
slices with the desired fragments were cut out from the gel. The DNA 
fragments were extracted from the gel using QIAquick™ Gel Extraction Kit 
according to the manufacturer’s protocol. Digested PCR products were purified 
using MinElute PCR Purification Kit according to the manufacturer’s protocol. 
The elution was performed for 15 minutes. Vector DNA was eluted with 30 µL 
of warm (~55°C) Milli-Q water and 15 µL of the vector eluate was used to elute 
the insert. The rest of the vector eluate was used as a vector-only control to 
assess the background level of non-digested and self-ligated vector upon 
transformation. Both vector-only and vector+insert eluates were combined with 
water, T4 DNA Ligase Reaction Buffer and 400 U of T4 ligase (NEB) in 20 µL 
ligation reaction mixtures which and left at room temperature. 55 minutes into 
the ligation reaction, competent E.coli cell aliquots were transferred from -80°C 
on ice to defrost: the number of aliquots matched the number of ligation 
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reaction mixtures. 10 µL of each ligation reaction were added per single E.coli 
aliquot, leaving the remaining 10 µL of the reaction incubating overnight at 
room temperature. The competent cells were left on ice for 30 minutes, 
followed by a two minute heat-shock at 42°C and one minute of incubation on 
ice. 900 µL of LB broth + 1% glucose were added to each aliquot and the tubes 
with the cells were incubated on a shaker at 37°C for 1 hour. The cells were 
pelleted at 5,000 rpm in an eppendorf® Centrifuge 5424 for 2 minutes. 900 µL 
of the media were removed, the cells were resuspended in the remaining LB 
and plated onto LB plates with an antibiotic (most often – ampicillin at 100 
mg/L) to select for transformants. The plates were incubated at 37°C overnight. 
The colonies were either screened by PCR (in the case of high background on 
the control plate) and/or inoculated into 5 mL of LB broth with a corresponding 
antibiotic for subsequent plasmid extraction (at least three colonies per 
cloning). The cultures were incubated at 37°C on a shaker for at least 8 hours. 
The plasmids were extracted Wizard® Plus Minipreps DNA Purification 
System according to the manufacturer’s protocol. At the elution step, 50-100 
µL of pre-warmed (~55°C) Milli-Q water were added to each column and the 
columns were incubated for 15 minutes at room temperature before the spin.  
Diagnostic digests were performed in 10 µL reaction mixtures and analysed by 
agarose gel electrophoresis. 2 clones with correct fragment size patterns were 
additionally verified by sequencing (see next section for Sanger sequencing) if 
the cloned DNA was generated by PCR.  
 
2.8.13. Sanger sequencing 
Materials: • QIAquick™ PCR Purification Kit (Qiagen, #28106) 
 
To validate sequences of plasmids and PCR products, 300-1,000 ng of 
plasmid DNA or 2-40 ng (depending on the molecular weight) of a purified PCR 
product were mixed with 3.33 pmoles of the corresponding primer in 6 µL 
volume and submitted for Big Dye Reaction Sanger sequencing to the 
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Edinburgh Genomics facility of the University of Edinburgh. PCR products 
were purified using QIAquick PCR Purification Kit prior to submission. The 
sequence reads were analysed in FinchTV software. 
 
2.8.14.  Quantitative analysis of yeast chromosomes 
resolved by Pulse-Field Gel Electrophoresis  
Materials: • Wash buffer: 10 mM Tris-HCl (pH 7.6), 50 mM 
EDTA 
 • SeaKem® LE Agarose (Lonza, #50000) 
 • Certified™ Megabase Agarose (Bio-Rad, #161-
3109) 
 • Lyticase from Arthrobacter luteus (Sigma-Aldrich®, 
# L2524) 
 • Lyticase stock: 17,000 U/ml of lyticase in 50% (v/v) 
glycerol, 10 mM K2HPO4, 10 mM KH2PO4 
 • Proteinase K, recombinant, PCR Grade (Sigma-
Aldrich®, #3115801001 
 • Proteinase K Buffer: 100 mM Na-EDTA (pH 8.0), 
0.2% sodium deoxycholate, 1% N-lauroylsarcosine 
sodium 
 • 1x TBE: 90 mM Tris, 86 mM boric acid, 2 mM Na-
EDTA (pH 8.0) 
 • 0.5x TBE: 45 mM Tris, 43 mM boric acid, 1 mM Na-
EDTA (pH 8.0) 
 • 10 mg/mL ethidium bromide (Fisher Scientific, 
#E/P800/03) 






For one sample, 1.5-3.0 OD units of cells were harvested from overnight plate 
patches and resuspended in 1 mL of the wash solution in microcentrifuge 
tubes. The cells were centrifuged at 5,000 rpm in an eppendorf® Centrifuge 
5424 for 2 minutes at room temperature. The cells were washed with 1 mL of 
the wash solution and resuspended in 100 µL of the wash solution. The tubes 
were inserted into an eppendorf® Thermomixer® comfort to keep them 50°C 
warm and shaking at 500 rpm. The samples were mixed with 100 µL of warm 
(50°C) 1.6-1.8% SeaKem® LE Agarose (in water) and cast into plug molds. 
The plugs were allowed to solidify at 4°С and then were transferred into 1.7 
mL tubes with 500 µL of the wash solution with 340 U/mL of Lyticase. The 
tubes were incubated at 37°C for 1 hour on a nutator and the wash solution 
was replaced with 500 µL of the Proteinase K Buffer with 1 mg/ml of proteinase 
K. The tubes were placed into the Thermomixer again and incubated overnight 
at 50°С with shaking at 500 rpm. Next day, the plugs were washed four 30-
minute rounds with 1 mL of the wash solution by incubating on a nutator at 
room temperature. The plugs were either used immediately or stored at 4°C in 
the wash solution. 
1.2 g of Certified™ Megabase Agarose were melted in 120 mL of 0.5x TBE 
buffer to cast a single gel. The plugs were cut into halves and a half of each 
plug was attached to the comb using molten agarose. The comb was inserted 
into a Standard Casting Stand (Bio-Rad) and the gel was poured into the Stand 
at 4°C. After the gel has solidified, the comb was removed, the gel was 
transferred into an Electrophoresis Cell of CHEF-DR® III System (Bio-Rad) 
with 3 L of 0.5x TBE buffer pre-cooled to 14°C. Yeast chromosomes were 
resolved under the following conditions: 
• Stage 1: Switch time - 60 seconds, electric field strength - 6 Volts/cm, 
included angle – 120°, temperature – 14°, length – 15 hours 
• Stage 2: Switch time - 90 seconds, electric field strength - 6 Volts/cm, 
included angle – 120°, temperature – 14°, length – 7.6-10 hours 
After the run was finished, the gel was stained in 500 mL of 1x TBE with 600 
µg/L of ethidium bromide for 30 minutes on an orbital shaker and then washed 
107 
 
two times with 500 mL of 1x TBE for 15 minutes on an orbital shaker. The DNA 
was visualized using Molecular Imager® Gel Doc™ XR System in the ethidium 
bromide visualization mode. The exposure time was adjusted to maximize the 
intensity while avoiding saturation of the target bands. To assess the number 
of CHRVIII copies per cell, the ratio of CHRVIII/CHRV band intensity was 
calculated and normalized to a diploid strain control using the Bio-Rad Image 
Lab™ Software.  
2.8.15. Southern blotting of PFGE-resolved yeast 
chromosomes 
Materials: • MagnaGraph Nylon Membranes, Tight pore size 
(0.22µM), 20 cm x 3 m (Osmonics, #NJTHYA0010) 
 • 10 mg/mL ethidium bromide (Fisher Scientific, 
#E/P800/03) 
 • Denaturing solution: 0.5 M NaOH, 1.5 M NaCl 
 • Neutralizing solution: 1.5 M NaCl, 0.5 M Tris-HCl, 1 
mM Na-EDTA, pH 7.2 
 • 20x SSC: 3 M NaCl, 0.3 M sodium citrate, pH 7.0 
 
The steps for the PFGE part of the protocol are the same as in the previous 
section, except that during the staining step the concentration of 1mg/L of 
ethidium bromide was used and the gel washing steps were omitted. After the 
visualization, the gel was incubated in 3 volumes of the denaturing solution for 
30 minutes on a rocker, rinsed with deionised water and incubated in 3 
volumes of the neutralization buffer. The gel was transferred onto 
MagnaGraph Nylon Membrane (0.22 μm pore size) using a capillary transfer 
system (as in Figure 2.3, but without the bottle) for six hours during the day 
and then overnight. During the first six hours the napkins were changed every 
1.5-2 hours. To avoid gel collapsing, a plexiglass sheet was used as the only 











Optimization of Co-immunoprecipitation of 
Est2 and Est3 
3. Optimization of Co-immunoprecipitation 






Previously, Millet et al. have demonstrated that elevated growth temperature 
decreases the steady-state level of Est2, causing senescence in yeast and 
that chromosome VIII monosomy can compensate for Est2 insufficiency at 
elevated growth temperature without increasing Est2 amount (Millet et al., 
2015). In order to understand the connections between aneuploidy and 
telomere biology in yeast and the potential relevance of these connections to 
cancer I set two main investigative aims, which would be detailed below: 
1. Gaining molecular insights into the mechanism of aneuploidy-
dependent compensation of temperature-induced telomerase 
insufficiency 
2. Understanding how the steady-state level of Est2 is controlled 
The first aim entails clarifying whether and how the increase in the amount of 
Est1 and Est3 proteins as well as TLC1 RNA compensates for insufficient Est2 
in aneuploids. One of the possible explanations could be that the higher levels 
of the telomerase components lead to more efficient incorporation of Est2 into 
telomerase complex, even with the same amount of Est2 present in each cell. 
This notion is supported by a study, in which two copies of EST1-MYC12 were 
introduced in tandem into a FLAG3-MYC12-EST2 yeast strain, resulting in an 
excess of Est1-myc12 over FLAG3-myc12-Est2. This was accompanied by a 
substantial increase in the amount of Est1-Est2 containing complex in the G1 
phase of the cell cycle, when Est1-Est2 interaction is normally hard to detect, 
despite the apparent parity in the numbers of Est1 and Est2 molecules at this 
cell cycle stage (Tucey and Lundblad, 2013). In order to test the hypothesis 
that aneuploid cells overcome temperature-induced telomerase insufficiency 
through increasing the amount of telomerase complex I was going to perform 
Est2-Est3 co-immunoprecipitation experiments and compare the amount of 
Est3 associated with Est2 or vice versa in aneuploid cells versus diploid cells 
grown at 38.5°C. Choosing Est3 as the co-immunoprecipitation partner of Est2 
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in the experiment was justified by the fact that Est3 subunit is included last 
during the full telomerase complex assembly (Tucey and Lundblad, 2014). 
The second aim concerns understanding the reasons underlying the fact that 
the amount of Est2 protein remains the same in aneuploids and diploids, 
despite the increases in all the other telomerase components (Millet et al., 
2015). We hypothesized that the steady level of Est2 is maintained through 
active Est2 degradation. A decrease in the Est2 level similar to the one caused 
by growth at elevated temperature has also been previously observed upon 
deletion of the TLC1 stem-loop structure responsible for the association with 
Est2 (Tucey and Lundblad, 2014). This suggests a possible connection 
between Est2-TLC1 interaction and the Est2 protein stability. There are known 
examples in prokaryotes, where an RNA hairpin is disrupted by an increase in 
temperature (Krajewski and Narberhaus, 2014). It is therefore possible that the 
stem-loop of TLC1 where Est2 binds could be similarly prone to temperature-
dependent destabilization. This hypothesis potentially links the temperature-
induced decline in the Est2 level to the loss of the Est2-TLC1 interaction. How 
exactly the impaired binding between Est2 and TLC1 renders Est2 unstable is 
not clear; one hypothesis speculates that in the absence of TLC1, the nuclear 
import of Est2 is decreased, Est2 remains trapped in the cytoplasm where it is 
recognised and marked for degradation. TLC1 itself is imported into the 
nucleus by the yKu protein complex (Gallardo et al., 2008) which could 




3.2. Selection of the tagging constructs for Est2 and 
Est3 
3.2.1. Pilot co-immunoprecipitation of Est3-myc13 with 
FLAG3-myc12-Est2 from haploid cells grown at 30°С 
or at 38.5°С 
Before performing the bona fide comparative co-immunoprecipitation of Est2 
and Est3 in aneuploid and diploid cells, I did pilot experiments in order to 
establish an optimal protocol for co-immunoprecipitation. The protocol 
described in Tucey and Lundblad, 2014 was used as a starting point for the 
optimization of the co-immunoprecipitation experiment and dictated the choice 
of the tagging constructs for Est2 and Est3 proteins (see section 2.7.5 and 
Figure 3.15 for the outline of the co-immunoprecipitation protocol). Initially, 
diploid strains were created with the tags fused to the single copies of EST2 
and EST3 genes. A FLAG-tag was fused to the Est2 N-terminus allowing to 
pull down Est2 from cell lysate with anti-FLAG resin, while a myc-tag was 
added to both the Est2 N-terminus and the Est3 C-terminus in order to quantify 
the amounts of these proteins by western blotting.  
First, I assessed the efficiency of FLAG3-myc12-Est2 immunoprecipitation. Cell 
lysates were obtained from 250 mL of log-phase cultures grown at 30°C to 
OD600≈0.8 and the Est2 protein was immunoprecipitated using anti-FLAG 
antibody covalently attached to agarose beads (resin). The IP samples as well 
as the samples of total lysate, pellet 1, pellet 2 (taken after two subsequent 
rounds of cell lysate centrifugation, respectively), cleared lysate (after the 
second centrifugation), depleted lysate (after IP) were taken. An isogenic 
diploid strain with untagged Est-proteins was used as a negative control for 
the FLAG3-myc12-Est2 and Est3-myc13 signals (Figure 3.1). FLAG3-myc12-Est2 
protein was efficiently depleted from the cleared lysate as evident from the 
comparison between the cleared and depleted lysate samples (lanes 8 and 
10, respectively). An intense band of about 50 kDa was observed in the 
negative control IP sample (lane 11), but not in the rest of negative control 
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lanes. I speculate that this band might correspond to the heavy chain of the 
mouse anti-FLAG antibody that could have detached from the beads present 
in the IP sample during the boiling step of protein sample preparation and then 
could have been recognised by the secondary antibody, since the size of the 
band corresponds to that of an antibody heavy chain. 
During the next step of the procedure, I pelleted the beads with the 
immunoprecipitated proteins, washed them and resuspended in a solution 
containing FLAG3 peptide for competitive elution of the bound FLAG3-myc12-
Est2 protein. The eluate was separated from the beads and both these 
fractions were mixed with Laemmli buffer and boiled. Equal portions of these 
samples were resolved in 10% SDS polyacrylamide gel along with total lysate 
samples in order to assess the efficiency of the elution as well as the Est3-
myc13 co-immunoprecipitation (Figure 3.2) 
The comparison between the amounts of FLAG3-myc12-Est2 protein in the 
eluate (lane 4) and remaining on the beads (lane 6) indicates that most of 
FLAG3-myc12-Est2 protein is present in the eluate. Also, I observed a 50 kDa 
band in the negative control eluate sample (lane 3) similar to the one previously 
found in the IP sample of the negative control (see Figure 3.1, lane 11). Given 
that this band overlapped in size with the predicted band for the Est3-myc13 
protein (as judged from the total lysate sample, Figure 3.2, lane 2), it might 
obscure the signal coming from the Est3-myc13 when in the same lane. The 
absence of the respective band in the depleted lysate sample of the negative 
control (Figure 3.1, lane 9) implies that the protein that produces this signal 
appears in the soluble fraction after the immunoprecipitation step. As noted 
above, this band may represent the heavy chain of the anti-FLAG antibody that 





Figure 3.1: Assessment of the efficiency of Est2 immunoprecipitation from 
FLAG3-MYC12-EST2/EST2 EST3-MYC13/EST3 cells  
IP – immunoprecipitate, M-molecular weight marker. The scale on the right denotes 
the sizes of the proteins in the marker sample. For a detailed description of samples 
loaded on the gel see the main text above. An isogenic diploid strain with no tags was 
used as a negative control for the Est2 and Est3 signals (lanes with odd numbers). 
Est2 is almost completely depleted from the cleared lysate (compare lanes 8 and 10). 
Est3-myc13 runs as a 50 kDa band in total lysate, despite the calculated size of 40.95 
kDa. The band of the corresponding size appears in the IP sample (lane 11) of the 






Figure 3.2: Pilot co-immunoprecipitation of Est3-myc13 with FLAG3-myc12-Est2 
from FLAG3-MYC12-EST2/EST2 EST3-MYC13/EST3 cells grown at 30°C 
The legend is as in Figure 3.1. White stripes denote the places where irrelevant lanes 
were cut out. An isogenic diploid strain with untagged Est-proteins was used as a 
negative control for the FLAG3-myc12-Est2 and Est3-myc13-tag signals (lanes 1, 3, 5)  
In order to prevent the resin contamination (which is the likely source of the 
heavy antibody chain) in the eluate I filtered it through 0.65 µm Durapore® 
filters before boiling. The 50 kDa band was not observed in the filtered eluate 
samples from the strain with untagged proteins upon elution with FLAG3 (see 
Figure 3.3, lanes 5 and 7). Considering that the elution by heating in SDS 
solution was previously found to be more efficient compared to FLAG-peptide 
elution (data not shown), I also tested, whether the 50 kDa band would still be 
recovered in the filtered eluate from the strain with no tags in case of elution 
with SDS at 65°C. I found the filters did not prevent the appearance of the 50 
kDa band in the eluate when SDS elution was used (data not shown) and 
therefore decided to adhere to using FLAG-peptide elution. 
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Since it has been shown that at 38.5°C the amount of Est2 protein is drastically 
decreased in yeast cells (Millet et al., 2015), it would be reasonable to expect 
that for cells grown at this temperature the yield of both FLAG3-myc12-Est2 and 
Est3-myc13 in the immunoprecipitate would be lower than for the same yeast 
grown at 30°C. Therefore, I performed a side-by-side co-immunoprecipitation 
of Est3-myc13 with FLAG3-myc12-Est2 from the cells grown at 30°C and at 
38.5°C in order to test whether the amount of Est3-myc13 co-
immunoprecipitated with FLAG3-myc12-Est2 would be sufficient for a reliable 
quantification (Figure 3.3). In the samples obtained from the cells grown at 
38.5°C, I could not see a clear band in the gel region corresponding to the 50 
kDa protein weight (Figure 3.3, lane 8). Also, in the samples from the same 
strain grown at 30°C, two closely running bands were discovered in the area 
of the expected Est3-myc13 mobility (Figure 3.3, lane 6). As discussed later, I 
introduced an additional negative control for the Est3-myc13 signal to 
determine which (if any) of these two bands represents the Est3-myc13 protein 
(see Figure 3.5). 
To increase the yield of Est3 protein in the immunoprecipitate, I constructed 
diploid strains with both copies of the EST2 and EST3 genes fused to the tag 
sequences, with the expectation of a 4-fold increase in the co-IPed Est3-myc13 
signal. This time I managed to see a distinct band corresponding in size to the 
Est3-myc13 protein in the samples from the cells grown at the elevated 




Figure 3.3: Comparison of the yield of Est3 co-immunoprecipitated with Est2 
from FLAG3-MYC12-EST2/EST2 EST3-MYC13/EST3 cells grown at 30°C or at 
38.5°C upon sifting samples through particle filters 
    - empty lanes; legend as in Figure 3.1. The eluates were centrifuged through 0.65 
µm filters which captured the agarose beads and thus the band of 50 kDa size was 
no longer observed in the samples from the strain with untagged proteins (lanes 5 
and 7). Two closely running bands are seen in the region corresponding to the 
expected Est3 protein band in the sample from the tagged strain grown at 30°C (lane 






Figure 3.4: Comparison of the yield of Est3 co-immunoprecipitated with Est2 
from FLAG3-MYC12-EST2/FLAG3-MYC12-EST2 EST3-MYC13/EST3-MYC13 
cells grown at 30°C or at 38.5°C 
Legend as in Figure 3.1. A - western blot of total lysate, eluate and beads samples 
from the strains with or without FLAG3-myc12-Est2 and Est3-myc13 grown at 30°C and 
38.5°C. The white stripe to the left of the marker indicates where a lane was cut off. 
The red rectangle highlights the area of the expected Est3 band. Note that the 50 kDa 
band can now be seen at both growth temperatures (blue arrowheads). B - area within 
the rectangle from the image in A shown at lower intensity threshold settings 
 
To verify that the 50 kDa band seen in the strain with the tagged proteins 
represents the Est3-myc13 protein I performed an experiment similar to the one 
shown in Figure 3.2, using a strain with the tag only on Est2 protein (FLAG3-
myc12-Est2), as a negative control for Est3-myc13 signal (Figure 3.5). A band 
of the same size as the aforementioned 50 kDa band, albeit less intense, was 
discovered in the negative control eluate sample (lane 6; compare to lane 5). 
Therefore, in the strain carrying tags on both proteins, the Est3-myc13 band 
might overlap with the corresponding band revealed in the negative control. 
There are two explanations for the origin of the latter band: the first attributes 
it to a degradation product of the tagged Est2 protein, the second – to some 
protein binding to FLAG3-myc12-Est2 and cross-reacting with anti-myc 
antibody. In order to distinguish between these two possibilities I performed an 
M 
M 
5        6       7 
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additional immunoprecipitation experiment with the same strains: two western 
blots were done in parallel with the same set of samples using two different 
primary mouse antibodies: anti-myc and anti-FLAG (Figure 3.6). The band 
previously seen in the 50 kDa region of the sample coming from the Est2-only 
tagged haploid strain was again observed in anti-myc WB (Figure 3.6A,С lane 
5). A band with a matching mobility was also discovered in anti-FLAG WB in 
the corresponding lane (Figure 3.6B,D, lane 5) as well as in the lane with the 
sample from the double-tagged strain (Figure 3.6B and D, lane 6). I concluded 
that the band in question is most likely a degradation product of Est2 rather 
than its binding partner (although, it’s still possible that a secondary antibody 
has a cross-reactivity with an FLAG3-myc12-Est2 binding partner). I tried to use 
PMSF in addition to cOmplete™ protease inhibitor cocktail to slow down 
possible degradation of FLAG3-myc12-Est2 in samples in vitro. However, the 
addition of PMSF did not produce any significant difference in the band pattern 
of the FLAG3-MYC12-EST2 strain (data not shown).  
 Figure 3.5: Est3-myc13 band might overlap with a non-specific band in 
western blot of samples from FLAG3-MYC12-EST2 EST3-MYC13 cells  
Legend as in Figure 3.1. Haploid strains were used in this experiment. The western 
blot shows that the band in the Est3-region of the sample from FLAG3-MYC12-EST2 
EST3-MYC13 strain has a counterpart in FLAG3-MYC12-EST2 strain, although the 
latter band is less intense. This might indicate that the Est3 band overlaps with one of 









Figure 3.6: FLAG3-myc12-Est2 degradation product band overlaps with Est3-myc13 band 
Legend as in Figure 3.1. The same strains were used as in Figure 3.5. A and B – full images of the western blots. C and D – close-up views of 
the areas within the red rectangles in A and B, respectively. The two bands marked by the two blue arrows in C and D have matching locations 
on the blots. They are likely to represent a degradation product of Est2 since Est2 is the only protein with both a myc and a FLAG tag in these 






3.2.2. Qualitative western blot analysis of signal intensity 
of Est2 and Est3 with various tags 
In order to tackle the problem of overlapping signal between the bands of Est3-
myc13 and the degradation product of FLAG3-myc12-Est2 I decided to try 
alternative tagging constructs for both Est2 and Est3 proteins (Table 3.1). The 
constructs were introduced into the genome either by a linearized plasmid or 
by a selective PCR product insertion (see Table 3.1). I assayed these 
constructs in pilot western blot experiments to determine, whether the epitope 
signal/background ratio was sufficient for reliable quantitative analysis in 
subsequent co-immunoprecipitation experiments (Figures 3.7-3.8). For the 
western blotting analysis of each construct, at least three clones were purified 
from a selective plate upon transformation. Clones resulting from a PCR 
cassette insertion were additionally pre-screened by colony-PCR before the 





Table 3.1: Tagging constructs for Est2 and Est3 proteins analysed in this 
study 
Target protein Tagging construct Vehicle for gene modification 
Est2 
N-FLAG3-myc12-Gly6-Est2 Plasmid (pVL5273/HpaI) 
N-FLAG3-Gly6-Est2 Plasmid (pYT413/HpaI) 
N-FLAG3-Gly6-HA3-Est2 Plasmid (pYT415/HpaI) 
N-FLAG3-Gly6-HA6-Est2 Plasmid (pYT419/HpaI) 
N-FLAG3-Gly6-HA9-Est2 Plasmid (pYT420/HpaI) 
N-myc12-Gly6-Est2 Plasmid (pYT416/HpaI) 
Est2-myc13-C 




PCR cassette amplified from 
pFA6a-MYC13-kanMX6 
Est3-myc13-Gly6-FLAG3-C Plasmid (pYT414/MfeI) 
Est3-HA3-C 
PCR cassette amplified from 
pFA6a-HA3-TRP1 
Est3-FLAG3-C 




cassette amplified from 
pEHB12009 with subsequent -






Figure 3.7: Qualitative western blot analysis of Est2 with different epitopes 
Red arrowheads point to the bands corresponding to the proteins of interest. Purple 
arrowheads point to the bands corresponding to proteins serving as positive controls 
of protein detection by western blotting. Green tick marks denote constructs encoding 
proteins whose expression results in high signal/background ratio, +/- sign denotes 
constructs with marginally detectable signal and red “X” sign denotes constructs with 
signal below detection limit. In cases where the target protein signal is below or at the 






Figure 3.8: Qualitative western blot analysis of Est3 with different epitopes 
Red triangles point to the bands corresponding to the proteins of interest. Purple 
triangles point to the bands corresponding to proteins serving as positive control of 
western blotting. Green tick marks denote constructs with high signal/background 
ratio, red “X” sign denotes constructs below detection limit. In case where target 
protein signal is below detection threshold (E), three separate clones are shown 
 
The constructs that demonstrated high signal/background ratio in the western 
blotting experiments were selected for further analysis, while the rest of the 





3.2.3. Temperature-sensitivity assay of the strains with 
tagged Est2 and Est3 proteins 
It has been reported in Tucey & Lundblad, 2014 that cells with Est3-myc13 have 
somewhat shorter telomeres than the cells with no tag on Est3. Shortened 
telomeres indicate that the telomerase function in the cells with Est3-myc13 is 
suboptimal, potentially due to the tag interfering with the binding of Est3 to the 
other telomerase subunits. If Est3-myc13 binding to the telomerase complex is 
significantly less efficient than that of the untagged Est3, then the quantitative 
output of the co-immunoprecipitation of Est2 with Est3 (or vice versa) might 
not be reflective of the amount of telomerase complex and therefore might fail 
to detect the difference in the telomerase complex levels between aneuploids 
and diploids. Thus, I decided to test whether the tagged versions of Est2 and 
Est3 or their combinations affect telomerase function, to eliminate the tags with 
the potential to significantly impact telomerase complex assembly. Since the 
design of the co-immunoprecipitation experiment entails using anti-FLAG 
affinity resin to pull down one of the two proteins, the strains were constructed 
in such a way that only one of the two proteins bore FLAG3-epitope in any 
given strain. 
Initially I performed an indirect preliminary assessment of the telomerase 
function by a temperature-sensitivity assay. This method takes advantage of 
the fact that the equilibrium length of S. cerevisiae telomeres decreases 
progressively as the growth temperature increases, with cells undergoing 
senescence after several passages when grown at temperature as high as 
38.5°C, but not at 37°С (Millet et al., 2015). Assuming that the tags affect 
telomerase performance independently of the temperature-related decrease in 
telomerase function, telomerase-inhibiting tags and growth temperature 
should have an additive effect on telomerase activity (see Figure 3.9). 
Consequently, tags that decrease telomerase function should lower the 
temperature threshold for senescence and thus can be identified by passaging 






Figure 3.9: Schematic illustrating the hypothetical additive effect of growth 
temperature and hypomorphic alleles of EST2 or EST3 affecting telomerase 
complex assembly on telomere length equilibrium 
 
Strains with tagged Est2, Est3 or both proteins were continually grown at 37°C 
for 3 or 4 passages (1 passage every two days) along with the isogenic WT 
control strain and a temperature-sensitive strain (yku80Δ) to reach telomere 
length equilibrium. As seen in Figures 3.10-3.12, the only three constructs that 
did not lead to senescence at 37°C either separately or in combination were 
Est2-myc13, myc12-Est2 and Est3-FLAG3 (note, that Est3-myc13-Gly6-FLAG3 







Figure 3.10: Temperature-sensitivity assay of haploid strains with Est2-myc13 
and/or either FLAG3-Est3 (A) or Est3-FLAG3 (B) 
Second and third passages are shown. FLAG3-EST3 alone causes senescence by 
the third passage at 37°С and by the second passage when combined with EST2-
MYC13. EST2-MYC13 and EST3-FLAG3 do not cause senescence either separately 







Figure 3.11: Temperature-sensitivity assay of haploid strains with FLAG3-HA9-
Gly6-Est2 (A), FLAG3-myc12-Gly6-Est2 (B) or FLAG3-myc12-Gly6-Est2 combined 
with Est3-myc13 (B) 
Second and third passages are shown. FLAG3-HA9-GLY6-EST2 causes senescence 
by passage 2 at 37°C, while EST3-MYC13 alone or in combination with FLAG3-
MYC12-GLY6-EST2 causes senescence by passage 3 at 37°C. Senescence was not 








Figure 3.12: Temperature-sensitivity assay of haploid strains with FLAG3-HA6-
Gly6-Est2, myc12-Gly6-Est2 or myc12-Gly6-Est2 combined with Est3-FLAG3 
Passages 2-4 shown. FLAG3-HA6-GLY6-EST2 causes senescence by passage 2 at 
37°C, while MYC12-GLY6-EST2 and EST3-FLAG3 do not cause senescence either 
separately or in combination by passage 4 at 37°. Note that FLAG3-HA6-GLY6-EST2 





3.2.4. Southern blot analysis of telomere length in strains 
with tagged Est2 and Est3 proteins 
In order to verify the conclusions of the temperature sensitivity assay, I decided 
to assess telomere length equilibrium of strains with tagging constructs more 
directly in a telomere-specific Southern blot. Haploid strains with epitopes on 
Est2, Est3 or both proteins were passaged 4 times at 30°C (~80 generations), 
their genomic DNA (gDNA) was extracted, digested with KpnI and resolved in 
a 0.85% agarose gel. Y’-telomere length was then analysed by Y’-telomere-
specific Southern blotting (see Figure 3.13 and section 2.8.8 for details).  
As seen in Figure 3.14, among the combinations of tagging constructs that 
were tested for their impact on telomere length equilibrium at 30°C, Est3-
FLAG3 as well as Est2-myc13 (Figure 3.14B) or myc12-Gly6-Est2 (Figure 3.14C) 
exert the least effect on telomere length, corroborating the results of the 






Figure 3.13: Schematic of the terminal region of a subtelomeric Y’-element 
showing the probe used in the telomere-specific Southern blot 
The KL1 probe anneals to terminal restriction fragment (TRF) of the Y’-element that 
includes 526 bp of Y’-element sequence and a varying length of telomeric repeats 
(~300-350 bp in WT cells). The stretch of telomeric repeats is therefore 526 bp shorter 
than the terminal restriction fragment. The probe also anneals to the 577 bp-long 






Figure 3.14: Southern blots showing Y’ telomere length equilibrated at 30°C 
compared between WT cells and cells carrying tagging constructs on Est2 
and/or Est3 








3.2.5. Pilot co-immunoprecipitation of Est2-myc13 with 
Est3-FLAG3 from haploid cells grown at 30°С or at 
38.5°С 
The tagging constructs Est2-myc13 and Est3-FLAG3 were selected based on 
their low impact on telomerase function for a test co-immunoprecipitation of 
Est2-myc13 with Est3-FLAG3 from haploid cells, before the construction of the 
corresponding aneuploid and diploid strains. For the first pilot co-
immunoprecipitation experiment, cells were grown at 30°C since the level of 
Est2-myc13 is higher in the cells grown at this temperature, than at 38.5°C 
(Millet et al., 2015), and therefore the protein is easier to detect. Once the cells 
were harvested from liquid cultures, washed and resuspended in lysis buffer, 
they were lysed by bead-beating to obtain total lysate. Total lysate was cleared 
by two subsequent centrifugation steps pelleting cellular debris (pellet 1) and 
chromatin (pellet 2) to obtain cleared lysate, from which Est3-FLAG3 was 
pulled down using anti-FLAG affinity resin (see section 2.7.5 and Figure 3.15 
for details). In this experiment the elution of Est3-FLAG3 from the resin was 
performed by competitive displacement with an excess of 3X FLAG peptide. 
I managed to successfully co-immunoprecipitate Est2-myc13 with Est3-FLAG3 
from cells grown at 30°C (Figure 3.16C), however, ~28% of Est2-myc13 
remained bound to the resin after the elution (Figure 3.16C, lane 12), indicating 
that Est3-FLAG3 was not completely displaced from the resin by competitive 
elution with the FLAG3 peptide. More than half of Est3-FLAG3 was pulled-
down from the cleared lysate, as evident from the comparison between the 
cleared lysate and the flow-through (Figure 3.16B, lanes 8 and 10; note, that 
the antibody light chain band obscures the Est3-FLAG3 band in lane 12), while 
only about 5% of Est2-myc13 was depleted from the cleared lysate (Figure 
3.16A, lanes 8, 10 and 12), suggesting that only a small fraction of Est2-myc13 
was associated with Est3-FLAG3. Approximately 16% of Est2-myc13 was 
retained in the chromatin-containing pellet 2 (Figure 3.16A, lane 6), consistent 








Figure 3.15: Outline of the protocol for co-immunoprecipitation of Est2 and 
Est3 
The Protocol steps are in red and light blue, descriptive notes are in green, sample 
aliquots are in green boxes. To allow direct comparison of the amount of target 
proteins in the pellet and supernatant fractions, the pellets and resin were 
resuspended in the volumes of lysis buffer matching the volumes of the supernatants 
(see steps 4a, 5a and 7) and the respective sample aliquots were taken. The elution 
of the bound protein from the anti-FLAG resin was performed either by competitive 




Figure 3.16: Pilot co-immunoprecipitation of Est2-myc13 with Est3-FLAG3 from 
haploid cells grown at 30°C 
A – Est2-myc13 in various fractions throughout the CoIP procedure, B – the same for 
Est3-FLAG3, C – co-immunoprecipitation of Est2-myc13 with Est3-FLAG3. - empty 
lane. *IP samples represent a fraction of resin (~1.5%) taken before the elution (see 




I next set out to attempt a pilot co-immunoprecipitation from haploid cells grown 
at 38.5°C, since aneuploidy-dependent suppression of telomerase 
insufficiency had been discovered at this temperature. This time the elution 
was performed by incubating the resin in 1% SDS at 65°C for 10 minutes to 
maximize the release of the target proteins from the resin. As a result, I 
managed to co-immunoprecipitate Est2-myc13 with Est3-FLAG3 from cells 
grown at 38.5°C, albeit the with a lower yield of Est2, than at 30°C (Figure 
3.17). 
 
Figure 3.17: Pilot co-immunoprecipitation of Est2-myc13 with Est3-FLAG3 from 
haploid cells grown at 38.5°C 
Small red arrowheads indicate Est2-myc13 in the total lysate. Note, that because the 
elution was performed by treating the resin with 1% SDS at 65°C, the antibodies 
became released from the resin, resulting in a 50 kDa band (heavy chain, not shown) 
and a 25 kDa band (light chain) on the western blot. The 25 kDa band overlaps with 




3.3. Optimization of the protocol for CoIP of Est2-myc13 
with Est3-FLAG3 
3.3.1. Testing benzonase treatment of lysate as means of 
the Est2-myc13 release from chromatin-containing 
pellets 
In the previous experiments, I have observed that some of Est2-myc13 is 
associated with the chromatin-containing pellet 2 (see Figure 3.16A). There 
exists a chance that some of Est2-myc13 found in the pellet 2 may be part of 
the telomere-bound telomerase complexes, which therefore would not be 
captured by the affinity resin, potentially resulting in a skewed output in the co-
immunoprecipitation experiments. To determine whether Est2-myc13 is 
associated with chromatin in pellet 2, I undertook an attempt to release Est2-
myc13 from the pellet 2 by treating the lysate with a chromatin-degrading 
enzyme Benzonase just prior to separating the pellet 2 from the cleared lysate 
(between steps 4 and 5 in Figure 3.15). Since Benzonase is inhibited by high 
Na+ and K+ concentrations (Figure 3.18), half of the cells were lysed in the lysis 
buffer with lower (100 mM) than previously used NaCl concentration, while the 
















Figure 3.19: (beginning) The effect of Benzonase treatment on the proportion of Est2-myc13 and Est3-FLAG3 associated with 
pellet 2 
A – anti-myc western blot of samples with 100 mM NaCl, B – anti-myc western blot of samples with 300 mM NaCl, C – anti-FLAG western 












Figure 3.19: (continuation) The effect of Benzonase treatment on the 
proportion of Est2-myc13 and Est3-FLAG3 associated with pellet 2 
E – mean Est2-myc13 content in pellet 2 relative to total lysate in blots in A and B, F –
mean Est3-FLAG3 content in pellet 2 relative to total lysate in blots C and D. P value 
was calculated using paired T-test. Error bars correspond to standard deviation of the 








Once the cells were lysed and the cellular debris was removed from the lysate 
by centrifugation, half of the lysate was treated with benzonase and then the 
pellet 2 was collected from both the Benzonase-treated and untreated samples 
in the second round of centrifugation. The western blot analysis of the pellet 2 
and total lysate samples performed in three parallel repeats demonstrated that 
Benzonase treatment does not significantly affect the fraction of either Est2-
myc13 or Est3-FLAG3 proteins associated with the pellet 2, regardless of the 
NaCl concentration in the lysis buffer (Figure 3.19). Of note, the increase in 
the salt concentration in the lysis buffer correlated with a decrease in the Est2-
myc13 and Est3-FLAG3 levels in the pellet 2. To assay chromatin degradation 
in the Benzonase-treated samples, (gDNA) was extracted from the pellet 2 
samples and analysed by agarose gel electrophoresis (Figure 3.20). 
Degradation of gDNA was apparent in the Benzonase-treated samples at both 
NaCl concentrations, however it was more pronounced, when the lysis buffer 
with 100 mM NaCl was used. This is consistent with the inhibition of 




Figure 3.20: Agarose gel electrophoresis of gDNA extracted from the pellet 2 
samples with and without the Benzonase treatment  
The skew of the gDNA smears towards the left side of the gel is due to a defect in the 





Telomeric heterochromatin may be less susceptible to the Benzonase 
treatment than the bulk of gDNA, thus preventing the release of the telomere-
associated telomerase complexes. If that were the case, then the fraction of 
the telomeric sequences in gDNA would be increased in the samples treated 
with Benzonase. To test this hypothesis, the ratio of telomeric DNA to non-
telomeric DNA was compared between Benzonase-treated and untreated 
pellet 2 samples in a dot-blot experiment. Telomere-specific probe signal was 
normalized to URA3 probe signal. 
 
Figure 3.21: (beginning) Comparison of telomeric DNA content relative to 
URA3 in benzonase-treated and untreated samples  
A – a dot blot of yeast genomic DNA extracted from total lysate or pellet 2 hybridized 






Figure 3.21: (continuation) Comparison of telomeric DNA content relative to 
URA3 in benzonase-treated and untreated samples 
B – mean ratio of the telomeric signal to the URA3 signal for the dot blot images 
above. The telomere/URA3 probe signal ratios were normalized to Benzonase-
untreated samples for each NaCl concentration. P values were calculated using 
paired T-test. Error bars correspond to standard deviation of mean of four repeats 
 
Dot blot analysis demonstrated that there had been no increase in telomeric 
DNA relative to URA3 DNA in the Benzonase-treated pellet 2 samples (Figure 
3.21). Combined with the agarose gel analysis of Benzonase-dependent 
degradation of bulk gDNA (see Figure 3.20) these results suggest that 
telomeric DNA was degraded by Benzonase more efficiently than the bulk of 
gDNA. Therefore, Est2-myc13 associated with pellet 2 was not was not kept 




3.3.2. Testing the effect of different NaCl concentrations 
on the distribution of Est2-myc13 between 
chromatin-containing pellet and cleared lysate 
The data obtained in the Benzonase-treatment experiment using two different 
NaCl concentrations for the lysis buffer suggest that Est2-myc13 was 
increasingly released from pellet 2 with the higher salt concentration. To test 
whether a significant amount of Est2-myc13 can be recovered from pellet 2 by 
further increase in NaCl concentration in the lysis buffer, I performed a western 
blot analysis of distribution of Est2-myc13 between pellet 2 and cleared lysate 
at a range of NaCl concentrations in the lysis buffer. To that end, the cells were 
ruptured in lysis buffer containing 100 mM NaCl, cellular debris (pellet 1) was 
removed by centrifugation and the resulting lysate was split into several 
aliquots in which a range of desired NaCl concentrations was set by adding 
0.25 volume of either isotonic or more concentrated NaCl solution. After an 
additional round of centrifugation, pellet 2 was separated from cleared lysate 
and the distribution of Est2-myc13 between the two fractions was assayed in a 
western blot (Figure 3.22). Despite a steady decrease in the fraction of Est2-
myc13 remaining in pellet 2 with the increasing NaCl concentration in the 
samples, the extent of Est2-myc13 release from pellet 2 was only marginally 
higher at 700 mM NaCl compared to 300 mM used in previous publications 
(Tucey and Lundblad, 2014). The steepest increase in the amount of Est2-
myc13 released into the cleared lysate was observed between the NaCl 
concentrations of 100 mM and 300 mM. Taking into account the potentially 
disruptive effect of increased NaCl concentration on telomerase complex 
stability, as well as negligible gain in the amount of Est2-myc13 released into 
cleared lysate at such concentrations, it was deemed impractical to use NaCl 





Figure 3.22: The effect of NaCl concentrations in lysis buffer on the 
distribution of Est2-myc13 between pellet 2 and cleared lysate 
A – western blots showing three biological repeats of the experiment, B – mean 
distribution of Est2-myc13 among different fractions relative to total lysate. TL – total 
lysate, CL – cleared lysate, P1 – pellet 1 (cellular debris and unbroken cells), P2 – 








3.4. Factors affecting telomerase steady-state level in 
different species of yeast 
3.4.1. Est2 steady state level is not dependent on Ku 
protein in S. cerevisiae 
It has been previously noted that, when TLC1 is absent or unable to bind to 
Est2 (as in tlc1-59 mutants), the steady-state level of the Est2 subunit 
decreases approximately two-fold (Taggart, Teng and Zakian, 2002; Lin and 
Blackburn, 2004; Tucey and Lundblad, 2014). A similar decrease was also 
observed in yeast grown at 38.5°C (Millet et al., 2015), which prompted a 
speculation that the effect of the elevated temperature on Est2 steady-state 
level might be mediated by TLC1: TLC1 secondary structure might be 
disrupted at 38.5°C thereby mimicking the effect of the tlc1-59 mutation on the 
TLC1-Est2 association and hence on the Est2 steady-state level. 
Some preliminary data indicated that Est2 was destabilized in tlc1Δ mutants 
compared to wild type cells and that this destabilization was partially rescued 
by proteasome inhibition (Figure 3.23). Consequently, it has been 
hypothesised that the impact of TLC1 deletion on the Est2 protein level is at 
least partially due to proteasome-dependent degradation. If melting of the 
TLC1 secondary structure is the actual reason for the decreased abundance 
of Est2 protein at high temperature, this effect might be to some extent 
mediated by the proteasome as well. Potentially, there could be at least two 
ways in which Est2 not bound to TLC1 is recognised and marked for 
subsequent degradation. In the first scenario, free Est2 subunit might be 
recognised per se. Alternatively, the Est2 degradation in the absence of TLC1 
could be a secondary effect of the Est2 disrupted nuclear localization. TLC1 
nuclear transport depends on binding to the Ku complex (Gallardo et al., 2008) 
and it is possible that Est2 is translocated into the nucleus in a complex with 
TLC1 via a Ku-dependent mechanism. In this case, Est2 localized in the 









Figure 3.23: Telomerase catalytic subunit not bound to telomerase RNA TLC1 
is degraded by proteasome 
Analysis of Est2 stability by western blotting. Cells with myc-tagged Est2 subunit were 
grown to mid-log phase and proteasome inhibitor MG132 was added at 75 μM 30’ 
before protein synthesis was blocked with 100 μg/ml cycloheximide (CHX). Cell 
aliquots were collected at the time-points indicated above the gel. Equal amount of 
protein extract was loaded in each lane. Notice much lower steady state level of Est2 
in the absence of TLC1 (compare 0’ time-points) 
If Est2 degradation in the absence of TLC1 was at least partially dependent on 
its cytoplasmic retention because of the abolished Ku-mediated transport, then 
I should have been able to observe some decrease in the Est2 steady-state 
level in yku70/80Δ and tlc1Δ48 mutants in which TLC1 cannot bind to the Ku 
complex. I constructed the strains with a myc-tag fused to the Est2 protein 
combined with either ykuΔ80 or tlc1Δ48 mutation and compared the steady-
state levels of Est2 in these strains to the corresponding WT strains (Figure 
3.24). No statistically significant difference was observed in these 
comparisons, suggesting that either Est2 nuclear import does not depend on 
Yku80 or that the defect in Yku80-dependent nuclear import of Est2 does not 




Figure 3.24: Analysis of the effect of the deletion of YKU80 or the Yku70/80-
binding stem-loop of TLC1 on the steady-state levels of Est2-myc13 
A – comparison of the Est2-myc13 steady state level between WT, tlc1Δ and yku80 
cells, B – the same for WT, tlc1Δ and tlc1Δ48 cells, C – mean Est2-myc13 steady-
state level from the western blot in A, D - mean Est2-myc13 steady-state level from the 
western blot in B. Mean Est2-myc13 band signals in yku80 and tlc1Δ48 mutants were 
normalized to a background band (not shown) and then to WT. The Error bars 
correspond to standard deviation of mean of four repeats. P values were calculated 









3.4.2. Higher growth temperature decreases the steady-
state level of the S. pombe Est2 homolog Trt1 
Similarly to S. cerevisiae telomeres, S. pombe telomeres have been previously 
reported to equilibrate at progressively shorter length with increasing growth 
temperature (Millet et al., 2015). If the underlying mechanism of temperature-
dependent telomere shortening between these two evolutionarily divergent 
species is conserved, then the temperature-induced telomerase insufficiency 
might be relevant to and has implications for species other than S. cerevisiae.  
Initially, I set out to test whether elevated growth temperatures are associated 
with a decrease in the steady-state level of the S. pombe telomerase catalytic 
subunit, as found previously for the S. cerevisiae telomerase reverse-
transcriptase (Millet et al., 2015). To that end, Trt1 – the S. pombe homolog of 
Est2 – was tagged with 13 myc repeats and the strains were grown either at 
23°C or at 37°C, the proteins were extracted and analysed by anti-myc western 
blot. Ponceau red staining was used as loading control (Figure 3.25). Despite 
the fact that the samples originating from cultures grown at 37°C seem to have 
been overloaded compared to the samples from yeast grown at 23°C, there 
was a statistically significant decrease in the steady-state levels of Trt1-myc13 
in the cultures grown at the elevated temperature. This result is consistent with 
the hypothesis that the decrease in the telomere length observed in S. pombe 







Figure 3.25: The steady-state level of Trt1 is decreased in S. pombe at an 
elevated temperature 
A – comparison of the steady-state levels of Trt1-myc13 at 23°C and 37°C in a western 
blot, B – quantification for A. Mean Trt1-myc13 steady-state levels were calculated 
from three biological repeats and normalized to the average Trt1 level at 23°C. the P 
value was calculated using paired T-test. The error bars correspond to standard 







3.5.1. Optimization of the co-immunoprecipitation of Est2 
and Est3 
The comparative quantitative co-immunoprecipitation of Est2 and Est3 is a 
direct way for assessing the relative amounts of telomerase complex in 
aneuploids and diploids. 
Despite the protocol for co-immunoprecipitation of Est2 with Est3 having been 
previously established (Hughes et al., 2000; Talley et al., 2011; Tucey and 
Lundblad, 2014), it had to be optimized to avoid quantitative artifacts and 
increase sensitivity of the target protein detection. Pilot co-immunoprecipitation 
experiments revealed a number of problems, such as an overlapping of target 
protein bands with bands of antibodies (see Figure 3.2) or protein degradation 
products (see Figure 3.6) in western blots and low co-immunoprecipitation 
output in diploid strains heterozygous for the epitope-carrying alleles of EST2 
and EST3 (see Figure 3.3). Moreover, it was discovered that EST3-MYC13 
cells have a shorter telomere length equilibrium (Figure 3.14A, also see 
Supplementary Material in Tucey and Lundblad, 2014), indicative of their 
suboptimal telomerase function, not unlikely due to an impaired interaction 
between modified Est3 protein and Est2 protein.  
These considerations prompted me to use haploid strains for pilot experiments 
and seek an alternative set of tags for Est2 and Est3, with following properties: 
1. Different tags for detection of Est2 and Est3 to prevent cross-reaction 
between Est2 degradation products and Est3.  
2. Detectability in a western blot. 
3. No significant effect on telomere length equilibrium (a commonly 
reported side-effect of telomerase tagging, e.g. Sabourin et al., 2007; 
Tuzon et al., 2011), to exclude tagging constructs that may impinge on 





Telomerase function of the strains bearing tags was assessed in a 
temperature-sensitivity assay (Figures 3.10-3.12) as well as in a Southern blot 
analysis to measure telomere length equilibrium (Figure 3.14). As a result of 
these tests, Est2-myc13 and Est3-FLAG3 were selected as constructs meeting 
the requirements laid out above. Subsequently, a pilot co-immunoprecipitation 
experiment was performed using haploid EST2-MYC13 EST3-FLAG3 strains 
grown at 30°C, in which Est2-myc13 was successfully co-IPed with Est3-FLAG3 
(Figure 3.16). When the same experiment was performed with strains grown 
at 38.5°C, Est2-myc13 band, although much less intense, was still detected in 
the co-immunoprecipitate (Figure 3.17). The pilot co-immunoprecipitation 
however raised another technical concern as a perceptible proportion of Est2-
myc13 was found in the insoluble chromatin-containing fraction of pellet 2 (see 
Figure 3.16A). Considering, that maximum interaction between Est1 and Est2 
occurs in S/G2 (Tucey and Lundblad, 2013), when all three protein subunits of 
telomerase show peak recruitment to the telomeres (Taggart, Teng and 
Zakian, 2002; Chan, Boulé and Zakian, 2008; Tuzon et al., 2011), it is possible 
that a significant fraction of the overall mature telomerase complex is telomere-
associated. To prevent a potential bias in the comparative assessment of the 
total amount of the telomerase complex in aneuploids and diploids caused by 
segregation of a sizeable proportion of telomerase holoenzyme from the lysate 
into chromatin pellet I attempted to release Est2-myc13 into the supernatant 
using either DNA-degrading enzyme Benzonase or an increased NaCl 
concentration in the buffer. Despite evidence indicating degradation of the bulk 
of chromatin (Figure 3.20), and specifically telomeric chromatin (Figure 3.21), 
in pellet 2 upon benzonase treatment, a detectable release of Est2-myc13 into 
cleared lysate was not achieved (Figure 3.19). Although increasing salt 
concentration in the lysis buffer was accompanied by a slight decrease in the 
proportion of Est2-myc13 associated with pellet 2 (Figure 3.22), the relative 
extent of such dissociation at NaCl concentrations higher than 0.3 M appears 
to be negligible compared to the risk of destabilizing interactions between 




The observed discrepancy between the extent of chromatin-degradation and 
the release of Est2-myc13 from pellet 2 may have several explanations. For 
instance, Benzonase nucleolytic activity may not be sufficient under the 
conditions of NaCl concentration of 0.1 M or higher (Figure 3.18) to generate 
chromatin fragments small enough to remain the supernatant upon 
centrifugation. This, however, appears unlikely, given that the bulk of the 
chromatin smear from pellet 2 samples post Benzonase treatment 
concentrates in 0.5 kb area of the agarose gel in case of 0.1 M NaCl 
concentration in the lysis buffer (Figure 3.20). Moreover, bead-beating method 
of yeast extract preparation is believed to produce an extensive level of 
chromatin shear (Deutscher, 1990) resulting in solubilisation of a major part of 
chromatin fraction, which is consistent with a prominent reduction in both 
URA3- and telomere-specific probe signal in pellet 2 compared to total lysate 
(Figure 3.21A). 
Alternatively, the presence of Est2-myc13 in pellet 2 could be attributed to 
unspecific protein aggregation, a frequently encountered issue during protein 
extraction (Bondos and Bicknell, 2003). This explanation is agreement with the 
observed effect of increasing NaCl concentration on solubilisation of Est2-
myc13, since NaCl has been shown to reduce protein aggregation in vitro 
(Bondos and Bicknell, 2003). In yet another scenario, pelleting of Est2-myc13 
may be due to an unspecific hydrophobic interaction with the crude membrane 
fraction or nuclear scaffold that have been reported to precipitate at 
approximately the same centrifugation speed, as the one used in our protocol 
to remove chromatin (Navarre et al., 2002; Xie, Bandhakavi and Griffin, 2005; 
Tran and Brodsky, 2012). In conclusion, Est2-myc13 found in pellet 2 is not 





3.5.2. The stability of the telomerase steady-state level in 
the context of genetic changes and telomerase 
functions and interacting partners 
Chromosome VIII monosomy is associated with significant increases in the 
steady state levels of a host of non-ribosomal proteins, including Est1 and 
Est3. However the abundance of Est2 remains unaffected in the wake these 
proteome-wide changes (Millet et al., 2015), implying a tight control of Est2 
expression possibly via a yet-undiscovered negative-feedback loop.  
The mechanisms responsible for the temperature-induced decrease in the 
amount of Est2 are equally obscure and are possibly related to the regulation 
of Est2 expression.  
According to one view, Est2 level regulation could predominantly occur via 
control of its degradation, rather than synthesis. A cycloheximide assay 
performed by S. Makovets demonstrates that Est2 is destabilized in the 
absence of TLC1 and that this destabilization can be partially mitigated by 
inhibition of the proteasome (S. Makovets, personal communication; Figure 
3.23). Given that RNA stem-loop structures can melt at higher temperatures 
(Krajewski and Narberhaus, 2014), it could be speculated that the 
temperature-induced decrease in Est2 levels might result from the melting of 
the TLC1 stem-loop regions responsible for Est2 binding, thus escalating the 
proteasome-dependent degradation of Est2.  
Multiple explanations could be proposed as to why cells evolved a pathway 
that identifies and degrades RNA-free Est2 subunits.  
A study performed in 2014 argued that the telomerase holoenzyme undergoes 
disassembly via dissociation of Est2 from the TLC1-Est1-Est3 complex (Tucey 
and Lundblad, 2014). Thus, free Est2 may represent an unwanted decay 
product of the telomerase complex which is dispensed with by the proteasome-




It could be similarly surmised, that the Est2 dissociation from the rest of the 
telomerase components could be a mandatory, yet reversible, step in the 
process leading to a full dismantling of telomerase complex and efficient cell-
cycle dependent degradation of Est1, the latter being a well-characterized 
event considered to limit fully assembled telomerase to the S-phase (Taggart, 
Teng and Zakian, 2002; Osterhage, Talley and Friedman, 2006). Degradation 
of Est2 could therefore prevent its re-association with the TLC1-Est1-Est3 
particle, thereby irreversibly sensitising Est1 to the subsequent clearance 
steps. 
Alternatively, free Est2 could be removed to prevent off-target effects, the likes 
of which have been extensively documented for its human homolog hTERT 
(Saretzki, 2016). However, such effects may not be immediately obvious, since 
overexpression of Est2 does not seem to exert any effect on the cell growth 
rate (Teixeira et al., 2002). It is possible that the selective disadvantage of 
yeast cells with an excess of telomerase manifests only under the conditions 
of stress. Also, in contrast to its mammalian homolog, Est2 lacks mitochondrial 
localization signal and has not been detected in mitochondria (Sickmann et al., 
2003). Given that human telomerase has been found to confer its adverse 
effect in mitochondria (Santos et al., 2004), the lack of mitochondrial import of 
Est2 argues against extrapolation of human telomerase off-target properties 
onto Est2.  
A. Bianchi and D. Shore have proposed that limiting the amount of telomerase 
is instrumental for ensuring preferential elongation of short telomeres (Bianchi 
and Shore, 2008), although whether such regulation necessitates degradation 
of free Est2 as opposed to Est2-TLC1 complex is an open question. 
Finally, the degradation of free Est2 might result from its mislocalization from 
telomeres to a different compartment, where it is recognized as a foreign 
protein and marked for destruction. It has been shown, that in the absence of 
TLC1 overexpression, overexpressed Est2 accumulated in the nucleolus 
(Teixeira et al., 2002). Est2 relies on TLC1 RNA for recruitment to telomeres 




by a nucleolar protein PinX1 in tlc1Δ cells (Lin and Blackburn, 2004). Yeast Ku 
protein complex has been also implicated in the recruitment of telomerase to 
telomeres (Fisher, Taggart and Zakian, 2004; Chan, Boulé and Zakian, 2008), 
and Gallardo et al. reported a role of yKu in the nuclear import of TLC1 
(Gallardo et al., 2008), raising a possibility of yKu participation in the nuclear 
trafficking of Est2-TLC1 complex. Therefore, it could be the case, that when 
Est2 fails to efficiently localize to the telomeres in the absence of yKu complex, 
it is redistributed to the nucleolus, as in tlc1Δ cells, or retained in the cytoplasm, 
where it could be rendered for degradation. As the initial step in testing the 
connection between the localization of Est2 and its stability I analysed the 
effects of deletion of YKU80 or yKu-interacting hairpin of TLC1 on Est2-myc13 
steady-state level. I discovered no statistically significant difference when 
comparing Est2-myc13 levels in mutants to WT cells (Figure 3.24), suggesting 
that either Est2-myc13 does not relocalize to the nucleolus in the absence of 
TLC1 interaction with yKu, or that such relocalization, if happens, does not 
confer instability to Est2. Alternatively, it could be argued, that the sample size 
of the experiment was insufficient to distinguish Est2-muc13 levels between the 
mutants and the wild type strains.  
3.5.3. The amount of S. pombe telomerase catalytic 
subunit is reduced at elevated growth temperature 
Budding yeast proved to be a valuable model eukaryote for investigating 
telomere biology. Nevertheless, species-specific properties of S. cerevisiae 
inevitably limit the extent to which the conclusions drawn from studying 
budding yeast telomeres and telomerase can be applied to mammalian cells. 
Understanding cancer and ageing is the ultimate goal of telomerase-related 
research in all species. The discovery of temperature-induced telomerase 
insufficiency and aneuploidy-dependent compensation of telomerase shortage 
in S. cerevisiae paved the way for establishing the first yeast model of 
telomerase reactivation (Millet et al., 2015). Expanding such a model across 




of the eukaryotes in general and facilitate understanding of the mechanisms 
underlying both telomerase insufficiency and its compensation in cancer cells.  
S. pombe telomere length equilibrium responds to the growth temperature 
similarly to S. cerevisiae (Millet et al., 2015), thus I tested the effect of 
temperature on the steady-state level of S. pombe telomerase catalytic subunit 
Trt1. I found that Trt1 level decreased in fission yeast grown at 37°C compared 
to 23°C (Figure 3.25), recapitulating the effect observed in S. cerevisiae. 
However, deletion of ter1+ (the gene encoding S. pombe telomerase RNA), did 
not seem to produce a significant decrease in the level of Trt1 (data not 
shown), consistent with previously obtained data (Leonardi et al., 2008). It 
remains to be elucidated, whether the nature of the temperature-induced 
decrease in the telomerase catalytic subunits in S. pombe and S. cerevisiae is 
the same. Given, that S. pombe haploid cells possess only 3 chromosomes, 
aneuploidy seems an unlikely possibility in fission yeast. For this reason 
telomerase reactivation in fission yeast might not be occurring by aneuploidy, 
which may limit the benefits of studying S. pombe telomere biology, or 
conversely, lead to a discovery of completely new aneuploidy-independent 












Dna2 and Rad27 Affect the Efficiency of 
DSB Healing via BIR and DNTA 
4. Dna2 and Rad27 Affect the Efficiency of 






RPA-coated ssDNA is a common feature of stalled replication forks and 
resected DSBs and is an important intermediate in homology repair, where it 
plays a vital role in the recruitment and activation of DNA damage checkpoint 
proteins. RPA-ssDNA tracts are also observed in the lagging-strand synthesis 
during normal DNA replication in the form of long 5’-flaps of Okazaki fragments 
(Rossi and Bambara, 2006; Rossi, Foiani and Giannattasio, 2018). 5’-flaps 
normally result from the displacement activity of Pol δ – the lagging strand 
polymerase – during the extension of an upstream Okazaki fragment (Maga et 
al., 2001). Both Dna2 and Pif1 participate in the metabolism of 5’-flaps, 
whereby Pif1 promotes the formation of long flaps capable of binding to the 
RPA, which thus become refractory to the flap-endonuclease (Rad27) 
nucleolytic activity and require cleavage by Dna2 (Rossi et al., 2008; Pike et 
al., 2009). Once the role of Dna2 in the S-checkpoint signalling was 
discovered, it has been proposed that persistent RPA-coated 5’flaps could 
promote Dna2-dependent S-checkpoint signalling (Kumar and Burgers, 2013; 
Wanrooij and Burgers, 2015). In addition, some of the models of BIR propose, 
that the synthesis of the lagging strand occurs via Okazaki fragments, which 
may require processing by Dna2 (Saini et al., 2013; Rossi, Foiani and 
Giannattasio, 2018). Thus, the metabolism of the 5’-flaps of Okazaki fragments 
might be relevant to homologous recombination and specifically to BIR, and 
the roles of Pif1 in BIR and Okazaki fragment maturation might be connected. 
Genetic studies of Dna2-related processes are somewhat difficult since the 
deletion of DNA2 is lethal (unless some other genes are deleted, e.g. PIF1, 
RAD9, POL32) however a hypomorphic dna2ΔN(1-248) mutant is available 
which is characterized by decreased nuclear localization of Dna2 and the lack 
of the amino-acids of Dna2 responsible for S-checkpoint signalling (Budd et 
al., 2006, 2011; Kumar and Burgers, 2013; Markiewicz-Potoczny, Lisby and 
Lydall, 2018). While looking into genetic interactions between PIF1 and DNA2 
in BIR, S. Makovets and O. Kotenko have found that dna2ΔN(1-248) partially 




Figure 4.1). Unexpectedly, when introduced into WT cells, dna2ΔN(1-248) 
caused a decrease of BIR efficiency. Subsequent genetic experiments and 
Southern-blot analysis confirmed that in contrast to pif1-m2 cells pif1-m2 
dna2ΔN(1-248) cells are capable of Pif1-independent long-range BIR. It was 
also revealed that dna2ΔN(1-248) alleviates BIR-defect incurred by other 
mutant pif1 alleles, such as pif1-4A (non-phosphorylatable), pif1-4D 
(phosphomimic) and pif1-R3E (deficient for the interaction with PCNA). In 
addition, RAD27 effects on the BIR efficiency were found to partially 
recapitulate the effects of DNA2. 
4.2. N-terminally truncated Dna2 (Dna2ΔN(1-248)) 
alleviates the requirement for Pif1 in BIR but not 
for Pol32 
As mentioned previously, O. Kotenko and S. Makovets have discovered a 
suppression of BIR defect in pif1-m2 cells by dna2ΔN(1-248) (Figure 4.1). The 
BIR efficiency in this experiment, as well as the experiments performed in this 
study, was assessed by a previously published plating assay (Vasianovich, 
Harrington and Makovets, 2014), wherein an inducible DSB was created by 
GAL1 promoter-regulated HO-nuclease that introduced a cut at an ectopic HO-
site (Figure 4.2). The HO-site was placed close to the MNT2 gene on chrVIIL 
and was flanked by the URA3 gene from the telomere-proximal side and by a 
3’-fragment of KAN from the centromere-proximal side. The 3’ KAN fragment 
shared 500 bp of homology with the 5’ KAN fragment located approximately 
100 kb away from the right end of chromosome II. The cells pre-grown on 
raffinose were plated in parallel on YPD and YPGal plates and the efficiency 
of BIR was calculated as the total number of G418R Ura- colonies on YPGal 
plates relative to the cell titer. All the plating experiments in chapter 4 were 
done using this system, unless specified otherwise. 
In order to test, whether dna2ΔN(1-248) increases the frequency of G418R 
Ura- survivors upon induction of a DSB in pif1-m2 cells through BIR rather than 




derivatives of PIF1 or pif1-m2 with DNA2 or dna2ΔN(1-248), which lack the 
Pol32 subunit of Pol δ essential for BIR (Lydeard et al., 2007). In this 
background, dna2ΔN(1-248) was unable to suppress the BIR defect (Figure 
4.3). Thus, pif1-m2 dna2ΔN(1-248) cells are partially proficient for BIR 
independently of Pif1. 
 
 
Figure 4.1: dna2ΔN(1-248) decreases BIR efficiency in WT cells, but partially 
suppresses BIR-defect in pif1-m2 cells 
Mean frequency of BIR was calculated from three technical repeats. Error bars 
correspond to standard deviation. dna2Δ strains are not viable and therefore could 
not be used in the assay. From Vasianovich, Harrington and Makovets, 2014, and O. 







Figure 4.2: Schematic of the BIR assay  
From Vasianovich, Harrington and Makovets, 2014 
 
DNA combing experiments performed by Malkova’s group have demonstrated 
that Pif1 is important for long-range (~100 kb) BIR, since in pif1Δ cells BIR 
terminated prematurely, resulting in half-crossover repair outcomes (Saini et 
al., 2013). In order to test if pif1-m2 dna2ΔN(1-248) cells are capable of long-
range BIR, I analysed several G418R Ura- clones recovered after the DSB 
induction from pif1-m2, dna2ΔN(1-248), pif1-m2 dna2ΔN(1-248) and WT cells 
for the presence of long-range BIR products using PFGE in combination with 
Southern blotting using a probe specific to the distal part of the BIR donor 
chromosome (Figure 4.4). In case of successful BIR repair, this region is 
copied to the broken chromosome, i.e. chrVII. As seen from Figure 4.5 (also 
see Table 4.1), all ten pif1-m2 dna2ΔN(1-248) clones, that were assayed by 
PFGE-coupled Southern blotting, had successfully copied the distal region of 




long-range BIR. In the pif1-m2 strain, out of nineteen G418R Ura- clones 
selected for analysis, one clone failed to copy the aforementioned region onto 
chrVII, apparently as a result of prematurely terminated BIR. In WT and 
dna2ΔN(1-248) strains, all the analysed clones carried the sequence in 
question on both chrII and chrVII, indicating successfully-completed long-
range BIR in the majority of G418R Ura- clones. Collectively, the results of the 
plating assay (see Figure 4.3) and the PFGE analysis of repair outcomes 
suggest that pif1-m2 dna2ΔN(1-248) cells are partially proficient for long-range 
Pif1-independent BIR.  
 
Figure 4.3: dna2ΔN(1-248) does not suppress the BIR deficiency in pol32Δ 
cells 
Mean frequency of BIR was calculated from three technical repeats. Error bars 
correspond to standard deviation. Here and henceforth the plating assay results 
obtained in this study are indicated below the diagram. Data for POL32 strains are 






Figure 4.4: Schematic of the repair product resulting from the completion of 
long-range BIR, that can be detected by probing for the region ~77 kb 
downstream from the invasion point on chrII 








Figure 4.5: (beginning) Analysis of repair outcomes in G418R Ura- clones 









Figure 4.5: (continuation) Analysis of repair outcomes in G418R Ura- clones 
recovered upon DSB induction in WT, dna2ΔN(1-248), pif1-m2 or double-
mutant strains 
Pulse-field gels are on the left and Southern blots are on the right. A WT strain with 
no DSB induction and a 5 kb homology between chrVII and chrII was used as a 
negative control for chrVII probing. The rest of the strains have 500 bp homology 
between chrVII and chrII. One pif1-m2 clone failed to copy the region 77 kb 
downstream of the invasion point (A, right side, lane 12), indicating that the BIR either 
terminated prematurely or has never occurred. The rest of the analysed clones 
successfully copied the region in question onto chrVII upon DSB induction, consistent 






Table 4.1: Summary of the repair outcomes in different genotypes analysed by 
PFGE-coupled Southern blotting 
Fractions indicate the number of clones that have copied the chrII fragment 77 kb 
downstream from the invasion point onto chrVII upon DSB induction relative to the 
total number of analysed G418R Ura- clones  
 WT dna2ΔN(1-248) rad27Δ 
PIF1 10/10 9/9 10/10 
pif1-m2 18/19 10/10 9/9 
pif1-4A 13/17 Not assayed Not assayed 
 
4.3. The suppression of the BIR defect in pif1-m2 
dna2ΔN(1-248) is dependent on the nuclease 
activity of Dna2 
Dna2 possesses two enzymatic activities – a nuclease and a helicase one 
(Budd, Choe and Campbell, 1995). In an attempt to gain insights into the 
mechanism underlying the suppression of BIR deficiency in pif1-m2 
dna2ΔN(1-248) cells, I analysed the effect of the missense mutations 
disrupting the catalytic functions of the truncated Dna2 protein on its ability to 
alleviate the BIR defect. In Dna2, the D657A amino acid substitution abolishes 
its nuclease activity, while the K1080E change inactivates the ATP-binding-
motif, thus effectively eliminating the helicase activity (Budd, Choe and 
Campbell, 1995, 2000). The plating assay demonstrated that only the 
nuclease, but not the helicase activity of Dna2ΔN(1-248) was essential for 
rescuing the BIR deficiency in pif1-m2 cells, since strains harbouring helicase-
dead, but not helicase-,nuclease-dead dna2ΔN(1-248) were able to supress 






Figure 4.6: The helicase, but not the nuclease activity of Dna2ΔN is 
dispensable for the partial suppression of BIR defect in pif1-m2 dna2ΔN(1-248) 
cells 
Mean frequency of BIR was calculated from three technical repeats. Error bars 
correspond to standard deviation. Data for the WT, pif1-m2, dna2ΔN(1-248), pif1-m2 
dna2ΔN(1-248) and pif1-m2 dna2Δ strains are from Vasianovich, Harrington and 





4.4. dna2ΔN(1-248) partially suppresses the BIR defect 
in different pif1 mutants 
Elucidating the mechanism of the dna2ΔN(1-248)-mediated suppression of the 
BIR deficiency phenotype in pif1-m2 may shed light on the Pif1 function in BIR 
and vice versa. Y. Vasianovich et. al. have demonstrated that the pif1-4A 
mutation, that abrogates the Rad53-dependent phosphorylation of the 
TLSSAES motif in Pif1, decreases the BIR efficiency in a similar to pif1-m2 
fashion (Vasianovich, Harrington and Makovets, 2014). Other BIR-deficient 
pif1 mutants have been subsequently reported in the literature and also 
identified in our lab (Buzovetsky et al., 2017 and O. Kotenko, personal 
communication), collectively suggesting that the engagement of Pif1 in BIR 
could involve several steps and/or molecular interactions. Identifying the pif1 
alleles that complement dna2ΔN(1-248) in BIR could help to pinpoint the 
specific step or process that is rescued by dna2ΔN(1-248). It should be pointed 
out that in WT background dna2ΔN(1-248) inhibits BIR, raising a possibility of 
a competition between Pif1 and Dna2ΔN(1-248) for some third factor. Thus, if 
a particular pif1 mutation happens to impair the Pif1 function in BIR without 
affecting the said competition with Dna2, it could potentially exacerbate the 
BIR defect observed in PIF1 dna2ΔN(1-248) cells.  
Using the same plating assay as before (Figure 4.2), I analysed the genetic 
interaction of dna2ΔN(1-248) with the following nuclear pif1 alleles: pif1-m1-
4A, pif1-m1-4D (with the threonine and serine residues in the TLSSAES motif 
replaced by either alanines or phosphomimic aspartates, respectively; 
Makovets and Blackburn, 2009), pif1-m1-R3E (deficient for the interaction with 
PCNA; Buzovetsky et al., 2017), pif1-m1-4A-R3E and pif1-m1-4D-R3E, all of 
which were co-expressed with an otherwise unaltered mitochondrial allele pif1-
m2 to avoid mitochondrial side-effects (Figure 4.7A). Comparable levels of the 
suppression of the BIR defects by dna2ΔN(1-248) were observed in all the 
studied pif1 mutants (Figure 4.7B), including cells exclusively expressing the 
nuclear null allele pif1-m2, suggesting a shared nature of the BIR deficiency 




Figure 4.7: dna2ΔN(1-248) partially suppresses the BIR defect of different 
mutant pif1 alleles to a similar extent 
A – schematic of a tandem arrangement of nuclear-null and mitochondrial-null pif1 
alleles in the PIF1 locus used in the BIR plating assay. PIP – PCNA interacting 
peptide, TLSSAES – a motif phosphorylated upon the DNA damage checkpoint 
activation. Amino acid sequence alterations introduced upon different mutations are 
indicated. B – BIR efficiency of the strains with different PIF1 alleles and DNA2, 
dna2ΔN(1-248) or dna2Δ. Mutations in the PIP and/or the TLSSAES motifs were 
introduced into the pif1-m1 (nuclear only) allele on an integration vector and the 
resultant mutant genes were co-expressed with pif1-m2 (mitochondrial only) allele to 
avoid any effect on the mitochondrial function of Pif1. Mean frequency of BIR was 
calculated from at least three technical repeats (except for pif1-m2 pif1-m1,4D 
dna2ΔN(1-248) strain, where only two repeats were used). Error bars correspond to 
standard deviation. Data for WT, pif1-m2, dna2ΔN(1-248), pif1-m2 dna2ΔN(1-248), 
pif1-m2 pif1-m1,4A, pif1-m2 pif1-m1,4D, pif1-m2 pif1-m1,4A,R3E, pif1-m2 pif1-
m1,4D,R3E and pif1-m2 dna2Δ strains is from Vasianovich, Harrington and 







4.5. Overexpression of DNA2 or its truncated forms 
affects both BIR and DNTA at DSBs 
Dna2ΔN(1-248) has been found to have a decreased localization to DSBs 
compared to the full-length protein (Chen et al., 2011), indicating that it might 
behave as a hypomorph in general and in BIR too. Of note, the efficiency of 
BIR is lower in pif1-m2 dna2Δ than in pif1-m2 dna2ΔN(1-248) cells and lower 
in pif1-m2 dna2ΔN(1-248)-D6575A,K1080E cells than in pif1-m2 dna2ΔN(1-
248)-K1080E cells (see Figures 4.1 and 4.6), suggesting that a minimal level 
of the Dna2ΔN nuclease activity is essential for the efficient BIR in the pif1-m2 
background. At the same time, dna2ΔN(1-248) cells have a decreased BIR 
frequency compared to pif1-m2 dna2ΔN(1-248) cells, indicating a requirement 
for an intricate balance between the activities of Pif1 and Dna2 for efficient 
BIR. Such a balance is supposedly upset whenever the activity of Pif1 exceeds 
that of Dna2ΔN(1-248) (however it is not clear whether the same is true for an 
inverse situation). If this hypothesis is correct, then dna2Δ cells could be 
expected to demonstrate even lower BIR efficiency, than dna2ΔN(1-248) cells, 
however DNA2 loss is lethal in the presence of Pif1 (Budd et al., 2006), 
preventing such strains from being constructed and analysed in the BIR assay. 
On the other hand, removal of the first 405 amino acids of Dna2 has been 
reported to increase the in vitro nuclease activity of Dna2 (Bae, 2001). This 
suggests an alternative interpretation of the BIR assay data obtained from the 
dna2ΔN(1-248) strains. The increased nuclease activity of the Dna2ΔN(1-248) 
protein might be compensating for the lack of Pif1 in pif1-m2 dna2ΔN(1-248) 
cells by an unknown mechanism. However in the presence of functional Pif1 
an excess of Dna2ΔN(1-248) nuclease activity might be somehow detrimental 
for BIR, possibly upsetting a finely tuned coordination between the many 
processes that underlie the progress of the repair. In an attempt to determine 
whether the efficiency of BIR in dna2ΔN(1-248) cells is limited by insufficient 
Dna2ΔN(1-248) activity, I assessed the effect of ectopic DNA2 and dna2ΔN(1-
248) overexpression on BIR in the WT and pif1-m2 backgrounds. DNA2 




not significantly alter the BIR efficiency in pif1-m2 cells (Figure 4.8). 
Overexpression of the ectopic dna2ΔN(1-248) in cells with the WT 
endogenous copy of DNA2 did not bring about a noticeable change in the BIR 
efficiency in either WT or pif1-m2 background. Surprisingly, overexpression of 
the ectopic dna2ΔN(1-248) in dna2ΔN(1-248) cells was associated with an 
almost 14-fold increase in the BIR frequency compared to the strain with no 
overexpression, whereas in pif1-m2 dna2ΔN(1-248) cells, the ectopic 
dna2ΔN(1-248) overexpression failed to produce an appreciable difference in 
BIR efficiency (P = 0.2; Figure 4.9). Collectively, these results indicate, that the 
full-length Dna2, whether endogenous or ectopic, limits the BIR efficiency, 
whereas Dna2ΔN(1-248) facilitates BIR, when its amount is sufficient, the 
threshold for the required level of Dna2ΔN(1-248) apparently being elevated 
in the presence of Pif1. Interestingly, ectopic overexpression of the first 405 
amino acid residues of Dna2 (dna2-N(1-405)), that lacks both the nuclease 
and the helicase domains, resulted in an approximately 1.5-fold increase in 
BIR in WT cells, suggesting that there might be more than one mechanism of 
the Dna2-related increase in the BIR efficiency.  
An unanticipated effect of DNA2 overexpression was discovered upon the 
induction of a DSB while analysing the frequency of G418S Ura- colonies, 
which were expected to form in case of addition of a telomere to the DSB by 
DNTA (see Figures 4.10 and 4.11). Specifically, ectopic overexpression of 
DNA2 produced an almost 4-fold increase in DNTA in pif1-m2 cells (up to 4% 
frequency), which lack Pif1 normally responsible for inhibiting DNTA (Schulz 
and Zakian, 1994). Overexpression of dna2-N(1-405), but not dna2ΔN(1-248) 
in pif1-m2 cells resulted in a similar rise of DNTA frequency, suggesting that 
the observed effect is specific to the N-terminal part of Dna2, rather than its 
catalytic domains. Y. Vasianovich has previously observed a 2-fold increase 
in DNTA frequency (up to 3.5% of total colonies) upon deletion of SGS1 in pif1-
4A cells (Y. Vasianovich, personal communication) and a 1.5-fold increase in 
BIR upon deletion of SGS1 in WT cells had been previously reported in a 
system with 1157 bp homology (Lydeard et al., 2010). Dna2 has been known 




the same pathway of DNA resection at DSBs (Cejka, Cannavo, et al., 2010) 
and the resection has been reported to inhibit DNTA, especially in pif1-m2 cells 
(Chung et al., 2010). Therefore, it could be hypothesised, that the ectopic 
overexpression of DNA2 or dna2-N(1-405) in pif1-m2 cells results in the 
sequestration of Sgs1 from the DSB, thereby abrogating the Sgs1-dependent 




Figure 4.8: Overexpression of DNA2 decreases the efficiency of BIR in WT 
cells 
Mean frequency of BIR was calculated from three technical repeats, except for pif1-
m2 PGAL1-DNA2 strains, where two technical repeats were used. Error bars 
correspond to standard deviation. Data for WT and pif1-m2 a strains is from 






Figure 4.9: The effect of ectopic overexpression of either DNA2 or its 
truncated forms on the BIR efficiency (combined data) 
Mean frequency of BIR was calculated from at least three technical repeats, except 
for the pif1-m2 PGAL1-DNA2 strains, where 2 repeats were used. Error bars correspond 
to standard deviation. Data for WT, pif1-m2, dna2ΔN(1-248) and pif1-m2 dna2ΔN(1-









Figure 4.10: Schematic of possible genetic outcomes upon the induction of a 
DSB in the genetic system used for the plating assay of the BIR efficiency 







Figure 4.11: The effect of ectopic overexpression of either DNA2 or its 
truncated forms on DNTA efficiency (combined data) 
Mean frequency of DNTA was calculated from at least three technical repeats, except 
for pif1-m2 PGAL1-DNA2 strains, where 2 repeats were used. Error bars correspond to 
standard deviation. Data for WT, pif1-m2, dna2ΔN(1-248) and pif1-m2 dna2ΔN(1-






4.6. The effect of the overexpression of mutant DNA2 
alleles on checkpoint activation  
As noted before (see section 4.5), overexpression of the full-length DNA2 
caused a decrease in the efficiency of BIR in the WT background and no 
increase in pif1-m2 background. In an effort to find out, whether this effect 
could be linked to a specific catalytic activity of Dna2, the strains with the 
inducible DSB, carrying helicase-, nuclease- or catalytically-dead versions of 
ectopic DNA2 under GAL1 promoter were created and tested in the BIR plating 
assay. However, all the strains overexpressing mutant DNA2 failed to form 
colonies on YPGal plates in both WT and pif1-m2 backgrounds (data not 
shown). The lethality of dna2Δ has been previously attributed to persistent 
checkpoint activation due to the accumulation of long RPA-coated 5’-flaps 
generated by Pif1 out of the Okazaki fragments during DNA-replication in the 
absence of Dna2 needed to remove them (Budd et al., 2011). It could therefore 
be proposed, that PGAL1-dna2-D657A and PGAL1-dna2-K1080E exert a 
dominant-negative effect by producing an excess of dysfunctional Dna2 
protein that displaces the WT Dna2 from the RPA-coated flaps, thus inhibiting 
their cleavage and promoting the checkpoint activation. However, this 
explanation does not account for the inviability of the pif1-m2 strains 
overexpressing dysfunctional DNA2, considering that pif1-m2 has been shown 
to suppress dna2Δ lethality (Budd et al., 2006).  
To test whether the overexpression of the mutant versions of DNA2 results in 
the checkpoint activation, the phosphorylation status of Rad53 was analysed 
in the strains with the overexpression of either the WT or the mutant DNA2 
variants (including the truncated versions). To that end, the cells were pre-
grown in YPRaf media at 30°C and then the overexpression of the ectopic 
DNA2 variants was induced by the addition of galactose and further incubation 
for three hours at 30°C. A detectable Rad53 mobility shift was observed in the 
cells overexpressing either the nuclease-dead dna2-D657A in both the WT 
and pif1-m2 backgrounds or the nuclease- and helicase-dead dna2-




damage checkpoint activation in the corresponding strains. Neither the full-
length WT DNA2, nor its truncated versions produced any noticeable Rad53 
band shift, consistent with the ability of the cells overexpressing these 
constructs to form colonies on YPGal plates. The lack of a detectable 
checkpoint activation upon overexpression of dna2-N(1-405) suggests, that 
Dna2-N(1-405) does not prevent the endogenous full-length Dna2 from 
cleaving the 5’-flaps of the Okazaki fragments during replication. Thus, the 
inviability of the cells overexpressing DNA2 with disrupted nuclease activity 












Figure 4.12: Overexpression of nuclease-dead DNA2 (dna2-D657A) leads to Rad53 phosphorylation in WT and pif1-m2 cells 
Phleomycin was added to the final concentration of 2µg/mL (for 3 hours) to two cultures used as the positive control of Rad53 






4.7. RAD27 overexpression inhibits BIR in both the WT 
and pif1-m2 backgrounds 
Both Rad27 and Dna2 play a role during DNA replication by removing 5’-flaps 
of the Okazaki fragments (Bae et al., 2001). In contrast to Dna2, Rad27 is not 
essential for cell viability, although rad27Δ causes accumulation of single-
stranded DNA and destabilization of telomeric repeats in yeast (Parenteau and 
Wellinger, 2015). Rad27 has been shown to physically interact with Dna2 in 
cells that overexpress both proteins (Budd and Campbell, 1997). However, the 
subsequent attempts to reconstitute the Dna2-Rad27 complex in vitro were 
unsuccessful, suggesting that either the interaction between the proteins is 
weak or it requires an additional bridging protein (Bae and Seo, 2000). It was 
later discovered by the Makovets’ group that rad27Δ affects BIR similarly to 
dna2ΔN(1-248) in that it partially suppresses the BIR defect incurred by pif1-
m2, but reduces the efficiency of BIR in WT cells (Figure 4.13). To further 
delineate the role of Rad27 in BIR, I assayed the effect of RAD27 
overexpression on BIR. Similarly to DNA2 overexpression, an excess of the 
Rad27 nuclease resulted in a significant decrease in the BIR efficiency, in both 
WT and pif1-m2 cells (Figure 4.13). Just as with pif1-m2 dna2ΔN(1-248) cells 
before and in contrast to pif1-m2 cells no incidents of premature BIR 
termination were discovered in the PFGE-coupled Southern blot analysis of 
repair outcomes in nine G418R Ura- clones (Figure 4.14), indicating proficiency 
for long-range BIR. Overall, the effects of RAD27 on BIR were reminiscent of 
the effects exerted by DNA2 (see Figure 4.13), raising a possibility of a 









Figure 4.13: RAD27 affects BIR similarly to DNA2 
Combined data on the effects of DNA2 and RAD27 loss or overexpression on the 
efficiency of BIR in WT and pif1-m2 cells. Data for WT, pif1-m2, rad27Δ, pif1-m2 
rad27Δ, dna2ΔN(1-248) and pif1-m2 dna2ΔN(1-248) strains are from Vasianovich, 






Figure 4.14: rad27Δ and pif1-m2 rad27Δ strains are capable of long-range BIR 
Left side – pulse-field gels, right side – Southern blots. A WT strain with no DSB 
induction and 5 kb homology between chrVII and chrII was used as a negative control 
for chrVII probing. The rest of the strains have 500 bp homology between chrVII and 
chrII. All of the analysed clones successfully copied the probed region onto chrVII 




4.8. Sgs1 interacts with the N-terminus of Dna2 
Dna2 is involved in a wide variety of functions in eukaryotic cells (Wanrooij and 
Burgers, 2015). Among these functions is the 5’-strand resection of a DSB, 
which Dna2 performs jointly with Sgs1 helicase in one of the two partially 
redundant DNA resection pathways (Zhu et al., 2008; Cejka, Cannavo, et al., 
2010). Recombinant Dna2 and Sgs1 interact in vitro (Cejka, Cannavo, et al., 
2010). Previously, I observed that overexpression of either the full-length 
DNA2 or dna2-N(1-405), but not dna2ΔN(1-248), was associated with 
increased DNTA in cells with an inducible DSB (see Figure 4.11). This effect 
was similar to the 3.5-fold increase in DNTA observed upon deletion of SGS1 
(Y. Vasianovich, personal communication), which likely results from a 
decrease in resection, since the resection has been shown to decrease the 
efficiency of DNTA (Chung et al., 2010). The effect of DNA2 or dna2-N(1-405) 
overexpression could thus be potentially explained by a hypothesis where the 
corresponding Dna2 proteins sequester Sgs1 from the DSB, thereby 
preventing Sgs1 from participating in the resection. Conversely, ectopic 
Dna2ΔN(1-248) fails to elevate DNTA, possibly due to the loss of the 
interaction with Sgs1, thus not being able to drive Sgs1 away from the full-
length Dna2 at the DSB site. To test whether Dna2-N(1-405) can interact with 
Sgs1 in vivo, I performed co-immunoprecipitation of either the full-length Dna2 
or Dna2-N(1-405) with Sgs1 under the conditions where all the involved 
proteins were overexpressed. Sgs1 co-immunoprecipitated with both the full-
length and the C-terminally truncated versions of the protein (Figure 4.15), 
consistent with the proposed hypothesis (also see Figure 4.11). This result is 
in line with the recently demonstrated interaction between Dna2-N(1-405) and 
Sgs1 helicase domain in a yeast-two-hybrid system (Mojumdar et al., 2019). 
Dna2ΔN(1-248) also could interact with Sgs1 (Figure 4.16). It could therefore 
be concluded that either there are several redundant regions in Dna2 
responsible for the interaction with Sgs1 or that the only such region is located 
in the stretch between the 248th and the 405th amino acid residues, shared by 




Identifying specific amino acid residues of Dna2 important for the interaction 
with Sgs1 could facilitate the creation of separation-of-function DNA2 mutants, 
which would allow to evaluate the role of the aforementioned interaction in the 
various effects that DNA2 and its truncated versions exert on BIR efficiency. 
To that end a set of nested DNA2 truncations expressed from the GAL1 
promotor was introduced into exo1Δ cells with the inducible DSB. The strains 
were tested for the frequency of DNTA upon DSB induction as the metric of 
Sgs1 sequestration by the truncated Dna2 proteins (in cells lacking Exo1-
dependent resection sequestration of Sgs1 from the DSB would result in a 
complete abruption of long-range resection and a prominent increase in DNTA 
frequency). A steep decrease in the frequency of DNTA was observed 
between the strains overexpressing dna2-N(2-370) and dna2-N(2-309) (Figure 
4.17), suggesting that the interaction with of Dna2-N(1-405) with Sgs1 requires 
the stretch located between the amino acids 309 and 370 of Dna2-N(1-405). 
The results of this plating assay and the co-immunoprecipitation of Sgs1 with 
full-length and truncated Dna2 isoforms are consistent with the presence of at 
least one Sgs1-interacting region between amino acids 248 and 370 of Dna2. 
However, the absence of an increase in DNTA in cells with ectopic Dna2ΔN(1-
248) (see Figure 4.11) suggests that interaction with Sgs1 is not sufficient to 
produce an increase in DNTA upon overexpression of truncated Dna2, which 
means that DNTA frequency is not a reliable proxy of Sgs1-Dna2 interaction. 
Thus, additional co-immunoprecipitation experiments are required to 








Figure 4.15: Sgs1 co-immunoprecipitates with Dna2 and Dna2-N(1-405) 






Figure 4.16: Sgs1 co-immunoprecipitates with Dna2, Dna2ΔN(1-248) and Dna2-
N(1-405) 
ΔN – PGAL1-dna2ΔN(1-248), N - PGAL1-dna2-N(1-405). Some degree of overflow from 
the neighboring lanes could be seen in lanes 4, 6 and 13 
 
Figure 4.17: The frequency of DNTA in strains overexpressing various 
truncated versions of DNA2 
Mean frequency of BIR was calculated from at least two technical repeats. Error bars 




4.9. Overexpression of Dna2 or its truncated forms 
does not affect the telomere length equilibrium in 
yeast 
Both Dna2 and Pif1 are relevant to BIR. Given that overexpression of DNA2 
inhibits BIR (see Figure 4.9), it could be speculated, that Dna2 antagonizes 
Pif1. This speculation would be supported in case other instances of 
antagonism between Dna2 and Pif1 were found. Notably, the two proteins are 
also involved in the telomere biology. For instance, Pif1 inhibits telomerase at 
telomeres (Schulz and Zakian, 1994), while Dna2 has been found to associate 
with the telomeres throughout most of the cell cycle (Choe et al., 2002) and 
proposed to modulate the DNA damage response at telomeres (Markiewicz-
Potoczny, Lisby and Lydall, 2018). With the aim of getting a more detailed 
understanding of the genetic interaction between DNA2 and PIF1, the effect of 
the ectopic overexpression of DNA2 or its truncated forms on the telomere 
length equilibrium of WT and pif1-m2 yeast grown at 30°C was investigated. 
Consistent with the previously reported observations (Schulz and Zakian, 
1994), pif1-m2 cells had elongated telomeres (Figure 4.18). The ectopic 
overexpression of DNA2, dna2-D657A,E1080K (nuclease- and helicase-
dead), dna2ΔN(1-248) or dna2-N(1-405) did not produce any noticeable effect 
on the telomere length equilibrium in either the WT or the pif1-m2 background. 
Thus, no genetic interaction between DNA2 and PIF1 was discovered at the 






Figure 4.18: Telomere length equilibrium of strains continually overexpressing 
ectopic DNA2 or its truncated/mutated forms at 30°C 
Average Y-telomere length was analyzed after 5 passages on YPGal plates at 30°C. 
TRF – terminal restriction fragment. See section 2.8.10 and Figure 3.13 for the 







Dna2 performs a variety of functions important for genome stability (Wanrooij 
and Burgers, 2015), increasing the chances that a mutation such as 
dna2ΔN(1-248) would have a pleiotropic effect. This might be one of the 
reasons behind the complex genetic interaction between DNA2 and PIF1 in 
BIR (see Figures 4.1 and 4.9). Several explanations could be brought forward 
to account for the results presented in this chapter. 
4.10.1. The interplay between Pif1-dependent D-loop 
migration, the resection and the recombination 
execution checkpoint might determine BIR 
efficiency  
The efficiency of BIR could be proposed to be the net result of a complex 
interplay between a number of factors and processes, as visualized in Figure 
4.19. Such factors could include recombination execution checkpoint 
(REC) (i), DSB resection (ii) and Pif1-dependent D-loop migration (iii). 
Both DNA resection at a DSB and Pif1-dependent D-loop migration have been 
shown to promote BIR (Symington and Gautier, 2011; Wilson et al., 2013). 
REC is performed by the Sgs1 and Mph1 helicases and exerts an inhibitory 
effect on BIR, possibly by destabilizing the D-loop (Jain et al., 2009, 2016). 
Hypothetically, in WT cells Pif1 might strongly antagonize Sgs1 and Mph1 in 
the execution of the REC (Pif1 has the opposite polarity to Sgs1 and Mph1 and 
hence might displace them from the DNA strand, see Figure 4.19A and B). 
Consequently, in cells lacking nuclear Pif1 REC could be rampant (Figure 
4.19C), further inhibiting BIR that is already down due to the lack of Pif1 D-
loop migration function (Wilson et al., 2013). 
(i). The possible effects of DNA2 alleles on recombination execution 
checkpoint in the context of BIR 
A possible explanation for the partial suppression of BIR defect by dna2ΔN(1-




REC. The co-immunoprecipitation experiments performed in this study 
demonstrated that Dna2ΔN(1-248) interacts with Sgs1 (see Figure 4.16). It 
could be speculated, that Dna2ΔN(1-248), which has a lower-than WT level of 
recruitment to the DSB site (Chen et al., 2011), causes reduced localization of 
Sgs1 to the D-loop, thereby hindering the Sgs1-dependent REC (Figure 
4.19D). Thus in pif1-m2 background dna2ΔN(1-248) may promote BIR by 
inhibiting runaway REC. 
It could also be proposed that the increase in BIR upon dna2ΔN(1-248) or 
dna2-N(1-405) overexpression in dna2ΔN(1-248) background (Figure 4.9) is 
due to intensified sequestration of Sgs1 from the D-loop by ectopic truncated 
Dna2 species, causing a severe REC defect (see Figure 4.19F).  
(ii). The possible effects of DNA2 alleles on resection 
However, if REC inhibition by dna2ΔN(1-248) promotes BIR, it is not clear why 
dna2ΔN(1-248) does not increase the efficiency of BIR in WT background and 
instead decreases it. Here I propose a model, which links the decrease of BIR 
efficiency upon introduction of dna2ΔN(1-248) into WT cells to a hypothetical 
increase in the interaction between Pif1 and Dna2ΔN(1-248) following the 
removal of Dna2 N-terminus (Figure 4.19E). The postulated strong Pif1-
Dna2ΔN(1-248) interaction might result from the removal of the part of Dna2, 
responsible for favoring the interaction with Sgs1 over the interaction with Pif1. 
Correspondingly, in dna2ΔN(1-248) cells the competition between Pif1 and 
Sgs1 for the association with Dna2ΔN(1-248) might be exacerbated compared 
to WT cells, dampening functions depending on the interaction between 
Dna2ΔN(1-248) and Sgs1. 
One of such functions could be Sgs1-dependent resection at the DSB. It is 
reasonable to assume that attenuated Sgs1-resection would reduce BIR 
efficiency, given the importance of resection for BIR and that Sgs1 and Dna2 
act together in the major pathway for the long-range resection (Zhu et al., 
2008). On a separate note, the importance of the Sgs1-dependent resection 
for BIR could also be the reason why the Dna2ΔN(1-248) nuclease activity is 




since the removal of nuclease activity of Dna2ΔN(1-248) would completely 
abrogate any Sgs1-dependent resection. 
Meanwhile, the absence of the nuclease domain in Dna2-N(1-405) prevents 
Dna2-N(1-405)-Sgs1 complex from participating in the resection, possibly 
accounting for the less pronounced gain in the BIR efficiency observed in 
dna2ΔN(1-248) cells overexpressing dna2-N(1-405) instead of dna2ΔN(1-
248). 
The hypothesis stating that some effects of dna2ΔN(1-248) on BIR are 
mediated by changes in resection efficiency is subject to several caveats. First 
of all, the helicase activity of Dna2ΔN(1-248) appears to be dispensable for its 
suppressive effect on BIR in pif1-m2 cells (see Figure 4.6), but recently P. 
Cejka’s group have discovered a noticeable drop in the Sgs1-dependent 
resection efficiency in cells harboring helicase-dead dna2-K1080E, albeit in an 
exo1Δ background (Levikova, Pinto and Cejka, 2017). Secondly, the overall 
significance of the Sgs1-dependent resection for BIR in cells expressing EXO1 
and possessing only 500 bp of homology between the broken end and an 
ectopic template may itself be questionable. 
(iii). The possible effects of DNA2 alleles on D-loop migration in the 
context of BIR 
Intensified interaction between Pif1 and Dna2ΔN(1-248), proposed above, 
might also hamper Pif1-dependent D-loop migration due to the sequestration 
of Pif1 away from the D-loop by Dna2ΔN(1-248) deficient in nuclear 
localization (see Figure 4.19E and F). However, the effect of overexpression 
of dna2ΔN(1-248) on BIR in dna2ΔN(1-248) background (see Figure 4.9) is 
not consistent with this notion, as ectopic Dna2ΔN(1-248) would be expected 
to decrease BIR through sequestration of Pif1 from the D-loop, when, in fact, 





(iv). Why DNA2 overexpression inhibits BIR. Explanations from the 
viewpoint of REC and DSB resection 
The inhibitory effect of DNA2 overexpression on BIR (Figure 4.9) may be due 
to the enhanced recruitment of Sgs1 to the D-loop that leads to a stricter 
recombination execution checkpoint. Alternatively, BIR inhibition could result 
from excessive resection upon overexpression of DNA2, as could be inferred 
with the previously published decrease in BIR efficiency upon overexpression 
of EXO1 or SGS1 (Lydeard et al., 2010). This idea also provides an alternative 
viewpoint as to the nature of the partial BIR rescue by dna2ΔN(1-248), which 
could stem from the possibility of a less extensive resection upon removal of 
the N-terminus of Dna2 being more optimal for efficient BIR in pif1-m2 cells. 
However the elevation of DNTA (see Figure 4.11) argues strongly against the 
possibility of intensified resection upon overexpression of DNA2, considering 













Figure 4.19: Hypothetical model of the interplay between resection, REC and 
D-loop migration in BIR in cells with different genotypes 
A – an overview of factors affecting BIR. Both resection by Sgs1-Dna2 and Pif1-
facilitated D-loop migration promote BIR. Sgs1-dependent D-loop disruption inhibits 
BIR, but is being counteracted by Pif1. B-F – Models depicting different contributions 
of the three factors to BIR efficiency depending on genetic background. 
B – in WT cells both DSB resection and D-loop migration are efficient and Sgs1-
dependent D-loop disruption is moderate due to Pif1-dependent removal of Sgs1 from 
the D-loop. C – in pif1-m2 cells lack of nuclear Pif1 leads to both inefficient D-loop 
migration and unrestrained Sgs1-dependent D-loop disruption. D – in pif1-m2 
dna2ΔN(1-248) cells BIR is partially rescued due to sequestration of Sgs1 away from 
the D-loop resulting in lower level of Sgs1-dependet D-loop disruption. E – in 
dna2ΔN(1-248) cells there is an antagonism between Pif1 and Dna2ΔN(1-248) due 
to their strong association. Pif1 outcompetes Sgs1 from the complex with Dna2ΔN(1-
248), thus hampering Sgs1-dependent resection. However, Pif1 also decreases the 
extent of Dna2ΔN(1-248)-dependent sequestration of Sgs1 from the D-loop, resulting 
in stronger REC. In addition, Dna2ΔN(1-248) sequesters Pif1 from the D-loop, thus 
hindering D-loop migration. F – overexpression of dna2ΔN(1-248) in dna2ΔN(1-248) 




4.10.2. The BIR efficiency might be affected by the 
competition between Pol δ and either Dna2 or Rad27 
for PCNA. 
It could be the case, that an excess of Dna2 or Rad27, both of which associate 
physically with PCNA (Gomes and Burgers, 2000; Krogan et al., 2006; 
Levikova and Cejka, 2015), inhibits BIR by competitive displacement of the 
Pol32 subunit of Pol δ from PCNA. Earlier, John R. Lydeard et al. have 
observed an almost two-fold decrease in BIR repair upon the removal of the 
PCNA-interacting domain of Pol32, indicating the importance of Pol32-PCNA 
interaction for BIR (Lydeard et al., 2007). Meanwhile, another group has 
discovered that pcna-90 and pcna-79 mutants, in which the PCNA protein is 
defective for the interaction with Pol32 and the other two subunits of Pol δ, 
respectively, result in lower DNA polymerization processivity when combined 
with Pol δ  in vitro compared to the combination of WT PCNA and Pol δ 
(Johansson, Garg and Burgers, 2004).  
4.10.3. Okazaki-fragment flaps might serve as recruitment 
pads for BIR-promoting factors  
The parallels between the effects exerted on BIR efficiency in WT and pif1-m2 
cells by dna2ΔN(1-248) and rad27Δ as well as the matching levels of BIR 
inhibition upon overexpression of either DNA2 or RAD27 (see Figure 4.13) 
may indicate that the two proteins share a common function in BIR. More to 
the point, the two proteins have been co-immunoprecipitated (Budd and 
Campbell, 1997), although their direct physical interaction has been 
questioned, since the attempts to reconstitute Dna2-Rad27 complex in vitro 
were unsuccessful (Bae and Seo, 2000). Given the lack of any reported 
participation of Rad27 in DNA resection and considering the highly-
documented role of the two proteins in Okazaki fragment metabolism 
(Ayyagari et al., 2003; Zheng and Shen, 2011; Balakrishnan and Bambara, 
2013), it stands to reason to suggest that Okazaki fragment metabolism may 




flaps of Okazaki fragments. Interestingly, Pif1 plays an opposite role in 
Okazaki fragment metabolism promoting the formation of long flaps (Pike et 
al., 2009). It could be the case, that one of the roles of Pif1 in BIR is generation 
of long flaps, which may be somehow involved in BIR, e.g. by recruiting 
proteins participating in the lagging strand synthesis. Accordingly, Rad27 and 
Dna2 might be inhibiting BIR by removal of the flaps along with BIR-promoting 
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